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Background and Aims 
 
Pelvic floor dysfunction (PFD) is a common problem among women, having a big impact 
on their quality of life and imposing a significant burden on society. The association 
between PFD and childbearing is commonly recognised, where the first delivery has 
been shown to have the greatest impact on the pelvic floor. However, the prevalence of 
various PFD symptoms in nulliparous women and associated risk factors are poorly 
described in the literature. Additionally, the role of prepregnancy pathology in postnatal 
PFD has not been investigated. This research aims to comprehensively investigate and 
describe PFD in young nulliparous women, and its correlation with postnatal pathology.
           
Structure and Methods 
 
The 4P-Study (Prevalence and Predictors of Pelvic floor dysfunction in Primps) is a 
prospective study nested within the bigger SCOPE Ireland study (Screening for 
Pregnancy Endpoints). It was performed in Cork University Maternity Hospital (CUMH), 
having approximately 9000 deliveries per annum, with approximately 40% being 
primiparous women. This study consisted of two phases. Initially all recruited 
nulliparous women (N=1484) completed the validated Australian Pelvic Floor 
Questionnaire at 15 weeks’ gestation, at the time of recruitment to the SCOPE study and 
repeatedly at one year postnatally (N=872). The questionnaire contained 4 sections 
with questions about urinary, faecal, prolapse and sexual dysfunction. In the second 
phase, which was performed at least one year postnatally, all women who did not have a 
second child and accepted the invitation (N=202), attended the clinical follow up 
including: pelvic organ prolapse quantification (POP-Q), 3D-Transperineal ultrasound 
scan (3D-TpUS) and collagen level assessment. 
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Results 
 
A high prevalence of various types of PFD in nulliparous women was found. Urinary 
dysfunction (UD) was present in 61% of participants, faecal dysfunction (FD) in 41%, 
pelvic organ prolapse (POP) in 5% and sexual dysfunction (SD) in 41%. In 35% of 
affected participants, symptoms were associated with bothersomeness and at least 25% 
of all symptomatic women graded their PFD symptoms as severe. The majority of 
participants (58%) reported more than one type of PFD. 
 
One year postnatally PFD had the following prevalence structure: UD- 73%, FD - 49%, 
POP - 14% and SD - 58%. More than half of total PFD were cases of prepregnancy PFD 
persisting postnatally. Multicompartment involvement was present in 71% of affected 
participants. Severe and bothersome symptoms were more common in participants 
with persistent PFD compared to Denovo pathology. Severity of prepregnancy PFD 
worsened in<15% cases postnatally.  
 
POP had a high prevalence on POP-Q examination at one year postpartum: uterine 
prolapse-89%, cystocele-90%, rectocele-70%, up to 65% having grade two on POP-Q 
staging. The majority had multi-compartment involvement but 80% were 
asymptomatic. In the univariate analysis significant associations were found between 
POP and joint hypermobility, vertebral hernia, varicose veins, asthma and high collagen 
type III levels (p<0.05), confirming the role of congenital predisposition. In the 
multivariate analysis levator ani muscle (LAM) avulsion was only significant in selected 
cases (p<0.05). Caesarean Section (CS) was significantly protective against cystocele 
and rectocele, but not for uterine prolapse. 
16 
 
Clinically significant POP (POP-Q staging grade ≥ 2) had a high prevalence: uterine 
prolapse-63%, cystocele-42%, rectocele-23%. On 3D-TpUS ballooning of the LAM hiatus 
was detected in 33.2% and LAM avulsion in 29% of participants, with partial LAM 
avulsion in 22% and complete in 14%, bilateral avulsion being most prevalent. 
Postnatal POP symptoms were positively associated with similar prepregnancy 
symptoms (odds ratio (OR) 7.2, 95% confidence interval [CI] 1.19-44.33), LAM avulsion 
(OR 4.9 [1.44-16.97]), forceps delivery (OR 1.8 [0.96-3.25]) and negatively associated 
with CS (OR-0.2 [0.09-0.63]). LAM abnormality was associated with forceps delivery 
(OR 4.9 [1.44-16.97]) cystocele (OR 11.7[1.73-78.51]) and uterine prolapse (OR 6.8 
[2.34-20.01]), whereas collagen levels did not play a role OR 1.01 [0.99-1.02]. 
 
Conclusion 
 
PFD is very common in nulliparous women, with approximately one third having 
clinically significant symptoms. The majority of affected participants had more than one 
type of PFD.  
 
It would seem that clinically significant changes to the pelvic floor occur in the majority 
of affected patients before the first pregnancy. However the first pregnancy and birth do 
not worsen prepregnancy PFD in the majority of cases. Childbearing appears to affect 
the preexisting symptoms of urgency and urge incontinence more than the symptom of 
stress urinary incontinence. CS seems to be more protective against postnatal 
deterioration of prepregnancy PFD compared to Denovo postnatal pathology. However, 
larger studies are needed to confirm these findings. 
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Mild to moderate POP has a very high prevalence in relatively young primiparous 
women. There is a significant association between POP, collagen levels, history of 
collagen disease and childbirth related pelvic floor trauma. These findings support a 
congenital contribution to the aetiology of POP, especially for uterine prolapse. 
However, pelvic trauma seems to be the risk factor with the greatest impact. CS is 
significantly protective against cystocele and rectocele only, with no effect on uterine 
prolapse.   
 
LAM avulsion was present in one third of participants, being associated with POP and 
symptoms related to it. Congenital factors seem to play little role in the aetiology of 
levator muscle trauma, with forceps delivery being the main risk factor. Avoidance of 
difficult vaginal deliveries may prevent severe pelvic floor trauma.  
 
This research could be a useful guide for power calculation and study design of future 
studies on PFD in nulliparous women and may provide a pre-pregnancy guide that 
could influence delivery options in “at risk” nulliparous women. 
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Thesis background: 
 
This study consisted of two phases. Initially the present project was commenced as an 
MD thesis, with the aim to investigate pelvic floor dysfunction (PFD) in nulliparous 
women before their first pregnancy and at 1 year postnatally. The project was called 
“The 4P-Study” (Prevalence and Predictors of Pelvic floor dysfunction in Primips). It 
was designed as an opportunistic prospective study, based on the cohort of participants 
enrolled in the parent SCOPE study (Screening for Pregnancy Endpoints). The SCOPE 
study is an international, prospective, multicentre cohort with the main aim of 
developing screening tests to predict preeclampsia, small for gestational age infants, 
and spontaneous preterm birth, which was performed on nulliparous women. There 
have been more than 50 publications based on the SCOPE project to date. 
Initially the 4P-Study was conceptualised as a questionnaire-based study using the 
Australian Pelvic Floor Questionnaire, comprehensively covering all types of PFD. The 
participants had to complete the questionnaires in early pregnancy and at 1 year 
postnatally. However, at a later stage it was decided that the initial data were very 
interesting and novel and as a result this project was extended to include a second 
phase – the clinical follow up of recruited participants who completed both 
questionnaires. Accordingly, the MD thesis was upgraded by University College Cork 
(UCC) to a PhD thesis. 
 
Thesis format: 
 
This is a publication based thesis with eight chapters.  
Chapter 1 Introduction: includes background information explaining the concept of 
pelvic floor dysfunction (PFD), focusing on its types and prevalence, burden to society, 
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causative factors and methods of investigation. This is followed by a review of the 
existing literature on female PFD and associated ultrasonographic and collagen changes, 
and concludes with the overall objectives and hypotheses for the present research 
project. 
 
 Chapter 2 Methods: provides a detailed description of the methods used and statistical 
analyses performed.  
 
The next four chapters were prepared for submission to peer reviewed journals and 
were all published. These papers investigated various aspects of PFD in nulliparous 
women and the impact of first pregnancy and delivery on postnatal PFD. 
 
Chapter 3 (Paper 1): An insight into the pelvic floor status of nulliparous women 
 
Chapter 4 (Paper 2): The role of prepregnancy PFD in the postnatal pelvic floor                           
morbidity of primiparous women  
 
Chapter 5 (Paper 3): Prevalence, aetiology and risk factors of pelvic organ prolapse in 
premenopausal primiparous women 
 
Chapter 6 (Paper 4): The status of the pelvic floor in young primiparous women 
 
Chapters 7 & 8: Discussion and conclusion of the overall thesis including directions for 
future research. 
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The publication-based format was chosen for the following reasons: 
 Although the four papers were based on data from the SCOPE study, the final 
cohort for different papers varied and thus the inclusion/exclusion criteria were 
not the same for all five papers 
 All papers focused on different aspects of PFD, such as questionnaire-based 
description of symptoms, objective clinical and ultrasound assessment or 
laboratory assessed collagen levels 
 
 
Thesis contributions: 
 
Constantin Durnea reviewed the existing literature under the supervision of Dr. Barry 
O’Reilly (Consultant urogynaecologist at Cork University Maternity Hospital [CUMH]); 
 Professor Louise Kenny (Consultant Obstetrician and Gynaecologist at CUMH) and Dr. 
Ali Khashan (PhD) (senior lecturer at the Department of Epidemiology and Public 
Health, UCC). In addition, all four participated in the study design, data revision and 
preparation of manuscripts for publication including writing and revision for important 
intellectual content. 
 
The initial statistical analysis was performed by Constantin Durnea under supervision 
and guidance of Dr. Ali Khashan. The initial analysis verification and complex 
multivariate analyses models were performed by Dr. Khashan.   
 
The initial recruitment of participants and collection of initial prepregnancy completed 
Australian Pelvic Floor Questionnaire was performed by the SCOPE midwives during 
each booking visit. The postnatal questionnaires were prepared, mailed and collected 
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by Constantin Durnea. Letter preparation and mailing was partly performed by final 
year medical students Vanessa Karlson, Sabina Tabirca and Maeve Smyth, whose final 
year projects were based on the same dataset and were supervised in part by 
Constantin Durnea. The data from the questionnaires were added to the database, and 
analysed by Constantin Durnea. The participants’ recruitment for the clinical follow up 
study, management of clinical appointments, and securing of required facilities and 
chaperone persons was carried out by Constantin Durnea.  
 
The clinical follow up study including: clinical assessment of pelvic organ prolapse 
(POP) using the pelvic organ prolapse quantification (POP-Q) system, joint 
hypermobility assessment, transperineal ultrasound scan, blood sample collection for 
the collagen test and pre-ELISA processing of the sample were all performed by 
Constantin Durnea. To ensure an optimal quality of POP-Q assessment – a training 
workshop was attended in Lisbon, Portugal, at the International Urogynecology Annual 
(IUGA) meeting.  Additionally, the POP-Q quality control was verified and assured by Dr. 
Barry O’Reilly.  
 
The 2-D, 3-D and 4-D transperineal ultrasound scan image acquisition and analysis 
were performed by Constantin Durnea. To ensure an optimal quality of transperineal 
ultrasound scan image acquisition – a training workshop was attended at the same 
IUGA meeting, which was hosted by Professor H.P. Dietz, consultant urogynaecologist at 
Sydney Medical School Nepean, University of Sydney, Australia. Professor Dietz is a 
leading specialist in the area who developed and validated a number of transperineal 
scan methodologies. A repeated workshop, hosted by the same specialist, was attended 
at CUMH, Cork, Ireland. As part of the second workshop, training involved a one-to-one 
practical teaching session with multiple patients. Some images acquired within the 
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project were shared with Professor Dietz via Dropbox, in order to ensure an adequate 
quality control of image acquisition and analysis. Additionally, Professor Dietz co-
authored the fourth article entitled “The status of the pelvic floor in young primiparous 
women”. 
 
The ELISA test was performed by Constantin Durnea under direct supervision and 
guidance of Dr. Lynne Kelly (PhD), research bioscientist at UCC. Dr. Kelly has extensive 
experience in performing ELISA tests. All the work was done in the Anu Research Centre 
laboratory, where a large number of ELISA tests were performed within the parent 
SCOPE study. All dilutions and standard set up was done by Dr. Kelly. 
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CHAPTER 1:  Introduction 
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1.1   Introduction – background 
 
1.1.1   Pelvic floor dysfunction definition 
 
Pelvic Floor Dysfunction (PFD) is defined as presence of symptoms of urinary 
incontinence (UI), faecal incontinence (FI), pelvic organ prolapse (POP), sensory or 
emptying abnormalities of the lower urinary tract, defaecation  dysfunction, sexual 
dysfunction and chronic pain syndromes, which can present separately or coexist1. 
Vaginal delivery has been repeatedly mentioned as one of the main contributing 
factors2-5. 
 
1.1.2   Prevalence overview 
 
In the general population, 1 in 3 women suffer from UI compared to 1 in 25 men, 
whereas this rate rises to 1 in 2 women after the age of 70. UI in women occurs 
regardless of childbearing, however in those who have been pregnant and have given 
birth this rate is much higher compared to those who were never pregnant6. Similarly, 
FI has a female to male ratio of 8:1 and is present in up to 10% of women who have 
given birth7. POP is an exclusively female problem and is seen in more than 40% of 
those aged between 50 and 75 years old8. The lifetime risk of undergoing an operation 
for prolapse is 11% and every 3rd woman will need at least one reoperation because of 
failed treatment9.  
 
1.1.3   Aetiology of PFD 
 
There is a large body of original research demonstrating that vaginal delivery or even an 
attempt at it can cause urinary and faecal incontinence, as well as prolapse by damaging 
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pelvic muscles, nerves and supporting tissue. Risk factors associated with such damage 
have been defined and include forceps delivery, long duration of labour, and big babies 
(>4kg)10-12. On the other hand, it is much less clear whether such trauma is the cause or 
triggering factor leading to PFD and how important it is in the occurrence of pelvic floor 
morbidity later in life13. There is some evidence that postnatal PFD develops on the 
background of preexisting prepregnancy disease. Childbearing carries a risk ≤1% of 
contributing to  persistent postnatal UI, with  intrapartum risk factors having an 
uncertain role for long-term postnatal pelvic pathology14. 
 
There are different explanations of mechanisms and causative factors leading to PFD. 
One of the theories involves mechanical trauma during delivery and its effect on pelvic 
organ support, which has been extensively investigated using transperineal ultrasound 
scans15-16. Another hypothesis suggests that POP and incontinence can be explained by a 
congenital predisposition mediated via collagen abnormalities. Thus, intrinsic 
congenital pelvic weakness is the cause of PFD rather than childbearing trauma. 
Collagen is a large molecule, of which there are five major types. Collagen type I and III 
are most commonly found in ligaments, skin and bones, constituting the backbone of 
these structures. The former is offering strength to the structure, whereas the latter 
offers elasticity, depending on the predominant type of collagen in each tissue.  
 
It has been demonstrated that patients with POP have a low level of general collagen in 
the pelvic fascial/ligamental tissue and a higher level of particularly collagen type III. 
This leads to imbalance between different types of collagen and specifically abnormal 
collagen I to III ratios17-22. Collagen abnormality seems to have a systemic clinical 
manifestation, about 50% of patients with recurrent pelvic prolapse having increased 
joint mobility17, 19.  
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However the majority of the studies underpinning the above hypothesises fail to fully 
elucidate the real causative factors leading to PFD after childbirth as they are not linked 
to the patient’s prepregnancy status, do not take into account risk factors present in 
labour and delivery and do not involve long term postnatal follow up to exclude those 
patients with transitory postnatal symptoms. 
 
1.1.4   Diagnosis of PFD 
 
 
PFD - Questionnaires 
 
 
There are different tools to diagnose and assess the severity of PFD. The functional 
status and severity of symptoms are investigated using various PFD questionnaires. The 
validated questionnaires play a distinctive role, assuring that obtained data are reliable, 
quantifiable, and reproducible. There are questionnaires investigating severity of 
symptoms and the impact on Quality of Life (QoL), e.g. International Consultation on 
Incontinence Questionnaire (ICIQ)23 investigating UI or Wexner Score24 for FI.  Other 
questionnaires are investigating symptoms only – such as the Urogenital Distress 
Inventory (UDI-6)25 and The Female Sexual Function Index (FSFI)26, or QoL only such as 
the Incontinence Impact Questionnaire (IIQ-7)25 and the Faecal Incontinence Quality of 
Life Scale27. QoL questionnaires can be either disease specific, as described previously 
or generic e.g. SF-36 (The Short Form (36) Health Survey - a patient-reported survey of 
patient health). Questionnaires investigating PFD symptoms can be focused on a single 
type of dysfunction or specific combinations of them such as urinary dysfunction (UD), 
faecal dysfunction (FD), POP or SD. There are very few questionnaires assessing 
comprehensively all four types of PFD along with the grade of bothersomeness 
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experienced by patients such as the Australian Pelvic Floor Questionnaire28 or the 
Epidemiology of Prolapse and Incontinence Questionnaire (EPIQ)29.  
  
 POP - Classification systems 
 
Quantification of POP is another aspect of PFD assessment. Different classifications have 
been proposed to measure the grade of POP. The most commonly used are the Baden-
Walker, Shaw and the Pelvic Organ Prolapse Quantification (POP-Q) Systems. Each has 
different grading and landmarks. The most comprehensive and commonly accepted 
system nowadays is POP-Q30. It consists of eight landmark points and four identical 
grades of prolapse for each compartment. It requires a measurement ruler and a Sim’s 
speculum. This is an objective way to quantify POP and has an excellent inter-observer 
reliability, with a kappa value of 0.88 for overall stage31, 0.89 for the anterior and 0.86 
for the posterior vaginal walls, 0.82 for the apex/cuff, and 0.72 for the cervix32 .  
 
PFD - Ultrasound changes 
 
PFD is often associated with morphological changes in the pelvic anatomy. Initially 
Magnetic Resonance Imaging (MRI) showed promise as a sensitive tool for the detection 
of anatomical disruption in patients with PFD33 however, it remains an expensive 
modality. In the recent decade there has been increasing interest in transvaginal34 and 
transperineal ultrasound scans35. The 3D transperineal ultrasound scan (3D-TpUS) is 
the most versatile diagnostic tool in evaluation of PFD, being easily accessible and very 
cost-effective. It can visualise and quantify various types of POP15, bladder neck 
mobility13, 36-39, anal sphincter injury40, levator ani muscle (LAM) trauma13, 41 and 
identify LAM hiatal area abnormalities 13, 42-45. 
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PFD - Collagen abnormalities  
 
One of the main modalities to assess the congenital predisposition to PFD is 
investigation of collagen abnormalities and collagen associated diseases. Different 
methodologies have been proposed to evaluate matrix metalloproteinase and collagen 
quantitative and qualitative changes. Initially, biopsies from sacrouterine ligaments or 
paraurethral tissue were taken with subsequent homogenisation and 
immunofluorescent analysis17. Later on equilibrium radioimmunoassay and ELISA test 
methodology were proposed to detect the concentration and correlation of different 
procollagen proteins in serum46. This investigation resembles the idea of detecting C-
peptide in order to quantify insulin production. 
 
1.1.5   Clinical manifestations of PFD  
 
Urinary Dysfunction 
 
Between 17% and 45% of adult women suffer from UI6. Although vaginal delivery plays 
a crucial role in the aetiology of UD, it is a recognised finding in nulliparous women as 
well as in primiparous women post CS12,47. Buchsbaum et al. reported that the rates of 
stress urinary incontinence (SUI) and urge urinary incontinence (UUI) were similar in 
nulliparous and multiparous postmenopausal women48. This is probably age related as 
well as a possible congenital predisposition. Additionally, Denovo UI is not a common 
postnatal finding without prior antenatal symptoms 49-51. The role of obstetric factors 
seems to be transient and is of uncertain aetiologic significance three months 
postpartum14. 
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Faecal Dysfunction 
 
The reported prevalence of FI including flatus incontinence varies between 2-24%, 
whereas FI excluding flatus incontinence is 0.4-18 %52. The American NHANES study 
reported a prevalence of 8.3% of FI in non-institutionalized US adults, which consisted 
of 6.2% liquid stool, 1.6% solid stool and 3.1% mucus53. There is an obvious logical 
association between instrumental vaginal delivery and postnatal FI due to traumatic 
anal sphincter disruption. However, such a link is not so evident for other types of 
bowel dysfunction. It has been demonstrated, for instance, that 12% of young 
nulliparous women have signs of rectocele with disruption of septal integrity on 3D 
transperineal ultrasound scan. The authors concluded that the problem could be 
congenitally determined54.  
 
Pelvic organ prolapse 
The Women's Health Initiative - one of the biggest studies investigating POP in the 
general population, reported the following rates of POP: uterine prolapse - 14.2%; 
cystocele - 34.3% and rectocele - 18.6%8. However, one of the biggest limitations of this 
study is the fact that it had not used the POP-Q classification system for assessment, 
which is considered the gold standard. On the other hand Swift et al. noticed that in 
some epidemiological studies POP grade I to II is detected in up to 90% of women on 
POP-Q assessment and questioned how clinically relevant this classification is55. POP is 
reasonably associated with parity and advanced age, because it is more common in 
these categories of women8, where the main risk factors include vaginal delivery, high 
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infant birth weight and BMI56. However, it has been demonstrated that various types of 
POP can be present in women at all ages and parities57.  
 
Sexual dysfunction 
SD is another aspect of PFD, which is becoming an important focus in the 
urogynaecological research field. The available data on SD have reported a prevalence 
of up to 50% of SD in women attending urogynaecological services. It has been shown 
that the major symptom is dyspareunia and sexual symptoms are associated with UD in 
26-47% of the population studied58.  Although SD is highly prevalent in women 
attending urogynaecological services, only a minority of urogynaecologists screen all 
patients for this type of dysfunction59.  
Information about the prevalence of SD in the general population is sparse, with the 
majority of studies focusing on impaired sexual function associated with various 
medical conditions (e.g. diabetes mellitus, neurologic diseases etc.). MacLennan et al. 
investigated various aspects of PFD in 1546 participants and reported a prevalence of 
dyspareunia of 3.9% and vaginal laxity of 5.2%6. Another study investigating SD in a 
relatively young sexually active population reported the following prevalences: SD - 
37.6%, low desire - 23.6%, arousal disorder - 25.4%, lubrication disorder - 36.8%, 
orgasm disorder - 30.6% and dyspareunia - 21.8% in urban Chinese women60. The 
difference in prevalence of dyspareunia probably can be explained by use of different 
questionnaires and differences in participant’s age groups. While the first study 
contained generic questions regarding PFD with answer options yes or no (no severity 
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grading was present), the latter used Female Sexual Function Index (FSFI) which is 
specifically designed to detect and score symptoms of SD. 
 
1.1.6   The impact of PFD on quality of life and burden to society 
 
PFD has an immense impact on a woman’s psychological well-being and QoL. A series of 
studies have shown that feelings of helplessness, sadness, depression, general health 
anxiety, SD and even self-harm are more common in women with UI61-62. 75% of 
patients with UI are bothered by their symptoms, and 30% of this disturbance is 
reported to be moderate to severe. More than half of the patients reporting bothersome 
disturbance feel that the symptoms have a negative impact on their physical and social 
activity and self-confidence63. In addition to the QoL impairment, PFD is a burden to 
society. The total cost of overactive bladder (OAB) to the United Kingdom (UK) health 
care system was estimated at £750 million in 2000 and forecasted to approach the 
figure of £1 billion. by 202064.  The annual cost-of-illness estimated for UUI in Canada, 
Germany, Italy, Spain, Sweden, and the UK was €7 billion in 200565. The life time 
medical cost for patients with SUI is 80% higher compared to those without 
incontinence66.  Considering all these, there has been increased public and professional 
attention recently, focused on PFD following childbirth and these symptoms are 
sometimes being cited as indications for elective Caesarean section (CS).  
 
1.2   Literature review 
 
1.2.1   Literature review aims 
 
The aim of the literature review is to assess how relevant pregnancy and delivery are in 
the aetiology of PFD. Childbearing may just trigger the development of PFD in someone 
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with a congenital predisposition. The best way to test this hypothesis is to compare 
prepregnancy and postnatal pelvic floor status in women embarking on their first 
pregnancy.  
 
1.2.2   Literature review methods 
 
Search strategy 
 
The literature review search was performed using two electronic databases (MEDLINE 
from 1966 and The Cochrane Library from 1993). Three search strategies were used for 
each search. Initially the search was conducted using all studies which included any of 
the search terms, secondly followed by the ‘OR’ operator and finally the last step 
included the ‘AND’ operator following the principles of Boolean logic. The relevance of 
the studies was determined by screening the titles and abstracts. Additionally, reference 
lists of searched papers were screened for further relevant studies. 
 
Search 1: Studies investigating symptoms of PFD in nulliparous/primiparous women 
 
As described earlier, this project has had two phases: 1) the initial questionnaire-based 
epidemiological phase; 2) the objective assessment of participants. The literature 
review search also consisted of two stages. Initially, in 2010, a search was performed for 
epidemiological studies investigating symptoms of PFD in nulliparous/primiparous 
women and the impact of first pregnancy and delivery on them. The following search 
words and truncations were used: nulliparous, nulliparas, nullip*,  primiparous, primip*, 
pelvic floor dysfunction, PFD, urinary *, urinary dysfunction, urinary incontinence, urinary 
frequency,  fecal (Latin spelling) dysfunction, faecal (Greek spelling) dysfunction,  fecal 
frequency,  faecal frequency,  fecal incontinence, faecal incontinence, fecal urgency, faecal 
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urgency, sexual dysfunction, dyspareunia, pelvic organ prolapse, POP, cystocele, rectocele, 
uterine prolapse, risk factors, RF, RFs, pre-pregnancy, pre-pregnancy, before pregnancy, 
antenatal, pregnancy, in pregnancy, during pregnancy, postnatally, post-natally, 
postnatal, 1 year, 12 months, prevalence, mode of delivery, MOD, instrumental delivery, 
forceps, vacuum, 3rd  degree tear, third degree tear, 4th degree tear, fourth degree tear, 
perineal tear. 
 
Search 2: Studies investigating the role of collagen changes in the development of PFD 
and POP; prevalence and risk factors for POP and transperineal ultrasonographic 
methodology and changes after the index delivery (first birth) 
 
Another literature search using the same search strategies as previously was performed 
in 2012 after the extension of the initial project. The second literature review 
investigated the role of collagen changes in the development of PFD and POP, the 
prevalence and risk factors for POP and the transperineal ultrasonographic 
methodology and changes after first delivery. The following search words were used: 
collagen, pro-collagen, procollagen, collagen type I, collagen type III, collagen type 1, 
collagen type 3,prolapse, pelvic organ prolapse, POP, cystocele, rectocele, uterine prolapse, 
transperineal scan, perineal scan, 2D transperineal scan, 2D perineal scan, 3D 
transperineal scan, 3D perineal scan, 4D transperineal scan, 4D perineal scan, labial scan, 
translabial scan, levator ani muscle avulsion, LAM avulsion, levator ani muscle trauma, 
LAM trauma, levator hiatus ballooning, levator hiatus distension. 
 
Eligibility Criteria 
 
The following criteria were taken into account when the results of the different studies 
were compared: 1) whether the presented data reported specifically nulliparous and 
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primiparous women 2) whether potential confounders were adjusted for 3) whether a 
significant association was reported 
 
1.2.3   Literature review results 
 
1.2.3.1   Prepregnancy and postnatal PFD in nulliparous women 
 
There is little research regarding PFD in nulliparous women with the majority of studies 
describing only the prevalence of particular symptoms. Although the postnatal aspect of 
PFD is slightly better elucidated, there are no studies to date linking prepregnancy and 
postnatal PFD in primiparous women. For this reason, in addition to reviewing studies 
on nulliparous /primiparous women, general data (unrelated to parity) on PFD were 
also analysed, in order to set up a reference point. The majority of studies focussed on a 
single type of PFD. However, occasionally studies investigated multiple dysfunctions6, 
which pointed out that women with one type of dysfunction are highly likely to suffer 
simultaneously from multiple PFDs67. Studies investigating PFD symptoms in 
nulliparous and primiparous women are reviewed in Table A-1.1 (Appendix I). 
 
1.2.3.2   Urinary dysfunction 
 
The biggest study investigating UI in nulliparous women is the Swedish EPINCONT 
study (27,900 participants). It reported a prevalence of UI ranging from  8% to 32% and 
increasing with age68. The lowest prevalence of UI – 6.5% was reported by the NHANES 
study, investigating UD, FD and POP in different age and parity groups69. In contrast to a 
previous study investigating all UI, the latter recorded only moderate and severe UI. 
There is some evidence that UI in sexually active nulliparous users of the combined oral 
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contraceptive pill (COCP) can be higher (21.5%) compared to the background 
population (12.6%)70. There are transitory postnatal PFDs, which can persist up to 6 
months postnatally or even longer71. That is why prevalence reported earlier in the 
postpartum period may appear higher. At 12 months after delivery a prevalence of 
25.9% for SUI and 8.2% for UUI was reported in primiparous women72-73. CS was only 
partially protective against UI in primips, with up to 22.9% reporting UI at six months 
after the operation74-75.   
 
Several prospective studies investigating the correlation between prepregnancy 
prevalence of UI and antenatal UI have been identified. Brown et al. reported a 5-fold 
higher incidence of UI in the 3rd trimester of pregnancy than the prepregnancy 
prevalence76. Similarly there are prospective studies correlating Denovo UI during the 
first pregnancy and postnatal pathology72, 77-78. However, only one study was identified 
correlating prepregnancy and postnatal pathology in nulliparous women79. It 
demonstrated that prepregnancy UI is an independent risk factor for postnatal UI at 9 
months postpartum. However, no studies have been found looking at the prepregnancy 
and postnatal correlation of PFD symptoms other than UI in primiparous women. 
 
1.2.3.3   Faecal dysfunction 
 
There are very few publications describing FD in nulliparous women. The reported 
prevalence of FI in nulliparous women in identified studies varied between 6.3% and 
7.7%69, 80. The reported prevalence in primiparous women, ranged between 4.0% and 
8.8%69, 72-73, 81. A single article reported the postnatal prevalence in primiparous women 
of flatal incontinence at 12%, liquid stool incontinence – 3.2% and solid stool 
incontinence – 1.1%73. FD seems to have a congenital predisposition. One study 
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investigated the association between parity and mode of delivery with symptoms of 
obstructed defaecation. It has been demonstrated, that the prevalence of rectocele, 
enterocele, intussusception and anismus leading to obstructed defaecation syndrome is 
not statistically different between nulliparous women, those post vaginal delivery and 
post CS82. There is a paucity of studies describing FD, particularly in young nulliparous 
women. No studies could be identified exploring the role of prepregnancy FD in 
postnatal morbidity. 
 
1.2.3.4   Pelvic organ prolapse 
 
The reported prevalence of prolapse in the general population is quite varied. For 
instance, the prevalence of cystocele has been reported to be between 34% and 90%8, 55. 
This is due to the use of different classification systems and grades of symptoms 
severity. For the same reason, H.P. Dietz proposed considering cystocele and rectocele 
grade I as part of the normal range83. This is confirmed by another study performed in 
young nulliparous women who were students of a US Military Academy, where 
asymptomatic prolapse stage I or II was diagnosed in 50% of participants, in the 
absence of any obvious risk factors84. The NHANES study reported a prevalence of 0.6% 
of moderate to severe prolapse in nulliparous women69.  
 
Congenital predisposition seems to play an important role in the aetiology of POP. 
When compared nulliparous women with their parous sisters there was a high 
concordance in prolapse stage within sister pairs (74.3% to 91.1% by compartment), 
with vaginal delivery offering slightly higher risk85. An even higher degree of 
concordance of continence and pelvic support status was demonstrated on sets of 
parous/nulliparous identical twins, regardless of differences in mode of delivery86. 
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Nevertheless, POP in nulliparous women remains an under investigated area, since 
there are no studies to date examining the prevalence of prolapse symptoms and their 
correlation with prolapse grade and postnatal pathology. 
 
1.2.3.5   Sexual dysfunction 
 
The reported combined prevalence for different symptoms of SD in the general 
population varies between 0.6-64%87. The same data for nulliparous women or after 
first delivery are not available. The most common symptom of SD is dyspareunia with a 
reported prevalence of 4.7%88. Bellelis et al. showed that dyspareunia is present in 55% 
of patients with endometriosis, which is more common in nulliparous women (55% of 
those affected)89. Coital incontinence has a reported prevalence of 2% in community 
based studies and 10-56% in clinical settings87. It has been demonstrated that it has a 
strong association with SUI and to a lesser extent with OAB90. About 80% of women 
having vaginal delivery reported vaginal laxity at 24 months postpartum. However 
when compared to CS, vaginal delivery did not have a statistically significant impact on 
SD91. In general, pregnancy and delivery does not seem to have a long term consequence 
on sexual function92. At 6 months postpartum 90% of women resumed having 
intercourse, of which 17% reported dyspareunia, with less than 5% describing it as 
severe and 61% of women reporting orgasm. Delivery mode and episiotomy were not 
associated with intercourse resumption or anorgasmia before pregnancy93. 
However, no studies specifically investigated SD in nulliparous women, and correlation 
of these symptoms with postnatal pathology.  The majority of studies investigating the 
impact of childbearing on postnatal SD have been focussed on prenatal versus postnatal 
sexual satisfaction or comparison of SD following different modes of delivery94.  
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1.2.3.6   Risk factors for PFD 
 
Age, obesity, chronic bronchitis, multiparity and hereditary diseases suggestive of 
collagen disorders are common risk factors for UD, FD and POP67. Furthermore, women 
suffering from one type of dysfunction are likely to have other types in addition. UI after 
the first pregnancy was demonstrated to be related to antenatal SUI, prolonged labour 
in combination with operative vaginal birth 49, 77, use of oxytocin in labour and foetal 
weight > 4kg 10. Other recognised risk factors are family history of similar conditions, 
multiple urinary tract infections11and depression95.    
 
Postnatal FI has been reported to be associated in primiparous women with a new 
onset of FI during pregnancy, positive family history and vaginal delivery72-73. In 
addition, CS does not seem to be completely protective against FI in primiparous 
women72, 74.  Other reported risk factors associated with FI are age, menopause, obesity, 
parity, and associated SUI, whereas elective CS in one study seemed to be totally 
protective against FI96.  Age seems to play a bigger role in the aetiology of FI than 
childbearing, whereas chronic diarrhoea appears to be a strong modifiable risk factor 
that may form the basis for prevention and treatment53, 97. 
The associated risk factors to POP are foetal birthweight, abdominal hernia surgery and 
chronic pulmonary disease, e.g. asthma.  However, POP being associated with parity, 
was not associated with instrumental and preterm deliveries. Familial history of POP is 
present in approximately 30% of women with prolapse98. While vaginal delivery is 
considered to be a risk factor for POP, there is some evidence that it does not cause 
advanced prolapse beyond the hymen, for which the menopausal change is to be 
blamed99.   
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Sexual function seems to be minimally impacted by childbearing. Sexual satisfaction 
does not appear to be associated with antenatal and intrapartum factors, with sexual 
dissatisfaction at 1 year postpartum being related only to sexual activity in early 
pregnancy94. Dyspareunia in the general population is associated with early sexual 
debut, primary level of education, and membership of minority ethnic communities88. 
Postnatal dyspareunia at 12 weeks postpartum was associated only with breast-feeding. 
Sexual function was described as similar to prepregnancy or improved after 
pregnancy93. Sexual function does not significantly differ at 12-18 months postnatally 
between women who had vaginal delivery without episiotomy, heavy perineal 
laceration, or secondary operative interventions and women having elective CS92. 
 
1.2.3.7   Transperineal ultrasound scan investigation of PFD 
 
Despite the fact that TpUS is a relatively new methodology in the investigation of pelvic 
floor morphology and PFD, it is already well positioned among other imaging methods, 
having good correlation with the “gold standard” - MRI investigation100. There are many 
publications describing different methodologies investigating various aspects of pelvic 
floor anatomy. Many of them have been retested in order to confirm their intra and 
inter observer repeatability and reliability. The studies investigating PFD using TpUS 
are summarised and reviewed in Table A-1.2 (Appendix I). The 2D-TpUS has been 
successfully used for ultrasound quantification of POP. A bladder on transperineal scan 
to ≥10 mm and of the rectum to ≥15 mm below the symphysis pubis has been shown to 
be strongly associated with presence of symptoms42. 3D-TpUS can be reliably used for 
identification of LAM trauma. It has been demonstrated that a levator-urethral gap of 
>25mm on tomographic ultrasound imaging (TUI) mode correlates with LAM 
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avulsion101 and abnormality specifically in three central slices can reliably distinguish a 
complete from a partial avulsion102. A distension of the levator hiatal area>25cm2 is 
considered abnormal, being called “ballooning” and is associated with LAM avulsion45. 
The 3D- TpUS can be used for measurement of the subpubic arch angle, which may have 
an impact on vaginal delivery outcome103. The reliability of these scanning methods has 
been repeatedly retested and reconfirmed104-105.  
 
The prevalence of LAM avulsion is virtually non-existent in nulliparous women and has 
been reported in 12-36% of primiparous women106. There is evidence that levator 
defect after vaginal delivery is more than seven times higher than after CS, however, 
emergency CS is not completely protective107. LAM avulsion has been shown to be 
associated with bigger foetal head circumference, long second stage of labour and 
forceps delivery, whereas epidural anaesthesia seemed to be protective41, 108. Although 
there is evidence that sonographic pelvic structures mobility and functional status may 
normalise by six months postnatally13, LAM trauma is considered to persist for life, with 
exceptional cases only being reported to heal109. 
 
 1.2.3.8    Collagen investigation of PFD 
 
There are very few studies to date investigating collagen abnormalities particularly in 
nulliparous women with PFD. The majority of previous studies were targeting the 
general population irrespective of parity, mostly paying attention to the menopausal 
status and associated collagen related diseases. Studies investigating the role of collagen 
abnormality in development of PFD are summarised and reviewed in Table A-1.3 
(Appendix I). The first comprehensive work in this area was done by Jackson who 
investigated vaginal-epithelial tissue in women with genitourinary prolapse18. He 
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demonstrated that POP is associated with a reduction in total collagen content due to 
increased collagenolytic activity, and collagen turnover accordingly, is up to four times 
higher in prolapse tissue.  The next step was investigation of expression of various types 
of collagen in prolapsed tissue. It was demonstrated that expression of collagen type I in 
cardinal ligaments correlates with menopausal status, use of hormone replacement 
therapy (HRT) and age rather than with prolapse110. Conversely collagen type III 
expression was directly related to uterine prolapse, having increased levels in affected 
women. This was confirmed in a later study investigating uterosacral ligaments111. A 
significantly higher concentration of collagen type III in prolapsed tissue was explained 
by its abnormal quality, leading to a weaker collagen molecule and quicker breakdown. 
This explains a higher turnover of this type of collagen and higher expression in affected 
tissues21 and is confirmed by increased levels of matrix metalloproteinases, an enzyme 
involved in collagen’s triple helix degradation112-113.  In contrast, a diminished turnover 
of collagen was reported by Keane et al.20 and Edwal et al.21 in women with UI and no 
POP.  
 
Although it is recognised that collagen synthesis genes expression may be different in 
various tissues, there is evidence that various body hernias are associated with the 
same pattern of abnormal collagen I/III ratio as POP114. Furthermore, it was 
demonstrated that young women (<35 years old) with POP are more likely than older 
women to have an increased prevalence of congenital anomalies, as well as 
rheumatologic and neurologic diseases115. Additionally, patients with POP have a higher 
prevalence of varicose veins, joint hypermobility, rectal prolapse and they are more 
likely to have family members with POP as compared to women without POP.  That is 
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why it was hypothesised that POP and other collagen-associated disorders may have a 
common collagen level based aetiology116.  
 
This hypothesis was explored by Knuuti et al.46, who investigated the correlation among 
POP, benign joint hypermobility and blood serum concentration of PICP (procollagen 
type I carboxyterminal) and PIIINP (procollagen type III aminoterminal) – as markers of 
collagen synthesis. It was demonstrated that recurrent genital prolapse is more 
common in women with joint hypermobility as compared to normal mobility. 
Additionally, plain hypermobility was associated with higher levels of type I collagen, 
whereas a combination of recurrent prolapse and joint hypermobility were associated 
with type III collagen. Although there are no studies to date investigating the correlation 
between collagen assessment in blood serum and urogenital tissue biopsies, the results 
from the latter study showed the same pattern of collagen turnover as previous studies. 
This suggests that the described methodology could be used in future research of 
collagen abnormality in context of POP.  
 
1.2.4   Literature review conclusion  
 1.2.4.1   PFD related symptoms 
 
There is a good body of evidence demonstrating the prevalence and associated risk 
factors of the main PFD symptoms like urinary and faecal incontinence, POP and 
dyspareunia in general population. However, there is little evidence regarding PFD 
symptoms and risk factors in nulliparous women. The available data is very sparse and 
fragmentarily reflects the whole spectrum of PFD. The existing figures on urinary and 
faecal dysfunctions are mostly focussed around the symptoms of urinary and faecal 
incontinence and overactive bladder. Such symptoms as urinary and faecal frequency, 
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obstructed micturition and defaecation, nocturia, flatal incontinence have been 
investigated very occasionally or not at all. Similarly regarding the sexual dysfunction, 
symptoms like vaginal tightness or laxity, vaginal sensation during intercourse, 
differences between the prevalence of superficial and deep dyspareunia are 
understudied or have never been reported in the literature. Furthermore, many of these 
symptoms have not been investigated in nulliparous women and very little is currently 
known about the correlation of these symptoms before and after the first pregnancy. 
 
1.2.4.2   Investigation of PFD using 3D - Transperineal scan  
 
Transperineal ultrasound scan is currently playing an increasing role in the 
investigation of PFD. Various validated methodologies for scanning different pelvic 
structures with their reliability and repeatability confirmed have been established. 
Postnatal morphological pelvic floor changes in primiparous women such as POP, LAM 
avulsion and hiatal area ballooning, as well as their prevalence, have been repeatedly 
reported in the literature. Similarly, the associated anthropometric and intrapartum 
risk factors have been extensively investigated. However, little is known about the role 
of congenital factors and PFD changes present before the first childbearing as risk 
factors for postnatal anatomical abnormalities in the pelvic floor structures. Therefore, 
further research is required to address this gap in the literature to date.  
 
1.2.4.3   Collagen investigation of PFD 
 
In the general population there is a difference in collagen levels between women with 
prolapse and healthy women. Women with POP have a higher turnover of collagen type 
I and especially type III, due to abnormal collagen structure and quicker breakdown. 
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Clinically this is manifested by more fragile tissue, and a predisposition to prolapse 
formation.  Collagen type III, demonstrates much more significant quantitative changes 
in prolapse and is a better marker of POP. Additionally, the change in collagen type I 
levels may be biased by age, menopausal status and use of HRT. 
Collagen abnormality seems to be a systemic issue with simultaneous multiple 
manifestations in different parts of the body. Thus, blood serum investigation of 
collagen turnover appears to be a good alternative to homogenates of tissue biopsy. The 
association between collagen abnormality and PFD in nulliparous women is very poorly 
elucidated in the literature. Although parity and vaginal delivery are considered the 
main risk factors for development of POP, there is a body of evidence demonstrating 
that POP is not an extraordinary finding in nulliparous women. Further research is 
required in this area to elucidate the natural history of POP and elaborate if possible on 
preventive measures. 
 
1.2.5   Directions for future research 
We would recommend that future investigations should cover the following areas: 
 
1.2.5.1   PFD related symptoms 
 
The investigation of nulliparous women before their first pregnancy and after delivery 
would help to elucidate the real impact of childbearing on pelvic floor structures. The 
knowledge of the prevalence of Denovo and persistent PFD in primiparous women and 
the rates of worsening or improvement of persistent symptoms would help to develop 
strategies diminishing morbidity in this group. Additionally, this could help to outline 
the group of asymptomatic nulliparous women who are at risk of postnatal PFD and 
possibly propose some preventive measures. 
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1.2.5.2   Investigation of PFD using 3D - Transperineal scan  
 
Future research ideally should include nulliparous cohorts of women before or in early 
pregnancy and repeatedly postnatally.  This would allow a better elucidation of the real 
impact of first childbearing on PFD. Postnatal ultrasound findings should be correlated 
with presence of prepregnancy symptoms including prolapse changes or ultrasound 
anatomical abnormalities. Studies of collagen association may yield extra information 
explaining the natural history and development POP and LAM trauma.  
 
1.2.5.3   Collagen investigation of PFD 
 
Collagen changes seem to have a widespread manifestation. A systemic approach should 
be implemented in the investigation of patients with POP.  Quantification of POP, using 
the POP-Q scoring system, should be correlated with complex exploration of family 
history of POP, presence of associated collagen related diseases, determination of 
collagen levels and presence of PFD symptoms. Especially this could add to the 
understanding of the natural history of POP, if performed in primiparous women and 
correlated with prepregnancy and intrapartum factors. 
 
1.2.6   Objectives of the present study 
 
There is a paucity of evidence on which to base counselling for individual patients about 
to embark on their first pregnancy with regard to potential PFD. It is unknown whether 
avoidance of potential childbearing related pelvic floor trauma is worth the risk, cost, 
and effort of elective CS. The goal of this study was to: 
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1) Quantify the background prevalence of PFD in nulliparous women and its 
correlation with potential risk factors. 
 
2) Assess the postnatal prevalence of PFD at one year after first delivery and its 
correlation with prenatal pathology and mode of delivery. 
 
3) Confirm postnatal POP related questionnaire findings by objective assessment of 
a cohort of participants at one year postnatally using POP-Q investigation and 
combining this data with information from the SCOPE study demographic data 
bank.  
 
4)  Assess the role of congenital predisposition in the development of PFD by 
investigating the collagen levels in a cohort of participants who participated in 
the objective assessment follow-up study. The goal of this sub-study is to test the 
hypothesis suggesting that high levels of collagen type III (conferring elasticity) 
is a putative cause of POP.  
 
5) Investigate the postnatal prevalence of anatomical changes in pelvic floor 
anatomy after 1 year postnatally using 4D - TpUS. To correlate the presence of 
postnatal symptoms with structural anatomical changes and to delineate the 
difference between two groups of participants, with maximum and minimum 
PFD scores. 
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1.2.7   Hypothesis 
 
The null hypothesis (H0) for the present research was that: 
 
1) The severity of Denovo postnatal PFD in primiparous women does not differ 
from persistent PFD with prepregnancy onset of symptoms. 
 
2)  Mode of delivery does not change the severity of persistent PFD postnatally. 
  
3) Congenital predisposing factors play little role in the development of PFD as 
compared to intrapartum trauma. 
 
4) Childbearing related PFD cannot be predicted before the first pregnancy 
 
5) Elective CS does not prevent the development of PFD in the at risk group.  
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2.1   Epidemiologic assessment of PFD in nulliparous and primiparous women 
 
 
The epidemiologic assessment of PFD in nulliparous women prepregnancy and one year 
postnatally constitutes the backbone of the present thesis. This part of the project aimed 
to elucidate the real impact of the first childbearing on postnatal PFD.  In the 
methodology section, in order to achieve the most comprehensive description of the 
methods used, each subheading begins with the rationale for the methodology followed 
by the performed measurements. 
 
2.1.1   Assessment of background prepregnancy PFD in nulliparous women 
 
The 4P-Study is a prospective study, nested within the Screening for Pregnancy 
Endpoints (SCOPE) Ireland study (www.scopestudy.net). The present study was 
reviewed and approved by The Clinical Research Ethics Committee of the Cork Teaching 
Hospitals (CREC), Ireland. It consisted of two parts: a questionnaire based survey 
followed by a detailed clinical, laboratory and imaging investigations in women 
approximately 12 months postpartum. We invited 2579 nulliparous women to 
participate in the SCOPE study, subsequently 1774 (69%) were recruited (Appendix II). 
This represents 17% of all nulliparous women who delivered in CUMH during the study 
period.  
 
The validated Australian Pelvic Floor Questionnaire28 was used to assess PFD 
prepregnancy and one year postnatally. We chose this particular questionnaire, because 
in contrast to others it covers all 4 compartments of PFD along with associated 
bothersome and condition specific quality of life problems. Unlike many other 
commonly used standardized questionnaires, it is a validated questionnaire, showing 
very good test–retest reliability (Kappa values ranged between 0.74 and 1.0 for 
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different sections) and good correlation with other questionnaires (Spearman’s 
coefficient for different sections ranging between 0.63 and 0.92), as well as association 
with urodynamic findings28. The first, prepregnancy questionnaire was handed to all 
SCOPE participants, to be answered specifically on the day of recruitment, at 15 weeks’ 
gestation and was returned completed by 1474 (83% of recruited to SCOPE) 
participants (Appendix II) . The prepregnancy questionnaires were completed between 
February 2008 and March 2011. All participants were specifically asked about 
prepregnancy symptoms, the questionnaire verbatim stating: “All these questions 
pertain to the period BEFORE you were pregnant”, additionally they were verbally 
instructed to ignore any symptoms newly developed in pregnancy.  
 
The questionnaire consists of 4 sections, including questions about all four types of PFD. 
Each section contains 10 – 15 questions (Appendix III). All answers are graded from 0 to 
3, where zero means no symptom present and 3 - most frequent or severe symptom. 
Additionally, each section has a question about the grade of bothersomeness, due to 
symptoms, rated 0 to 3 (0 indicates no bother and 3 indicates severe bothersomeness). 
All questions from each section can be logically divided into primary symptoms, which 
are mandatory to diagnose a condition and secondary – giving extra information on 
severity of primary symptoms; for example, reduced fluid intake, pad usage, laxative 
use, grade of bother etc. The primary symptoms from the questionnaire were selected 
according to International Continence Society (ICS) definitions for various types for 
faecal or urinary dysfunction. Since we aimed to comprehensively investigate all 
possible types of dysfunctions, besides commonly described incontinence, we added 
symptoms related to overactive bladder in the urinary section; obstructed defaecation  
in the faecal dysfunction section – as a potential marker of congenital rectovaginal 
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septum defect and/or major rectocele54. It would be sensible to add “incomplete bowel 
emptying” question here, however there could be a potential for confusion, since this 
symptom is very prevalent and could be diet related. For the sexual section, we used 
dyspareunia, vaginal laxity and tightness – as primary symptoms. Regarding the 
prolapse, all questions included in this section can be regarded as primary symptoms 
for prolapse. These symptoms were selected as primary, because they were included in 
the pelvic floor distress inventory and repeatedly utilized in previous studies 6, 8. The 
questionnaire additionally contains a total section score for “urinary”, “faecal”, 
“prolapse” and “sexual dysfunction”. This score is meant to better characterise the 
severity of primary symptoms rather than representing a scale score 28 and it was 
calculated by adding all individual symptom scores in each section. In our analysis we 
considered clinically significant symptoms those with grade 2 or 3 severity from the 
questionnaire (meaning symptom present at least once weekly) or grade 1 with 
associated bother. 
 
2.1.2   Assessment of PFD in primiparous women at one year postnatally 
 
Postnatal questionnaires were completed at one year postnatal, in order to exclude 
postpartum short term transitory changes in the pelvic floor. These questionnaires 
were mailed by post with detailed instructions on how to complete them. Contact 
details were also provided in case further clarification was required. Each questionnaire 
was sent along with a pre-stamped envelope with a return address on it. In order to 
improve the response rate, a reminder letter was sent if the participant had not replied 
within 2 months. The postnatal questionnaire, similarly to prepregnancy one consisted 
of four sections, assessing all compartments of PFD, each section containing 10 – 15 
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questions (Appendices – III & IV). The only difference consisted in a remark on the top 
of the questionnaire asking if the participant is not pregnant at the time of completion.  
Here, all answers were graded similarly from 0 to 3, where zero means no symptom 
present and 3 most frequent or severe symptom. Additionally, each section had a 
question about the grade of bothersome, due to symptoms, rated 0 to 3 (0 indicates no 
bother and 3 indicates severe bother). In the postnatal questionnaire, again questions 
were divided into primary symptoms - mandatory to diagnose a condition and 
secondary symptoms – giving extra information on the severity of those primary 
symptoms e.g. reduced fluid intake, pad usage, laxative use, grade of bother etc. The 
selection criteria for primary symptoms were similar as in prepregnancy questionnaire.  
In our analysis of postnatal symptoms we considered clinically severe symptoms in 
those having grade 2 or 3 severity (meaning symptom present at least once weekly). 
The mode of delivery was classified into abdominal, including emergency and elective 
CS and vaginal, including spontaneous vaginal delivery (SVD), forceps and vacuum 
delivery. Main outcome measures were postnatal prevalence of various PFD symptoms, 
persistence rate of prepregnancy symptoms postnatally, the difference in severity of 
Denovo postnatal onset PFD (DNPFD) and prepregnancy PFD Persisting postnatally 
(PPFD), the rate and structure of multicompartmental PFD and the impact of mode of 
delivery on postnatal PFD. 
 
2.2   Pelvic organ prolapse assessment 
 
All 872 participants, who completed prepregnancy and postnatal Australian Pelvic Floor 
Questionnaire28, were invited for pelvic organ prolapse (POP) assessment, which 
occurred between March and December 2012. We had a response rate of 60.8% (530), 
where the proposal for follow up was accepted by 46.8% (408). Those participants who 
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had more than one delivery, or were repeatedly pregnant at the time of follow up 23.6% 
(206), were excluded from the study (Appendix - II). Clinical follow up of 202 (23.2%) 
participants who met the inclusion criteria consisted of: pelvic organ prolapse 
quantification (POP-Q) assessment, joint hypermobility assessment - using Beighton 
hypermobility score, transperineal 2D/4D ultrasound scan for quantification of 
prolapse, a blood serum collection for procollagen quantification and lastly history 
taking on personal and family history of collagen related or other diseases shown 
previously to be associated with PFD and POP.  
 
2.2.1   POP-Q assessment 
 
The American Urogynecologic Society, the Society of Gynecologic Surgeons and the ICS 
approved a standardisation of terminology regarding female POP and PFD in 199630. 
The pelvic organ prolapse quantification (POP-Q) classification, a part of this 
terminology standardisation process, is currently considered as gold standard in 
quantification of POP.  
 
The POP-Q contains a set of standard points which are measured with a ruler. These 
points are located on the anterior and posterior vaginal wall and additionally include 
the most distal point of the uterine cervix. The line of hymenal insertion or the 
projection of hymenal remnants is considered as reference line, from which is measured 
the distance to all POP-Q points.            
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Figure 2.1:  Explanation of the POP-Q points 
 
 
 
 
 
 
The coordinate of each POP-Q point was measured in centimetres, using a disposable 
measurement tape fitted on a disposable wooden spatula normally used for cervical 
screening. The measurement was done on maximal Valsalva manoeuvre held for at least 
6 seconds in order to achieve maximal descend of the pelvic structures, as shown in 
previous studies117. 
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Figure 2.2:  POP-Q Staging criteria 
 
 
POP-Q assessment was performed before the transperineal ultrasound scan. The patient 
was placed in a semisupine position to facilitate both assessments. A disassembled 
disposable Cusco’s speculum was used for visualisation of all target points on maximal 
Valsalva. The entire examination procedure was chaperoned by a female staff member, 
who also assisted with recording findings on a standard data sheet. In order to assess 
the impact of mode of delivery on POP, the POP-Q data were matched against 
demographic characteristics and mode of delivery as major confounders.  
 
2.2.2   Prolapse quantification using 2D - Transperineal scan  
 
The transperineal ultrasound scan makes use of a 3D 4-8 MHz probe used for obstetric 
practice. The probe is covered with a sterile cover and is applied to the interlabial / 
supraperineal area in sagittal plane. This methodology allows visualisation of the main 
pelvic structures such as pubic symphysis, bladder, urethra, uterus, vagina, rectum and 
anal canal in 2D mode (Figure 2.3).  
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Figure 2.3:  2D - transperineal ultrasound scan 
 
 
The POP can be quantified on a transperineal 2D ultrasound scan according to Dietz et 
al42.  Two images were acquired – the first on rest and the second on maximal Valsalva, 
which was kept for not less than 6 seconds in order to achieve the best pelvic organ 
descend117. The inferior margin of the pubic bone was considered as a reference line. 
The distance from urethrovesical or anorectal junction was measured to the reference 
line (Figure 2.4).  
 
Prolapse is classified into clinically significant and non-significant. For significant 
cystocele it was proposed a cut-off level of 10mm below the symphysis pubis (outside 
the pelvis) and for rectocele 15 mm. The authors did not propose a cut-off for uterine 
prolapse, probably because in a large number of cases the image of the uterine cervix 
can be occluded by the bowel loops and this measurement could be imprecise.  
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Figure 2.4:    Prolapse quantification on transperineal ultrasound scan 
 
 
 
2.2.3   Joint hypermobility assessment 
 
Beighton joint hypermobility score is a system proposed to quantify joint hypermobility 
(Figure 2.5), mainly used in rheumatological and orthopaedic practice. It is considered 
that joint laxity is due to abnormal collagen levels in joint’s capsular and ligamental 
connective tissue. It has been reported that POP is associated with joint hypermobility 
and various medical conditions linked with abnormal collagen17, 116. All these facts are 
indicative of a systemic manifestation of collagen abnormalities and suggest a role for 
congenital predisposition in the aetiology of POP86, 118-119. 
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Figure 2.5:    Thumb hypermobility 
 
 
 
 
Figure 2.6:    Beighton score assessment: 
 
 
 
1.                                                            1.  Score one point if you can bend and                            
2.                                                            place you hands flat on the floor                                                                                  
                                  without bending you knees 
3.  
 
                           
 
 
            
 
 
 
 
 
         2. Score one point for each knee  
          that will bend backwards 
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        3. Score one point for each elbow  
          that will bend backwards 
 
 
 
 
 
                           4. Score one point for each thumb   
                           that will bend backwards to 
                           touch the forearm 
           
 
 
      
                 
                          5. Score one point for each hand  
                          when you can bend the little 
                          finger back beyond 90°               
 
 
 
 
 
 
 
 
Table 2.1   Beighton joint hypermobility scoring 
 
 
Test Points   
Able to put hands flat on the floor with knees straight   1   
Able to bend left elbow backwards (hyperextend beyond 10°)   1   
Able to bend right elbow backwards (hyperextend beyond 10°)   1   
Able to bend your left thumb back on the front of your forearm   1   
Able to bend your right thumb back on the front of your forearm   1   
Able to bend you left little (fifth) finger back beyond 90°   1   
Able to bend your right little (fifth) finger back beyond 90°   1   
Able to bend your left knee backwards(hyperextend beyond 10°)   1   
Able to bend you right knee backwards (hyperextend beyond 10°)   1   
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2.2.4   Collagen Investigation 
 
The process of collagen synthesis consists of five steps. The first two are intracellular, 
occurring in the fibroblasts, the following three steps are extracellular120. When a 
procollagen molecule leaves the cell, during stage three, it is transformed from 
procollagen into tropocollagen by proteolytic cleavage of carboxy- and aminoterminals 
(Figure 2.7). These aminoterminals can be detected and quantified as markers of 
collagen synthesis in the blood serum or frozen tissue homogenates121. Procollagen N-
Terminal Propeptides (PNP) and C-Terminal Propeptides (PCP) are collagen type 
specific and can be quantified by radioimmunoassay46 or ELISA test122.   
 
 
Figure 2.7:  Collagen synthesis mechanism 
 
 
A blood sample was collected from 120 participants in plain 10 ml. vacutainers at the 
time of clinical follow up. Participants with highest and lowest value for point C (leading 
edge of cervix on POP-Q assessment) were selected from the cohort for procollagen 
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quanti ication.  According to manufacturer’s protocol, after collection the blood sample 
was kept in the fridge overnight at  4  C.  On the following day the samples were 
centrifuged, in order to separate and store the blood serum.  The serum samples were 
labelled and stored at minus  0  C for a maximum of 3 month as per manufacturer 
recommendation. When the required number of samples was achieved, serum 
procollagen quantification was performed in 96 participants by ELISA of procollagen 
type III (PIIINP), as a marker of collagen synthesis.  
 
We utilized commercial ELISA tests manufactured by Uscn Life Science Inc. Wuhan. The 
Enzyme-linked Immunosorbent Assay Kit E90573Hu was used for quantification of 
procollagen type III N-Terminal Propeptide (PIIINP). Each plate contained 96 wells. All 
tests were performed in triplicates following the protocol below: 
 
Figure 2.8:   ELISA assay procedure summary 
 
1. Prepare all reagents, samples and standards; 
2. Add 100µL standard or sample to each well. Incubate 2 hours at 37ºC; 
3. Add 100µL prepared Detection Reagent A. Incubate 2 hours at 37ºC; 
4. Aspirate and wash 3 times; 
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37ºC; 
6. Aspirate and wash 5 times; 
7. Add 90µL Substrate Solution. Incubate 10-15 minutes at 37ºC; 
8. Add 50µL Stop Solution. Read at 450nm immediately. 
 
The initial samples were diluted according to the manufacturer instructions. 
A dilution of 1:200 was used for the PIIINP test kit, as per manufacturer 
recommendation (Figure 2.9). 
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Figure 2.9:    Sample dilution protocol 
 
 
Following the addition of the Stop solution, the plate was read in a micro-titre plate 
spectrophotometer at a wavelength of 450ηm immediately. The average background 
value was subtracted from the mean of the triplicate test values for each sample. A 
standard curve was constructed using the mean optical density of the results from the 
standards against known concentrations. Sample values were interpolated from the 
curve and corrected for the dilution factor to determine the sample PIIINP 
concentrations. 
 
To ensure reliability of all results obtained, the inter- and intra- assay coefficient of 
variation (CV) was calculated. The intra-assay CV was <13.6% and inter-assay was 
CV<19.2%. We acknowledge that these values do not reflect the best variation (ideally 
inter assay CV<15%), however this is within the robust limits of variation for clinical 
studies (CV<20%), where values up to 30% would be acceptable123. 
 
2.2.5   Association between personal and family history of medical conditions   
              with collagen abnormalities association  
               
Collagen abnormality appears to be a systemic issue. Although the genetic coding for 
collagen synthesis may have different expressions in various tissues, there is a body of 
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evidence indicating that collagen related problems seem to have a systemic 
manifestation. It has been demonstrated that POP is associated with joint 
hypermobility, abdominal, inguinal and vertebral hernias, varicose veins, mitral valve 
prolapse etc.17, 46, 115-116. 
 
In order to exclude a subjective impact on the POP-Q and transperineal scan 
assessment, the personal and family medical history was taken at the end of 
investigation. All participants completed a questionnaire containing questions 
regarding various medical conditions (Appendix VI), demonstrated in previous studies 
to correlate with POP and PFD. The majority of these diseases are considered to be 
associated with abnormal collagen or involve other mechanisms linking it to the PFD.  
 
2.3   Assessment of postnatal PFD using 3D - Transperineal scan  
 
The 3D scan consists of a set of 2D images acquired as separate slices and combined 
together. The 3rd spatial axis appears here, which is made up of a sequence of separate 
2D slices. Thus, the final rendered 3D image can be considered a cube rather than a 
square, as in case of 2D scan. This cube can be rotated and examined from all sides. 
Additionally it can be “sliced” at different thicknesses and in different planes, and 
examined as a tomographic image. 
 
The main goal of 3D scan in investigation of PFD is to visualise the anatomy of the 
puborectalis muscle, the medial most part of levator ani muscle (LAM) (Figure 2.10).  
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Figure 2.10:    The axial view of a pelvic model 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 demonstrates an excellent correlation of  clinical findings of puborectalis 
muscle avulsion with 3D ultrasound scan and MRI124 .   
 
Figure 2.11:    Correlation among clinical findings, 3D-USS and MRI investigation  
 
As described previously, the transperineal ultrasound scan makes use of a 3D 4-8 MHz 
probe intended for obstetric practice. The probe is covered with a sterile cover and is 
applied to the interlabial / supraperineal area in sagittal plane. This methodology 
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allows visualisation of the main pelvic structures such as pubic symphysis, bladder, 
urethra, uterus, vagina, rectum, anus and puborectalis muscles. The images can be seen 
simultaneously in 2D Sagittal / Coronal / Axial planes and as 3D rendered image (Figure 
2.12).  The initial image is acquired in render mode then rotated and focussed at level of 
minimal hiatal dimension (the green line) (Figure 2.12)  
 
 
Figure 2.12:    Transperineal image acquired in 3D “Render” mode 
 
The following structures can be observed on the picture: 
S – symphysis pubis            U – urethra            B – bladder           V - vagina 
A – anus                            LAM – levator anal muscle (puborectalis part) 
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The image is switched then to the Tomographic Ultrasound Investigation (TUI) mode 
(Figure 2.13). TUI mode is a sequence of 2D images sliced from the acquired 3D image 
in render mode. 
 
Figure 2.13:  Tomographic Ultrasound Investigation mode 
 
A slice thickness of 2.5 mm is used to investigate LAM trauma. The reference slice (first 
slice in the second row with a red arrow on it) demonstrates the morphology of LAM at 
the level of minimal hiatal dimension. The ultrasound criterion, confirming that the 
reference slice is chosen correctly, consists in symphyseal junction opening status in 
middle 3 slices. There should be an open / closing / closed sequence. Two slices on top 
of it demonstrate the LAM status at 2.5 and 5 mm. below or caudad to the reference plan 
(the USS image is inversed anatomically), whereas the remaining five at 2.5 – 7.5 mm 
79 
 
cephalad or above it. A complete avulsion is considered to be present if trauma is 
present in all 3 middle slices. Any other combination not including middle 3 slices are 
considered partial avulsions102. The levator–urethral gap measurement has been shown 
to be an objective criterion in detecting LAM avulsion with a cut-off of >25 mm101 
(Figure 2.14). 
 
Figure 2.14:  Complete right sided LAM avulsion (the image is anatomically reversed) 
 
Additionally we measured the angle of the subpubic arch (Figure 2.15). The image 
acquired in render mode was rotated in plane A (sagittal) until the highest length of 
symphysis pubis rami was obtained in plane C (axial). This image was rotated 90 
degrees to the right, in order to obtain a normal anatomical position, and the subpubic 
arch angle was measured103  
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Figure 2.15:    Subpubic arch angle measurement 
 
2.4   Statistical analysis 
 
All statistical analyses were performed using Stata Software 10.0. and IBM SPSS 
Statistics 19.0. All statistical tests were two-sided and a p-value of less than 0.05 was 
considered statistically significant. 
 
2.4.1  Study 1 – “Prepregnancy PFD” 
 
Descriptive statistics were used to analyse the Median score value and Interquartile 
Range (M [IQR]) for each primary symptom of the questionnaire. Non-parametric 
Spearman correlation test was used to measure the relationship between the score in 
each section of the questionnaire and the reported associated bothersome score in that 
section. 
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2.4.2   Study 2 – “Postnatal PFD” 
 
Descriptive statistics were used to analyse the median score value and interquartile 
range (M [IQR]) for the primary symptoms in each section of the questionnaire. Log-
linear binomial regression was used to estimate the relative risk (RRs) of having 
Denovo or worsening postnatal symptoms in relation to mode of delivery. RRs were 
adjusted for maternal age, body mass index (BMI), education, smoking and marital 
status. When convergence was not achieved, a recognized problem with this model, log-
linear Poisson regression with “robust” estimation variance was used125 
 
2.4.3   Study 3 – “Prolapse and collagen abnormalities” 
 
POP-Q assessment statistical analysis 
 
Log-linear binomial regression was used to estimate the RRs of developing various 
types of POP in relation to mode of delivery. RRs were adjusted for maternal age, body 
mass index (BMI), education, smoking and marital status. When convergence was not 
achieved, a recognized problem with this model, log-linear Poisson regression with 
“robust” estimation variance was used125. 
 
2D-Transperineal scan statistical analysis 
 
Descriptive statistics and cross-tabulation was used to assess the number of 
symptomatic participants among those diagnosed with significant POP on transperineal 
scan. 
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Beighton hypermobility score statistical analysis 
 
The correlation between Beighton hypermobility score and POP was tested with 
Kruskal-Wallis test and Spearman rank correlation as appropriate. We investigated the 
correlation between the hypermobility score and the presence of various types of 
prolapse in isolation as well as in combination. 
 
Collagen investigation statistical analysis 
 
The association between various POP types and procollagen type III levels was assessed 
using Student’s t-test. 
 
Medical history association with POP statistical analysis 
 
The association between POP and various medical conditions was analysed using chi-
square test.  
 
2.4.4  Study 4 – “ Postnatal pelvic floor anatomy change on 3D TpUS”” 
 
To investigate the effect of potential risk factors on PFD, stepwise ordinal logistic 
regression was used to calculate the Odds Ratio (OR) and 95% Confidence Interval 
(95% CI). In ordinal logistic regression, the outcome measure was ordinal with more 
than two categories. RRs with borderline statistical significance (p<0.1) were used for 
multivariate logistic regression. Main outcome measures were, rectocele, uterine 
prolapse, LAM trauma, and LAM hiatal ballooning. The examined risk factors were 
subpubic arch angle, collagen type 3 levels, personal / family history of collagen related 
diseases,  induction of labour, mode of delivery, Oxytocin augmentation, duration of 
labour, foetal  head circumference and birthweight. 
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3.1   Abstract 
 
Introduction: Few studies have comprehensively investigated the prevalence of 
various types of pelvic floor Dysfunction (PFD) in women before their first pregnancy. 
However, no previous studies have investigated in detail all four compartments of PFD 
and the correlation between them.  
 
Methods: This was a cross-sectional study nested within a parent prospective study 
Screening for Pregnancy Endpoints (SCOPE) performed in a tertiary referral teaching 
hospital with approximately 9,000 deliveries per annum. Nulliparous women comp-
leted the validated Australian Pelvic Floor Questionnaire at 15 weeks’ gestation, at the 
time of recruitment to the SCOPE study. The questionnaire contained four sections, with 
questions about urinary, faecal, prolapse and sexual dysfunction in the prepregnancy 
period. 
 
Results: A total of 1,484 participants completed the prenatal questionnaire. Urinary 
dysfunction was present in 61 % of participants, faecal in 41%, prolapse in 5% and 
sexual in 41 %; in 37 %, dysfunction was perceived as bothersome. At least one 
clinically significant symptom, defined as severity grade 2 or 3, or grade 1 associated 
with being bothersome, was reported by 58.2% of participants. More than one type of 
PFD was present in 57.6% of cases. The severity score of each symptom within a PFD 
section was associated with total section score. 
 
Conclusions: We confirmed a high rate of PFD in nulliparous women. Clinically 
significant symptoms and associated bother were very common among symptomatic 
participants. The majority of affected women had more than one type of PFD. Postnatal 
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follow-up is needed in order to elucidate the role of pre-pregnancy symptoms in the 
aetiology of postnatal pelvic floor pathology.   
 
3.2   Introduction 
 
Pelvic floor dysfunction (PFD) has been defined as presence of symptoms of urinary 
(UI) or faecal (FI) incontinence, pelvic organ prolapse (POP), sensory or emptying 
abnormalities of the lower urinary tract, defaecation dysfunction, sexual dysfunction 
(SD) and chronic pain syndromes, which can present separately or coexist1. Many 
theories have been advanced to explain the association between morbidity of pelvic 
structures and different risk factors. Obesity, childbearing, advancing age and 
menopause are major recognized predisposing factors126. In the last few decades, 
various epidemiological and clinical studies have repeatedly shown that pregnancy and 
vaginal delivery are among the main risk factors for PFD6, 11-12, 57. However, UI is a 
recognised finding in nulliparous women, as well as in primiparous women post- 
Caesarean section (CS)12. There is an increasing body evidence showing that PFD cannot 
be explained by childbearing alone, as thought previously, and is probably linked to 
preexisting pelvic morbidity or intrinsic weakness36, 127. The major change in pelvic 
floor status seems to occur after the first pregnancy and delivery8, 128. It is recognised 
that CS reduces the risk of PFD79, 129, although it does not offer total protection against 
it12, 130. Furthermore, Denovo urinary incontinence is not a common postnatal finding 
without prior antenatal symptoms49-50.  Moreover, pregnancy and delivery carries a risk 
of <1% of initiating persistent postnatal stress urinary incontinence (SUI). The role of 
obstetric factors seems to be transient and is of uncertain aetiologic significance after 3 
months postpartum14. For this reason, it remains unclear as to whether childbearing-
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related risk factors are causative or just triggering events on a background of 
prepregnancy, preexisting PFD. 
Despite the fact that there are many large epidemiologic studies, such as the 
Epidemiology of Incontinence in the County of Nord-Trondelag (EPINCONT) and 
National Health and Nutrition Examination Survey (NHANES), none have focussed on 
detailed prepregnancy pelvic floor status, particularly in premenopausal, nulliparous 
women. In addition, the majority of them investigated various types of incontinence or 
POP, which are only a limited part of the entire spectrum of PFD. There is a paucity of 
information on problems such as urinary frequency and urgency, SD or correlation 
between different components of PFD specifically in premenopausal, 
nulliparous women.  
 
In the Prevalence and Predictors of Pelvic Floor Dysfunction in Primips (4P-study) 
reported here, we aimed to fill this gap in knowledge and test the hypothesis that PFD is 
not a condition caused by childbearing alone but could be a clinical manifestation of 
background preexisting pathology or congenital predisposition. As an initial step, we 
intended to comprehensively describe the PFD status in premenopausal nulliparous 
women by assessing the prevalence of all four types of PFD: urinary, faecal, prolapse 
and SD. In addition, we aimed to assess the correlation among the four types of PFD, 
along with associated bothersome symptoms, in women before their first pregnancy. 
 
3.3   Materials and Methods 
 
The 4P is a cross-sectional study nested within the larger parent Screening for 
Pregnancy Endpoints (SCOPE) Ireland study (www.scopestudy.net). SCOPE is an 
international, prospective, multicentre cohort study with the main aim of developing 
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screening tests to predict preeclampsia, small for gestational age infants and 
spontaneous preterm birth. The SCOPE database contains detailed information 
regarding family history of various medical conditions, personal medical history, 
antenatal and intrapartum outcomes, mode of delivery, foetal and maternal outcomes, 
postpartum period and associated complications. Inclusion criteria required the 
participants to be nulliparous in their first ongoing pregnancy and having a singleton 
foetus with a gestational age <15 weeks. Exclusion criteria consisted of preexisting risk 
factors for pregnancy complications, such as diabetes, hypertension, three or more 
terminations or miscarriages and previous cervical knife cone biopsy. SCOPE Ireland 
was performed in a tertiary maternity hospital with approximately 9,000 deliveries a 
year, where 40–42% were nulliparous women.  
 
The study reported here was reviewed and approved by the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals (CREC), Ireland, and consists of two parts: a 
questionnaire-based survey, followed by detailed clinical, laboratory and imaging 
investigations in women approximately 12 months postdelivery. We invited 2,579 
nulliparous women to participate in the SCOPE study; subsequently, 1,774 (69%) were 
recruited (Appendix II). This represents 17% of all nulliparous women who delivered in 
the maternity hospital during the study period.  
 
The validated Australian Pelvic Floor Questionnaire28 was used to assess PFD 
prepregnancy and 1-year postnatally. We chose this particular questionnaire because it 
covers all four types of PFD plus investigates associated bother and condition-specific 
quality of life (QoL) problems. It is a validated questionnaire showing a very good 
correlation with other questionnaires and an association with urodynamic findings28. 
The first prepregnancy questionnaire was handed to all SCOPE participants to be 
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answered specifically on the day of recruitment and at 15 weeks’ gestation and was 
returned completed by 1,474 (83% of recruited to SCOPE) participants (Appendix II). 
The prepregnancy questionnaires were completed between February 2008 and March 
2011. All participants were specifically asked about prepregnancy symptoms, with the 
questionnaire stating (verbatim): “All these questions pertain to the period BEFORE you 
were pregnant”. Additionally, patients were verbally instructed to ignore any symptoms 
newly developed during pregnancy. The second questionnaire was completed 1 year 
following delivery in order to characterise the long-term consequences of pregnancy on 
the pelvic floor; collection and processing of postnatal questionnaires continues.  
 
The questionnaire consists of four sections, including questions about all four types of 
PFD. Each section contains 10–15 questions (Appendix III). All answers are graded from 
0 to 3, where zero means no symptom present and 3 means the most frequent or severe 
symptom. Additionally, each section has a question about the grade of bother due to 
symptoms, rated 0–3 (0 indicates no bother and 3 indicates severe disturbance). Not 
each separate question from the questionnaire has an individual clinical value when 
assessing PFD. All questions from each section can be logically divided into primary 
symptoms, which are mandatory to diagnose a condition, and secondary symptoms, 
giving extra information on severity of primary symptoms, such as reduced fluid intake, 
pad usage, laxative use, bother etc. (Table 3.1). For analysis, primary symptoms from 
the questionnaire were selected according to International Continence Society (ICS) 
definitions for various types for faecal (FD) or urinary (UD) dysfunction.  
 
As we aimed to comprehensively investigate all possible types of symptoms and 
dysfunctions besides incontinence symptoms commonly described in other studies, we 
investigated more questions from the questionnaire related to symptoms of overactive 
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bladder in the urinary section and obstructed defaecation in the FD section. For the 
sexual section, we used dyspareunia and vaginal laxity and tightness as primary 
symptoms. Regarding the prolapse, all questions included in that section can be 
regarded as primary symptoms for prolapse. These symptoms were selected as primary 
because they were included in the Pelvic Floor Distress Inventory and repeatedly 
utilized in previous studies6, 8.  The questionnaire additionally contains a total section 
score for UD, FD, POP and SD. This score is meant to better characterise the severity of 
primary symptoms rather than represent a scale score28; it was calculated by adding all 
individual symptom scores in each section. In our analysis, we considered clinically 
significant symptoms as those with grade 2 or 3 severity from the questionnaire 
(meaning symptom present at least once weekly), or grade 1 severity with associated 
bother due to presence of symptoms (Table 3.1). 
 
3.3.1    Statistical analysis 
 
All statistical analyses were performed using Stata Software 10.0. Descriptive statistics 
were used to analyse the median score value and interquartile range (IQR) for each 
primary symptom listed in the questionnaire. Nonparametric Spearman correlation test 
was used to measure the relationship between the score in each section and the 
reported bother score due to symptoms in that section. All statistical tests were two 
sided, and a p value <0.05 was considered statistically significant. 
 
3.4   Results 
Mean participant’s age was 30 years, mean body mass index (BMI) 24.9 kg/m2, 88% 
had >12 years of education and 27% were smokers. The characteristics of 4P study 
participants were similar to those from SCOPE (Table 3.2).  
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The response rate for prepregnancy questionnaires was 83% from all SCOPE 
participants; <1% of answers were missed at the time of completion. The prevalence of 
all questionnaire symptoms is presented in Table 3.3. 
 
Overall, 19% (276) of all participants were asymptomatic for primary symptoms in all 
questionnaire sections, whereas 81% (1,208) reported at least one symptom and 58% 
(868) at least one clinically significant symptom. Figure 1 demonstrates the association 
among different types of PFD. In the majority of cases (58%), participants reported 
associated primary symptoms from more than one section. Thus, simultaneously, two 
types of PFD were reported by 37% (445) participants, three by 19% (232) and four by 
2% (22).  
 
3.4.1    Urinary Dysfunction 
 
In the urinary section, 61% (900) of all participants reported at least one primary 
symptom, among them 21% (318) of all participants or 35% of symptomatic patients 
showed clinically significant symptoms. There was a high prevalence of various UD 
symptoms (Table 3.3): 24.5% of all participants were incontinent of urine, 8.8% having 
clinically significant symptoms. Looking at the structure of UI we found that SUI alone 
was present in 50% (181), urge urinary incontinence (UUI) alone in 20% (73) and 
mixed urinary incontinence (MUI) in 30% (110) of all UI participants. We found an 
association between symptom severity and total section score, as well as presence of 
bother, where severely affected patients had higher values (Table 3.4).  
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3.4.2    Faecal Dysfunction 
 
In this section, 605 (41%) patients were symptomatic for primary symptoms; 18% 
(260) of all participants and 42% of those symptomatic had clinically significant 
symptoms. FI was reported by 79 (5.3%), flatus incontinence by 36.8% (540) and 
obstructed defaecation by 5.5% (80) (Table 3.3). Clinically significant symptoms were 
encountered by 2.4% (35), 15.5% (230) and 3.2% (47) accordingly. Again, we found an 
association between severity of symptoms/presence of bother and total section score 
(Table 3.4). 
 
3.4.3    Pelvic Organ Prolapse 
 
POP symptoms were reported by 4.8% (70) of women, where 1.2% (18) of all or 26% of 
symptomatic patients were clinically significant. The most commonly reported 
symptom was vaginal pressure or heaviness, which was present in 3.3% participants 
(Table 3.3). 
 
3.4.4    Sexual Dysfunction  
 
In this cohort, 41% (608) mentioned at least one primary SD symptom, of which 11% 
(162) of all or 27% of those symptomatic were clinically significant. The most 
commonly reported primary symptom was dyspareunia (31%), followed by vaginal 
tightness/vaginismus (25%) and vaginal laxity (5%) (Table 3.3). In general, dys-
pareunia was reported as mild, and similar rates of superficial and deep dyspareunia 
were noted (Table 3.5). As with previous sections, we found an association between 
symptom severity and total section score (Table 3.4).  
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3.4.5    Impact of symptoms on grade of bother 
 
Some degree of bother was reported by 37% (519) of all symptomatic participants. A 
significant relationship was found between each section’s total score (Table 3.1) and 
grade of bother; bother score increased with increasing total section score (Table 3.6).  
 
Eleven percent of women reporting urinary symptoms considered that their symptoms 
disturbed them, and 5% claimed that symptoms had an impact on their QoL. A positive 
correlation was found between bother grade and total urinary section score (Table 3.6). 
The highest bother due to symptoms among all sections was noted in the FD group. One 
in four women (26%) reported associated bother in this section. Bothersome symptoms 
from prolapse and SD were reported by approximately 1% and 10% of participants, 
respectively (Table 3.3). 
 
3.5   Discussion 
 
This is one of the few studies to cover all four domains of prepregnancy PFD, specifically 
in relatively young women, who were recruited in early pregnancy. Although it included 
the entire age range of premenopausal women, 87% (1,285) were <34 years old, which 
is the first cut-off point for age when participants were classified into age categories in 
previous studies6, 57. There was at least one of four types of PFD present in 57.6% of 
participants. This is comparable with data presented by a large population-based study 
from Australia (46%)6, which is the only other study covering all four types of PFD. 
However, that study concerned the general population and was not confined to 
nulliparous women. Some of our figures seem to be slightly higher compared with 
previous studies, probably because we described more types of PFD and thus more 
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symptoms, such as frequency, urgency, obstructed defaecation etc. Also, some studies 
investigated all women, including postsurgical and medically treated women57.  
 
3.5.1    Urinary and Prolapse Dysfunction 
 
We found a high prevalence of UD in this cohort, in which one third had clinically 
significant symptoms. Urinary frequency and urgency, which have not been described 
previously in nulliparous women, were more prevalent than UI. Our findings correlate 
with data from the Finnish National Nocturia and Overactive Bladder (FINNO) study 
showing a prevalence of urgency of 57% and UUI of 25%; however, we cannot compare 
those studies directly because they targeted the general population, not nulliparous 
women only 131. The prevalence of UI varies in different studies from 17% to 45% due 
to different grades of severity used for definition6. Thus, we compared our data in two 
ways: overall prevalence and clinically significant prevalence, as described in the 
“Methods” section. The overall prevalence of UI in our study was 24%, which is 
comparable with data from another big nulliparous cohort reporting a UI rate up to 
21.5%70, but it was higher than in the nulliparous group from EPINCONT (8–15%) or 
NHANES (6.5%). However, our prevalence of clinically significant UI (8.8%) correlated 
well with data from both studies57, 68. Also, we found good correspondence with 
EPINCONT in ratios of various types of UI (SUI 50 %, UUI 14 %, MUI 36 %)132. 
 
One in 20 participants in our study reported POP symptoms and 1.2% of the total 
cohort clinically significant symptoms. However, the number of women who reported 
POP symptoms was small, and results should be interpreted with caution. Also, there is 
a potential for confusion, as some bowel- or bladder-related symptoms may resemble 
prolapse. Even though the prevalence appeared low, it was comparable with result for 
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nulliparous women from the NHANES study— 0.6%—where they examined clinically 
significant symptoms only57. The two fold difference could be explained by the fact that 
the nulliparous group in their study included postsurgical patients, which was 
mentioned in their limitations. 
 
3.5.2   Faecal Dysfunction 
 
The present study is not the first to describe bowel related problems in nulliparous 
women. However, it is probably one of most comprehensive studies to date, covering a 
wide range of bowel disorders. The FD section had the highest median total section 
scores for primary symptoms and highest occurrence of bother of symptoms among all 
sections. This could be partially explained by high prevalence of pre-existing bowel 
pathology. In this study 11% of women had medical history of irritable bowel 
syndrome, additional 6 respondents had coeliac disease and another 6 - inflammatory 
bowel disease. However the rates of defaecation straining, constipation and faecal 
urgency were 4–6 folds higher than number of patients with medical history of bowel 
problems.  
 
Our rate of FI, 5.3% was comparable with data from NHANES study (6.3%) and with 
Australian Survey reporting the prevalence in general population—3.5%6. Similarly 
with the latter, we had comparable prevalence of significant flatus incontinence —15% 
vs. 11%. Unfortunately we could not weigh our findings of flatus incontinence and 
Obstructed Defaecation (OD) against other studies reporting similar data in nulliparous 
women, since we could not find such publications. However, we think this is an 
important aspect to be considered, when describing PFD of the posterior compartment. 
Usually flatus incontinence is considered to be as a result of severe perineal trauma or 
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pudendal nerve damage in labour and delivery, but this could be also a congenitally 
determinate condition or predisposition to it.  
 
3.5.3    Sexual Dysfunction  
 
We found a high prevalence of SD in nulliparous women, not reported previously. 
Nearly half of participants had at least one primary SD symptom, where more than a 
quarter were clinically significant. Whereas we would expect up to one third of 
participants to complain of dyspareunia, an interesting finding was vaginal laxity in 
4.8% and coital UI in 1.8% of respondents. This is consistent with data from previous 
studies for general population showing a vaginal laxity prevalence of 5.2%6  and coital 
incontinence of 2%133. Regarding dyspareunia, in many cases it is thought to be caused 
by endometriosis, which has been shown to be more prevalent in nulliparous women 
(56% of all affected) and dyspareunia was one of the leading symptoms present in 55% 
of patients with SD89.  We could not identify studies specifically describing SD in 
nulliparous women. The majority of studies focused on prenatal versus postnatal sexual 
satisfaction or comparison of SD following different modes of delivery. SD in the general 
population has a reported prevalence of 19–50%58, which correlates with our findings.  
   
3.5.4    Quality of life and degree of bother 
 
A large pan-European study demonstrated that UI symptom severity was the most 
important predictor of QoL and bother134. Indeed, many clinicians consider that 
presence of bother is more important than the absolute score in predicting severe PFD. 
It has been observed that the degree of bother is a more useful parameter in identifying 
patients who may require surgical treatment135. Our study shows a strong correlation 
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between symptom severity reported bother scores, which emphasises the role of using 
questionnaires to assess degree of bother in addition to symptom severity.  
 
3.5.5    Correlation among different types of PFD 
 
This study demonstrates that in the majority of nulliparous women with PFD, the 
disorder affects more than one pelvic floor compartment simultaneously. BMI, age, 
chronic cough etc. could be common risk factors for UD, FD, POP and SD. Moreover, 
sometimes there is an overlap among symptoms presented from different sections. For 
instance, dyspareunia could reflect a uterine, bladder or bowel prolapse, obstructed 
defaecation with incomplete bowel emptying or recurrent lower urinary tract infection. 
This fact emphasises the role of comprehensive investigation of pelvic floor status in 
order to diagnose and address all issues leading to PFD. Detailed questionnaires 
covering all four sections involved in PFD are appropriate for achieving this goal. 
 
The high prevalence of PFD and multicompartment involvement in nulliparous women 
could possibly suggest that congenital factors play an important role in PFD 
development. In order to understand the real role of childbearing in pelvic floor 
morbidity, it is important to elucidate the natural history of PFD by studying 
primiparous women before and after first delivery. Very few studies specifically target 
premenopausal nulliparous women in detail, often having a very narrow angle of view 
by describing UI only68, 70, 76. Others describe PFD in nulliparous women regardless of 
age, which is a major confounder6, 57 or compare incontinence status before and during 
pregnancy76. Our study aimed to fill the existing gaps in understanding PFD and add to 
the knowledge base of PFD in women before their first pregnancy. Our main goal was to 
elucidate the prevalence of all components of PFD specifically in premenopausal, 
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relatively young nulliparous women and to describe the relationship between them. 
Associated risk factors is another important topic to be described in the future but was 
beyond the goals of this article. Further research is needed to clarify the role of 
childbearing on PFD development in nulliparous women and specifically investigating 
the correlation between pre- and postnatal pathology, rates of postnatal persistence of 
prepregnancy pathology and difference in severity between de novo and persistent 
postnatal pathology. Ideally, epidemiological studies should be combined with clinical 
examinations. This knowledge would help identify the group of patients at higher risk of 
severe PFD and possibly implement some measures to prevent it. 
 
3.5.6    Study strengths and limitations 
 
The main strength of this study is the large number of nulliparous participants 
comprising extensive and detailed demographic characteristics and medical history of 
participating women. In addition, we used a validated questionnaire, correlating with 
clinical findings and comprehensively covering all areas of PFD, including presence of 
bother due to symptoms. Although we have no detailed characteristics of the general 
nulliparous population, this study can be considered representative of an entire 
population from a statistical point of view. For studies >300 participants, a sample size 
of 10 % is considered to represent the population with an acceptable error of <3 %136. 
The SCOPE Ireland database included 17% of all nulliparous women who delivered 
during study period in our maternity hospital. The 4P study sampled 13% of 
nulliparous women and had no difference in maternal characteristics with SCOPE study 
(Table 3.2 and Appendix III).  Another strength is high homogeneity of the study 
population, which allows overcoming naturally occurring confounders for PFD like 
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advanced age and interracial differences. The majority were relatively young (87% 
<34y.o.) and Caucasian (98%). There are numerous studies mentioning interracial 
difference in pelvic floor anatomy and prevalence of PFD, with white women being 
considered more prone to develop prolapse and UI8, 137.  
 
The main limitation of this study is that patients were not clinically examined to verify 
the questionnaire’s findings. Additionally, participants completed questionnaires in 
early pregnancy, and we cannot rule out the potential for confusion or recall bias, as 
questions pertained to prepregnancy status only. However, as incontinence is such an 
important event for women, it is unlikely this information would be prone to recall 
bias138. This is a common limitation for such studies, and other research groups 
collected prepregnancy data in the same way76. In addition, we are not aware of any 
evidence that pelvic floor status is affected in early pregnancy. 
 
3.6   Conclusion 
 
We confirmed the high prevalence of different types of incontinence in nulliparous 
women and found good correlation with previously reported data. However, the 
spectrum of PFD symptoms in our study was larger than has been shown previously. 
There seems to be a higher correlation among studies when prevalence of moderate and 
severe symptoms are compared. One third of participants had clinically significant 
symptoms, showing an association between severity of primary symptoms from 
questionnaire results of total sections and bother scores. A total section score cut-off 
value could be determined used to screen patients in order to identify those at higher 
risk of severe PFD. SD had a high prevalence in nulliparous women. The majority of 
patients had more than one component of PFD affected simultaneously. A 
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comprehensive approach to investigating nulliparous women is required to elucidate 
the natural history of PFD. Postnatal follow-up is needed to detect the role of 
prepregnancy PFD in the structure of postnatal pathology and delineate the group of 
patients who could be at higher risk of severe postnatal PFD. 
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Figure 3.1:   Prevalence of symptoms and association of various types of PFD  
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 Table  - 3.1    Commonly used definitions in this chapter       
            
                        
  
Primary Symptoms    -    symptoms contained in the ICS definitions or core  
                                        symptoms for a specific type of PFD 
 
              
  
Secondary Symptoms  -  symptoms not mandatory present for diagnosis of PFD,  
                                        but their association adds to the understanding of  
                                        severity of primary symptoms 
         
              
  
Mild Symptoms         -     symptoms reported as severity grade 1 and no  
                                                associated bother  present                 
    
              
  Severe Symptoms     -     symptoms reported as severity grade 2 or 3         
         
 
 
     
  
Clinically Significant Symptoms   -   symptoms reported as grade 2, 3 or 1 with  
                                                                          associated  bother   
                        
 
Total Section Score   -    a sum of all individual symptom scores within one  
                                                questionnaire’s  section  
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Table 3.2    Demographic characteristics of the 4P-Study                                                                                                                                                                                                                       
                        population and  Scope Ireland study                
  
4P-Study          
(n=1484) 
SCOPE Ireland                        
(n=1774)                                            
Caucasians 1450(97.7%) 1733(97.7%)* 
Age in years 
17-24 170(11.4%) 207(11.7%) 
25-29 440(29.7%) 545(30.6%) 
30-34 675(45.5%) 787(44.4%) 
35-45 199(13.4%) 235(13.3%) 
BMI 
Underweight 19(1.3%) 22(1.2%) 
Normal 867(58.5%) 1036(58.4%) 
Overweight  412(27.8%) 495(27.9%) 
Obese  184(12.4%) 221(12.5%) 
Education 
≤12 years 185(12.5%) 230(13%) 
>12 years 1297(87.5%) 1544 (87%) 
Smoking 
Non smokers 1088(73.4%) 1285(72.4%) 
Smokers 394(26.6%) 489(27.6%) 
Alcohol consumption 
No 289(19.5%) 339(19.1%) 
Yes 1193(80.5%) 1435(80.9%) 
Mean values A 
Age in years 30. 0(4.5)   29.9(4.5) 
BMI 24.9(4.1) 24.9(4.2) 
Weight in kg. 67.5(12.1) 67.5(12.2) 
    
 * All values presented as number of cases and ( %) of total 
A Data presented as mean value and Standard Deviation (SD) 
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Table 3.3        Prevalence of individual PFD Symptoms  (n=1485) 
  
      Total * 
Symptomatic 
Clinically * 
Significant 
Symptomatic 
 
Urinary Dysfunction 
 
Urinary Frequency   A,B 29.2%(431) 11%(162) 
Nocturia 17.6%(260) 8.3%(123) 
Nocturnal enuresis 0.3%(4) 0.2%(3) 
Urgency 42%(619) 12.5%(184) 
Urge Incontinence 12.4%(183) 5.4%(79) 
Stress Incontinence 19.7%(291) 6.3%(93) 
Weak Stream 24.3%(358) 7.7%(113) 
Incomplete Bladder Emptying 24.9%(367) 8.7%(128) 
Strain to Empty 14.1%(207) 4.7%(69) 
Pad Usage 6.5%(96) 3.1%(46) 
Reduced Fluid Intake 4.9%(72) 3.2%(47) 
Recurrent UTI 14.3%(211) 5.1%(75) 
Dysuria 9.4%(139) 3.3%(49) 
Impact on Social Life 4.7%(69) 3.5%(51) 
Bladder - How much of a bother N/A 11.1%(163) 
 
 
Faecal      Dysfunction 
 
Defaecation   Frequency 19.8%(290) 10.1%(147) 
Consistency of Bowel Motion 52.5%(771) 18.4%(270) 
Defaecation   Straining 59.9%(880) 23.9%(351) 
Laxative Use 7.9%(116) 5.6%(83) 
Do You Feel Constipated 51.6%(757) 23.6%(346) 
Flatus incontinence 36.8%(540) 15.7%(230) 
Faecal      Urgency 46.6%(683) 18.3%(269) 
Faecal      Incontinence with diarrhoea 4.8%(71) 2%(30) 
Faecal      Incontinence with normal stool 1.2%(18) 0.6%(9) 
Incomplete Bowel Evacuation 41.2%(603) 20.9%(305) 
Obstructed Defaecation   5.5%(80) 3.2%(47) 
Bowel - How much of a bother N/A 26%(380) 
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Prolapse Dysfunction 
Prolapse sensation 1.1%(16) 0.3%(5) 
Vaginal Pressure or heaviness 3.3%(48) 0.8%(12) 
Prolapse reduction to void 0.3%(5) 0.3%(5) 
Prolapse reduction to defaecate 1%(14) 0.5%(7) 
Prolapse - How much of a bother N/A 0.9%(13) 
 
 
Sexual Dysfunction 
Sufficient lubrication (No) 18.4%(263) 22.4%(321) 
During intercourse vaginal sensation is 
(abnormal) 
12.7%(183) 9.1%(131) 
Vaginal Laxity 4.8%(70) 1.2%(17) 
Vaginal tightness/vaginismus 25.1%(363) 8.4%(121) 
Dyspareunia 31%(449) 9.6%(139) 
Coital Incontinence 1.8%(26) 0.3%(5) 
Sexual Function - How much of a bother N/A 9.9%(143) 
* - In both columns figures are given out of total participants 
  
 
A  - The symptoms are worded similarly as seen in the questionnaire (however  
     in the  questionnaire they have extra explanation in layman terms) 
 
B – Primary symptoms are highlighted in bold 
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Table 3.4    Primary symptoms matched against the median section scores   
                        and associated bother 
       
Primary symptoms 
    Severity 
      Grade 
Median 
section   
score and IQR  
M(IQR) 
*Prevalence of         
 associated  
bother   
Urinary    
Urinary Frequency Mild 4(0-8)      61((18.5%) 
 Severe A 7(0-14) 40(39.6%) 
Nocturia Mild 5(1-9) 44(24%) 
 Severe 8(2-14) 29(37%) 
Urgency Mild 3(0-6) 80(16%) 
 Severe 9(3-15) 53(51%) 
Urge Incontinence Mild 6(2-10) 51(33%) 
 Severe 9(3-15) 13(46%) 
Stress Incontinence Mild 5(1-9) 60(23%) 
 Severe 9(2-16) 18(55%) 
Faecal         
Flatus incontinence Mild 5(1-9) 147(33%) 
 Severe 8(3-13) 38((46%) 
Faecal      Incontinence with normal 
stool 
Mild 7(4-10) 5(39%) 
 Severe 6.5(0-13.5) 1(25%) 
Faecal      Incontinence with 
diarrhoea 
Severe 7(4-10) 25(40%) 
 Mild 14(6-22) 5(100%) 
Obstructed Defaecation  Mild 7(3-10) 58(54%) 
 Severe 11(2-20) 8(100%) 
Prolapse    
Vaginal Pressure or heaviness Mild 1(0-2) 6(14%) 
 Severe 2(1-3) 1(17%) 
 
 
Sexual 
   
Vaginal Laxity Mild 2(0-4) 12(19%) 
 Severe 3(0-3) 0(0%) 
Vaginal tightness/vaginismus Mild 2(1-3) 65(21%) 
 Severe 6(2-10) 71(73%) 
Dyspareunia Mild 2(0-4) 106(26%) 
 Severe 8(5-11) 32(97%) 
  
  
  
 
* -  The prevalence of associated  bother  out of total affected in the respective group: 
mildly or severely affected accordingly 
A  - Moderate and severe  symptoms were grouped together, in order to reflect the 
prevalence of significant pathology 
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Table 3.5   Dyspareunia in nulliparous population  (n = 1447) 
Grade of dyspareunia 
 
Severity Cases (%) 
 
No 1012(70%) 
Mild 402(28%) 
Moderate 28(2%) 
Severe 5(1%) 
Type of dyspareunia 
 
 
Superficial 218(50%) 
Deep 172(40%) 
Mixed 45(10%) 
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Table 3.6   Grade of bother correlated to total section scores (n=1484)   
 
Grade 
Total section score & prevalence  
Urinary * Faecal * Prolapse * Sexual * 
0    1(0-3) A   1312(89%) B       2(1-4)     1081(74%)      0(0-0)    1440(99%)      0(0-1)      1305(90%) 
1    8(5-10)   136(9%)       7(5-8)     290(20%)      3(2-3)    290(0.7%)      4(3-6)      116(8%) 
2    11(10-15)   21(1.5%)       10(8-12)     73(5%)      5.5(4.5-6.5)    73(0.3%)      8(7-9)      23(1.7%) 
3    11.5(9-20)   6(0.5%)       13(10-14)     17(1%)        11(8.5-13)      4(0.3%) 
* Spearman correlation test showed a significant relationship between the  bother  grade and section symptoms score the in each  
 
saaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaection (p<0.001) ((P<0.001) (p<0.001);  (p<0.001 ) 
   subsection (p<0.001) 
A Median section symptom score and Interquartile Range M(IQR);  
B Prevalence shown as:  № of cases (% of total) 
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4.1   Abstract 
 
 
 
Introduction  Little is known about the natural history of pelvic floor dysfunction 
(PFD).We investigated the association between prepregnancy and postnatal PFD in 
premenopausal primiparous women and the associated effect of mode of delivery. 
 
Methods A prospective cohort study, nested within the parent Screening for Pregnancy 
Endpoints (SCOPE) study, was performed in a tertiary hospital with approximately 
9,000 deliveries per annum. The validated Australian pelvic floor questionnaire was 
completed by  72 nulliparous women at 15weeks’ gestation, at the time of recruitment 
to the SCOPE study and 1 year postnatally. The questionnaire contained four sections 
with questions about urinary, faecal, prolapse and sexual dysfunction. 
 
Results One year postnatally urinary dysfunction was present in 73%, faecal in 49%, 
prolapse in 14% and sexual in 58% of participants. Prepregnancy PFD persistent 
postnatally constituted more than half of total PFD. The majority of affected (71%) had 
multicompartment involvement. Participants with persistent PFD had higher 
prevalence of severe symptoms and bothersome symptoms within the group. Severity 
of prepregnancy PFD worsened in <15% cases postnatally. 
 
Conclusions The main damage to the pelvic floor seems to occur in the majority of 
patients before first pregnancy, where first childbearing does not worsen prepregnancy 
PFD in the majority of cases. Pregnancy appears to affect more preexisting symptoms of 
urgency and urge incontinence comparing to stress incontinence. Caesarean section 
seems to be more protective against postnatal worsening of prepregnancy PFD 
comparing to de novo onset pathology. However, larger studies are needed to confirm 
these findings. 
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4.2   Introduction 
 
The association between childbearing and pelvic floor dysfunction (PFD) is commonly 
recognised6, 8, 11-12. Although vaginal delivery is considered one of the most significant 
risk factors for PFD, urinary incontinence (UI) is common in nulliparous women as well 
as in primiparous women post caesarean section (CS)12, 47. There is a body of evidence 
demonstrating that initial onset of PFD during the first pregnancy is more likely to be 
associated with persistent postnatal PFD compared to de novo postnatal onset49-51; 
however, the natural history of PFD is poorly understood75. Despite the fact that many 
studies investigated the correlation between the onset of UI during the pregnancy and 
its correlation with postnatal PFD, there are no researches at the moment on the 
relationship between the prenatal and postnatal pathology in nulliparous women. Such 
a study would add to the understand-ding of the natural history of PFD.  
 
We hypothesised that prepregnancy PFD in nulliparous women plays an important role 
in postnatal prevalence of pelvic morbidity, which is worsened by childbearing and 
reflects a congenital predisposition to pelvic floor weakness. 
 
In the present 4P study (Prevalence and Predictors of Pelvic floor dysfunction in 
Primips), we aimed to investigate the correlation between the prepregnancy and 
postnatal PFD in premenopausal primiparous women, by assessing all four types of 
PFD: urinary, faecal, prolapse and sexual dysfunctions. Additionally, we intended to 
investigate the persistence rate of prepregnancy pathology postnatally, its relation-ship 
with mode of delivery (MOD) and the association among all four types of PFD. 
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4.3    Materials and methods 
 
The 4P is a prospective cohort study, nested within the larger parent international,  
multicentre Screening for Pregnancy Endpoints study (SCOPE, www.scopestudy.net), 
which has been described previously along with inclusion/exclusion criteria and 
detailed methodology for the 4P study139. SCOPE Ireland was performed in a tertiary 
maternity hospital with approximately 9,000 deliveries a year, with a 40–42% rate of 
nulliparous women.  
 
The present study, consisting of two parts, was approved by the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals (CREC), Ireland. The first stage was a 
questionnaire-based survey. In the second phase, we performed a detailed clinical 
assessment involving family and personal history of collagen-related diseases 
collection, joint hypermobility assessment, collagen type III quantification, Pelvic Organ 
Prolapse Quantification (POP-Q) assessment and 3D transperineal ultrasound scan 
approximately at 12 months post delivery. This article describes the first phase only: 
questionnaire findings analysis. 
 
The validated Australian pelvic floor questionnaire was used in the first phase to assess 
PFD28. Specifically, this questionnaire was chosen because it covers all four 
compartments of PFD plus associated bother due to symptoms. Additionally, it is a 
validated questionnaire, showing a very good correlation with other questionnaires and 
an association with urodynamic findings28.  The questionnaire was answered twice: on 
the day of recruitment and at 15 weeks’ gestation by 1,4 4 ( 3%) and at 1 year post 
delivery by 1,060 (60%) from all SCOPE participants. Of those who were recruited for 
the 4P study (1,484), 424 (28%) were excluded from postnatal analysis due to failure to 
112 
 
complete the postnatal questionnaire and another 188 (12%) due to second ongoing 
pregnancy (Appendix II). 
 
 Less than 1% of PFD answers were missing at the time of completion; therefore, 
women with missing data on specific variables were excluded from the analysis of these 
variables. The recruitment phase occurred between February 2008 and March 2011. At 
recruitment all participants were specifically asked about prepregnancy symptoms, the 
questionnaire stating (verbatim): “All these questions pertain to the period BEFORE you 
were pregnant”, additionally being verbally instructed to ignore any symptoms newly 
developed in pregnancy. Postnatal questionnaires were completed at 1 year postnatally, 
in order to exclude postpartum short-term transitory changes in the pelvic floor. 
 
There are four sections in this questionnaire, assessing all types of PFD. Each section 
contains 10–15 questions (Appendices III & IV). All answers are graded from 0 to 3, 
where 0 means no symptom present and 3 indicates most frequent or severe symptom. 
Additionally, each section contains a question about the grade of bother due to 
symptoms, rated similarly from 0 to 3. Not each separate question from the 
questionnaire has an individual clinical value when assessing PFD. That is why the 
questions from each section can be logically divided into primary symptoms, mandatory 
to diagnose a type of dysfunction and secondary symptoms, giving extra information on 
the severity of those primary symptoms like reduced fluid intake, pad usage, laxative 
use, grade of bother etc. The primary symptoms from the questionnaire were selected 
for analysis according to International Continence Society (ICS) definitions for faecal 
(FD) or urinary (UD) dysfunction. Because we aimed to comprehensively investigate all 
possible types of symptoms and dysfunctions, besides incontinence commonly 
described in other studies, we investigated symptoms related to overactive bladder 
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(OAB) in the UD section and obstructed defaecation (OD) in the FD section. 
Dyspareunia, vaginal laxity and tightness were used as primary symptoms for the sexual 
dysfunction (SD) section. All questions included in the pelvic organ prolapse (POP) 
section can be regarded as primary symptoms, as they were included in the Pelvic Floor 
Distress Inventory and used in other studies8, 11. Additionally, this questionnaire 
contains a total section score for UD, FD, POP and SD, which is meant to better 
characterise the severity of primary symptoms rather than representing a scale score28. 
It is calculated by adding all individual symptom scores in each section (Table 4.3 & 
Appendix III). In our analysis we considered clinically severe symptoms those rated as 
grade 2 or 3 severity (meaning symptom present at least once weekly). The assessed 
PFD was classified into general, de novo postnatal onset PFD (DNPFD) and 
prepregnancy PFD persisting postnatally (PPFD). The main outcome measures were: 
total prevalence of various symptoms of all PFD, DNPFD and PPFD and prevalence of 
clinically severe symptoms, persistence of prepregnancy symptoms postnatally, 
prevalence of persistent symptoms which worsened postnatally, characteristics of 
women in whom prepregnancy symptoms worsened postnatally, characteristics of 
women in whom prepregnancy symptoms worsened postnatally, quantification of 
multiple compartment involvement and the effect of MOD on postnatal PFD. 
 
4.3.1    Statistical analysis 
 
All statistical analyses were performed using Stata Software 10.0. Descriptive statistics 
were used to analyse the median score value and interquartile range [M (IQR)] for the 
primary symptoms in each section of the questionnaire (Table 4.3). All statistical tests 
were two-sided and a p value<0.05 was considered statistically significant. Log-linear 
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binomial regression was used to estimate the relative risk (RR) of having Denovo or 
worsening postnatal symptoms in relation to MOD. RR were adjusted for maternal age, 
body mass index (BMI), education, smoking and marital status. When convergence was 
not achieved — a recognised problem with this model —log-linear Poisson regression 
with “robust” estimation variance was used125. 
 
4.4   Results 
 
The study population consisted of 98.4% Caucasian women, with a mean age of 30.5 
years and mean BMI of 25 kg/m2. All demographic characteristics of women who 
participated in the 4P study were similar to the SCOPE study (Table 4.1). It has been 
previously demonstrated that the SCOPE cohort is representative of the study 
population139. 
 
Table 4.2 demonstrates the prevalence of all questionnaire’s symptoms at 1 year post 
delivery in three columns: the general prevalence of symptoms, DNPFD and PPFD. Each 
column has two sets of data, showing the total prevalence of symptoms in the group and 
prevalence of severe symptoms present ≥1 a week. Additionally, we marked primary 
symptoms (described in the “Materials and methods” section) for clarity. 
 
Overall only 10% (88) of all participants were asymptomatic for primary symptoms, 
whereas 90% (784) reported at least one symptom and 31% (268) at least one severe 
symptom. Among postnatally symptomatic women, 71% reported primary symptoms 
from>1 section of the questionnaire: 31% (272) had primary symptoms from two 
sections, 24% (213) from three and 8% (69) from four sections (Figure 4.1). The 
correlation between primary symptoms with related section scores for DNPFD and 
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PPFD groups, and postnatal persistence rate of prepregnancy symptoms, is presented in 
Table 4.3. In order to comprehensively describe the PFD in the following results’ 
sections, we are presenting the data as total prevalence in the cohort, prevalence of 
severe symptoms in the same cohort out of all participants and percentage of severely 
affected out of those symptomatic only. 
 
4.4.1    Urinary dysfunction  
 
UD was solely present in 17% of cases only, in the remaining cases being associated 
with other types of PFD (Fig. 1). At least one primary UD symptom was reported by 
73% (640) of all participants; among them 17% (146) of total or 23% of symptomatic 
participants presented severe symptoms. Of those 640 participants with postnatal UD, 
67% (429) had PPFD and 33% (210) DNPFD (Section Score in Table 4.2). UI was 
present in 54 % (465) of all participants, where 18% (83) of those affected or 9.6% of 
all presented severe symptoms (Table 4.2). Of all 4P study participants, stress urinary 
incontinence (SUI) was present in 24% (204), urge urinary incontinence (UUI) in 8% 
(72) and mixed urinary incontinence (MUI) in 22% (189), giving a ratio of 44/15/41 % 
in urinary incontinent women. It is worth mentioning that 63% of incontinent women 
had de novo onset symptoms; however, the prevalence of severe UI was nearly similar 
in the DNPFD and PPFD groups, giving a higher rate of severe UI within the PPFD group 
(Table 4.2). The total urinary section score was also higher in PFD (Table 4.3). In 
contrast to UI, symptoms related to OAB, frequency, nocturia and urgency, were more 
prevalent in the PPFD group. Severe symptoms were at least twice more prevalent than 
in DNPFD (Table 4.2). Interestingly, prepregnancy symptoms of UD persisted 
postnatally on average in 61% of participants; however, initial pathology worsened 
postnatally in 16% of cases of PPFD only (Table 4.3). 
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4.4.2    Faecal dysfunction  
 
Primary FD symptoms were reported by 49 % (425), where 10 % (87) of all partici-
pants or 21 % of those symptomatic had severe symptoms. PPFD was present in 57 % 
(429) of all affected (Table 4.2). Flatus incontinence (Fl.I) was more prevalent in the 
PPFD group, whereas faecal incontinence (Fe.I) and OD were more prevalent in the 
DNPFD group, though the prevalence of severe pathology was similar in both groups; 
the only exception was Fl.I, which was higher in the persistent group. In the FD section 
the difference in section scores between DNPFD and PPFD groups was minimal.  
Prepregnancy symptoms persisted postnatally on average in 50%, where they 
worsened after first childbearing in 15 % only (Table 4.3). 
 
4.4.3    Prolapse dysfunction 
 
Only 0.2% of all participants indicated POP as the single presenting symptom, whereas 
in the majority it was combined with symptoms from other compartments (Fig. 4.1). 
POP symptoms were reported by 14% (121) of women, where in 3% (24) of all or 20% 
of symptomatic participants they were severe. DNPFD was most prevalent at 87% (105) 
(Table 4.2). Most commonly reported symptoms were “vaginal pressure or heaviness” 
present in 11% (94) and “prolapse sensation” (feeling a lump) in 7% (57) of study 
participants (Table 4.2). In those affected, severe symptoms were present in 18% (17) 
and 25% (14) respectively. All symptoms were more severe in the DNPFD group. 
 
4.4.4    Sexual dysfunction  
 
At least one primary SD symptom was reported by 58% (504), of which 10% (91) of 
total and 18% of symptomatic participants had severe symptoms. PPFD constituted 
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53% (268) of those affected. The most prevalent primary symptom in all participants 
was dyspareunia 44% (367), followed by vaginal tightness 29% (244) and vaginal laxity 
21% (180) (Table 4.2). Severe forms of pathology in those affected were reported by 
14% (50), 2 % (49) and 13% (23) accordingly. Similar rates and severity of superficial 
and deep dyspareunia were noticed in both DNPFD and PPFD groups (Table 4.2). The 
median section score was similar in both groups; prepregnancy symptoms persisted 
postnatally on average in 59% and worsened in 12% compared to baseline 
prechildbearing status (Table 4.3). 
 
4.4.5    Impact of symptoms on grade of bother 
 
Some degree of bother was reported by 52 % (406) of symptomatic participants (784). 
The prevalence of the associated bothersome symptoms in different sections ranged 
between 21 and 24 % (Table 4.2). There was a trend towards a higher disturbance from 
symptoms in the DNPFD group. Severe bother due to symptoms was more prevalent in 
UD and FD groups (Table 4.2). 
 
 
4.4.6    PFD and mode of delivery 
 
We evaluated the effect of MOD on postnatal PFD for the Denovo and persistent groups 
separately. The main aim for the PPFD group was to investigate the impact of MOD on 
worsening postnatal symptoms, thus only cases where postnatal score worsened 
compared to prepregnancy were included in the analysis. Since CS is considered to be 
protective against PFD, the women who delivered by CS were chosen as reference 
group. 
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Postnatal symptoms worsened only in 14% of PPFD (Table 4.3), that is why sometimes 
the number of observations was low to reach statistical significance. However we are 
reporting data for majority of primary symptoms, to show the general tendency (Table 
4.4). In an attempt to address this issue, in addition to separate primary symptoms, we 
are presenting the Relative Risk (RR) for a combination of all primary symptoms within 
the relevant section. There was a consistency between the findings for each separate 
primary symptom and the whole section analysis, with forceps delivery increasing the 
risk for the majority of primary symptoms followed by spontaneous vaginal delivery 
(SVD) and vacuum delivery (Table 4.4). A trend towards higher increase of RR of PFD 
from vaginal delivery was observed in PPFD vs DNPFD for urinary urgency, SUI and Fl.I; 
however, the number of observations was too small to allow a definite conclusion. 
Participants with PPFD which worsened postnatally had a trend towards a higher rate 
of prepregnancy bothersome symptoms and more types of simultaneous prepregnancy 
PFDs (Table 4.5).  
 
4.5   Discussion 
 
There are no previous studies, to our knowledge, investigating the relationship between 
all types of prepregnancy and postnatal PFD, specifically in relatively young 
primiparous women. While our study included all premenopausal women, 85% (739) 
were less than 34 years old, which is the first cut-off point for age, when participants 
were classified into age categories in other studies6, 57. There are several studies 
investigating the postnatal prevalence of UI at different periods of time in primiparous 
women77, correlation between the prepregnancy onset of UI and its persistence during 
pregnancy76 or de novo onset of symptoms in pregnancy and postnatal persistence49, 51; 
119 
 
however, no studies have described the role of prepregnancy PFD in postnatal pelvic 
floor morbidity. The main goal of our study was to investigate the difference between de 
novo and persistent postnatal PFD, besides describing the prevalence and severity. The 
associated risk factors is another important topic to be described in the future; 
however, it was beyond the goal of the present article. 
 
4.5.1    Urinary and prolapse Dysfunction 
 
Although it has been previously demonstrated that UI first diagnosed in pregnancy 
plays an important role in development of persistent postnatal pathology, it is 
important to consider that a part of these symptoms could have existed prepregnancy. 
This is consistent with our findings, showing a high prevalence of persistent pathology. 
 
The highest prevalence of PPFD was found In this section, which exceeded DNPFD 
(Table 4.2). The prevalence of UI varies in different studies from 17 to 45% due to the 
use of different grades of severity for definition of UI6. The prevalence of any UI in the 
4P study was comparable with data from the National Health and Nutrition Examination 
Survey (NHANES) presenting only severe pathology— 9.7%57. Also we found a good 
correspondence with the Epidemiology of Incontinence in the County of Nord- 
Trøndelag (EPINCONT) study in correlation with various types of UI (SUI43 %, UUI 
16%, MUI 4%)132. The prevalence of de novo SUI and UUI was nearly double compared 
to persistent; however, the percentage of severe pathology was nearly similar in both 
groups (Table 4.2). It is interesting to mention that the majority of prepregnancy UI 
(76%) persisted postnatally and total urinary section score was higher in the PPFD 
group, reflecting a more severe pathology (Table 4.3). 
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We found a high prevalence of symptoms of OAB (urinary urgency and UUI) , which is 
consistent with data from the Finnish National Nocturia and Overactive Bladder 
(FINNO) study, where urgency was present in 54.7% of respondents and UUI in 25.7%. 
Interestingly, in contrast to UI, the prevalence of both total and severe urinary urgency 
was higher in the PPFD group compared to DNPFD. The bother from symptoms was 
higher in the PPFD as well. For both UUI and urgency, vaginal delivery seemed to 
increase the RR at least by 50% with a trend to a higher risk in the persistent group 
with worsened symptom score postnatally (Table 4.4). However, the numbers were too 
small to allow a firm conclusion. The highest impact on UI and OAB was noted from 
forceps delivery.  
 
The prevalence of postnatal POP in our study is comparable with data for primiparous 
women from the NHANES study - 2.5% - reporting severe pathology only57. However, 
the results here should be interpreted with caution, since the number of women who 
reported POP symptoms was small. Also there is a potential for confusion, since some 
bowel- or bladder-related symptoms may resemble prolapse. The highest increase in 
prolapse symptoms from vaginal delivery was found in the DNPFD group with virtually 
no protection from CS in the PPFD group (Table 4.4). A higher grade of bother was also 
noted in the DNPFD group (Table 4.2). 
 
4.5.2    Faecal Dysfunction 
 
FD, similar to the previous section, had a higher overall prevalence of PPFD compared 
to the DNPFD group. Our prevalence of Fe.I was similar to that reported by the NHANES 
study (8.8%) and comparable with the Childbirth and Pelvic Symptoms study (8.2–
17%)74. The majority of cases of Fe.I had de novo onset. Also, we detected a high rate of 
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Fl.I, and the majority had PPFD with a high postnatal persistence rate. The rate of severe 
Fl.I is comparable with previous studies showing a prevalence of 10.9–19.2%6, 49. OD 
appeared to be a prevalent symptom in our study at 6.4 % (0.7 %) with approximately 
similar distribution between PPFD and DNPFD. We could not compare our findings of 
OD against other studies reporting similar data in primiparous women, since we could 
not find such publications.  
 
Usually Fl.I is put on account of severe perineal trauma or pudendal nerve damage in 
labour and delivery, but this could be also a congenitally determined condition. A 
similar causative factor could be in the case of OD. Murad-Regadas et al. showed that in 
women with OD there is no statistical difference in rectocele, enterocele, 
intussusception and anismus among nulliparous women, post vaginal delivery and post 
CS82. Dietz and Clarke reported a 12% prevalence of rectocele with disruption of septal 
integrity in nulliparous women and hypothesised that the problem could be 
congenitally determined54.  
 
4.5.3    Sexual Dysfunction  
 
The rate of SD, apart from vaginal laxity, was similarly distributed between DNPFD and 
PPFD. However, a higher prevalence of severe dyspareunia and vaginal tightness was 
noticed in the PPFD group. Entirely, the risk of SD was minimally affected by the MOD, 
vaginal laxity only achieving statistical significance and being substantially affected by 
vaginal route of delivery (Table 4.4). Interestingly, prepregnancy vaginal laxity did not 
worsen postnatally, de novo only pathology being affected by MOD.  
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4.5.4    PFD as integrity 
 
The present study demonstrated a high rate of various PFD symptoms at 1 year 
postnatally. Our prevalence seems to be higher compared to previous studies, probably 
because we included more types of PFD containing more symptoms such as frequency, 
urgency and OD. Also previous studies investigated all women, including those post 
surgical and medical treatment.  
 
However, when we compared our PFD rates using the same definition criteria with 
previous studies, without including OAB symptoms and SD and excluding mild pa-
thology, as in the NHANES study, we got comparable estimates of PFD at 13.2 vs 18.4 %, 
considering that our primiparous population is relatively young. 
 
Multicompartment PFD was preponderant in primiparous women with the majority 
having persistent PFD. There was a high persistence rate of prepregnancy symptoms, on 
average 60 %; however, only in a minority of cases did severity of prepregnancy 
pathology worsen postnatally (Table 4.3). The vaginal route of delivery increased the 
risk of different types of PFD, to a higher degree in those in whom the prepregnancy 
symptoms worsened postnatally (Table 4.4). The latter group seemed to have more 
bother from prepregnancy symptoms and more coexisting types of PFD (Table 4.5), 
which could be potentially used as a prediction tool. However, future research with a 
larger number of participants is needed, in order to better understand the natural 
history of PFD and to develop prediction criteria for those with persistent PFD symp-
toms worsening postnatally. 
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4.5.5    Strengths and limitations   
 
Among the strengths of this study is the large number of well phenotyped nulliparous 
participants, followed up to 1 year postnatally. The use of a validated questionnaire, 
correlating with clinical findings and comprehensively covering all areas of PFD, 
including questions on the presence of associated bothersome symptoms, is another 
strength. Previously it has been demonstrated that participants of the 4P study 
prepregnancy were representative of the entire population139. In the present follow-up 
study, characteristics of our participants do not differ from initial subjects. High 
homogeneity of the study population is another strength of the present project, which 
allows overcoming naturally occurring confounders for PFD like advanced age and 
interracial differences. The majority was relatively young (85 % <34 years of age) and 
Caucasian (98 %). Several studies mentioned interracial differences in pelvic floor 
anatomy and prevalence of PFD, with white women being considered more prone to 
develop prolapse and UI8, 137.  
 
The fact that patients were not clinically examined to verify questionnaire findings is 
the main limitation of this study. Regarding the prepregnancy questionnaires, which 
were completed in early pregnancy, there is a potential for confusion and recall bias 
since questions pertained to prepregnancy status. However, PFD and especially 
incontinence is a very important event for woman and it is unlikely to be prone to recall 
bias138. This is a common limitation for this type of study and other research groups 
collected prepregnancy data in the same way76. A part of our participants have 
undergone clinical examination at 1 year postnatally. Those, in whom symptoms 
improved postnatally, confirmed that this is not a bias. This could probably be partially 
explained by lifestyle alteration due to childbearing, such as reduced smoking and 
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alcohol consumption, more physical activity while looking after a newborn baby and 
doing pelvic floor exercises, which could also potentially play a role as naturally 
occurring confounders. Another important limitation is the loss to follow-up in 28%and 
occurrence of second pregnancy in another 12 % of participants. Finally, for some 
analyses the sample size was small, which prevented robust conclusions. However, for 
the main analyses, the study provided adequate statistical power. 
 
4.6   Conclusion 
 
Prepregnancy PFD plays an important role in postnatal pelvic floor morbidity, where 
the majority of patients have persistent pathology. However, in a minority only the 
prepregnancy symptoms worsen postnatally. The main damage to the pelvic floor is 
probably made before first pregnancy due to congenital intrinsic weakness of pelvic 
floor structures. Childbearing seems to affect more substantial pre-existing symptoms 
of urgency and urge incontinence comparing to stress incontinence. PPFD has a higher 
prevalence of severe symptoms compared to DNPFD and higher grade of associated 
bothersome symptoms. The majority of affected patients have more than one 
compartment affected, and a comprehensive approach is needed when PFD is evaluated. 
CS seems to be protective against the development of some symptoms of PFD, and even 
more protective in the case of PPFD. However, from this study there is no strong 
evidence that CS significantly reduces the risk of severe postnatal PFD in those affected 
prepregnancy. Though, women with high grade of bother, especially with symptoms of 
OAB or UUI and multiple PFD types present prepregnancy, need to be counselled on an 
individual basis regarding the potential benefit of CS, in particular considering the 
actual obstetric approaches offering CS on demand. However, larger studies are needed 
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to confirm this trend and to determine characteristics of women being at higher risk of 
worsened postnatal PFD.  
 
 
Figure 4.1: Prevalence of primary symptoms for various types of PFD and their 
combinations 
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Table 4.1     Demographic characteristics of the population in  
                          the 4P-Study and  SCOPE Ireland study                                                                                                                                                  
  
4P-Study          
(n=872) 
SCOPE Ireland                        
(n=1774)                                           
Caucasians 858(98.4%)
* 1450(97.7%) 
Age in years 
17-24 73(8.4%) 207(11.7%) 
25-29 251(28.8%) 545(30.6%) 
30-34 415(47.6%) 787(44.4%) 
35-45 133(15.3%) 235(13.3%) 
BMI 
Underweight 12(1.4%) 22(1.2%) 
Normal 489(56.1%) 1036(58.4%) 
Overweight  259(29.7%) 495(27.9%) 
Obese  112(12.8%) 221(12.5%) 
Education 
≤12 years 101(12%) 230(13%) 
>12 years 771(88%) 1544 (87%) 
Smoking 
Non smokers 661(75.8%) 1285(72.4%) 
Smokers 211(24.2%) 489(27.6%) 
Alcohol consumption 
No 176(20.2%) 339(19.1%) 
Yes 696(79.8%) 1435(80.9%) 
Mean values a 
Age in years 30.5 0(4.2)   29.9(4.5) 
BMI 25.0(4.1) 24.9(4.2) 
Weight in kg. 67.8(11.8) 67.5(12.2) 
* All values presented as number of cases and ( %) of total 
a Data presented as mean value and Standard Deviation (SD)              
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Table 4.2   Prevalence of PFD at 12 months postnatally*    (n = 872)      
                              
 Total PFD prevalence               Denovo      PFD           Persistent PFD  
  Tot PFD  Severe PFD   Tot PFD Severe PFD   Tot PFD Severe PFD 
 
 
%*   (№) %*   (№)  %*   (№) %*   (№)  %*   (№) %*   (№) 
 
Urinary Dysfunction 
 
              
Urinary Frequencya 21,1% (184) 2.4% (21)  9.4% (81) 0.8% (7)  11.9% (103) 1.6% (14) 
Nocturiaa 8,8% (77) 1.6% (14)  3.8% (33) 0.6% (5)  5.1% (44) 1.0% (9) 
Nocturnal enuresis 0,8% (7) 0.2% (2)  0.6% (5) - -  0.2% (2) 0.2% (2) 
Urgency 49,6% (432) 9.4% (82)  20.1% (175) 1.6% (15)  29.6% (257) 7.6% (67) 
Urge Incontinencea 29,8% (261) 5.3% (47)  21.0% (183) 3.1% (27)  8.7% (77) 2.2% (19) 
Stress Incontinencea 45,1% (393) 7.5% (66)  29.7% (258) 3.7% (32)  15.4% (135) 3.8% (33) 
Weak Stream 23,8% (207) 2.8% (24)  13.8% (119) 1.9% (16)  10.2% (88) 0.9% (8) 
Incomplete Bladder Emptying 27,6% (240) 3.8% (33)  15.5% (135) 1.5% (13)  12.0% (105) 2.3% (20) 
Strain to Empty 14,8% (129) 1.7% (15)  10.3% (89) 1.0% (9)  4.6% (40) 0.7% (6) 
Pad Usage 14,3% (125) 6.0% (52)  10.7% (94) 4.9% (42)  3.6% (31) 1.2% (10) 
Reduced Fluid Intake 6,3% (55) 2.2% (19)  3.7% (32) 1.7% (15)  2.6% (23) 0.5% (4) 
Recurrent UTI 9,4% (82) 0.8% (7)  5.0% (43) 0.2% (2)  4.5% (39) 0.6% (5) 
Dysuria 7,8% (68) 0.9% (8)  5.7% (50) 0.8% (7)  2.0% (18) 0.1% (1) 
Impact on Social Life 8,7% (76) 1.0% (9)  6.9% (60) 0.7% (6)  1.7% (16) 0.3% (3) 
Bladder - How much of a bother 20,9% (182) 3.8% (33)  14.4% (125) 1.6% (14)  6.4% (57) 2.2% (19) 
Bladder section overall b 73.3% (640) 16.6% (146)  32.8% (210) 10.6% (92)  49.2% (429) 6.1% (53) 
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Faecal     Dysfunction 
 
Defaecation   Frequency 13,7% (119) 2.2% (19)  5.1% (45) 0.3% (3)  8.5% (74) 1.9% (16) 
Consistency of Bowel Motion 50,3% (438) 0.7% (6)  17.6% (153) 0.0% (0)  32.8% (285) 0.7% (6) 
Defaecation   Straining 60,8% (523) 7.1% (61)  17.7% (153) 0.8% (7)  42.9% (370) 6.3% (54) 
Laxative Use 6,8% (59) 0.6% (5)  4.1% (35) 0.5% (4)  2.8% (24) 0.1% (1) 
Do You Feel Constipated 46,7% (407) 5.0% (43)  11.9% (104) 0.7% (6)  35.0% (303) 4.3% (37) 
Flatus incontinencea 44,8% (385) 9.3% (80)  20.1% (173) 3.7% (32)  24.7% (212) 5.6% (48) 
Faecal     Urgency 53,7% (467) 8.4% (72)  19.4% (168) 0.9% (8)  34.5% (299) 7.4% (64) 
Faecal     Incontinence with diarrhoeaa 7,2% (63) 0.5% (4)  5.7% (49) 0.2% (2)  1.5% (14) 0.2% (2) 
Faecal     Incontinence with normal stool 1,9% (16) - -  1.9% (16) -  -   -  -  -  -  
Incomplete Bowel Evacuation 41,5% (356) 4.7% (40)  16.0% (137) 1.2% (10)  25.5% (219) 3.5% (30) 
Obstructed Defaecation  6,4% (55) 0.7% (6)  3.7% (32) 0.3% (3)  2.7% (23) 0.3% (3) 
Bowel - How much of a bother 24,1% (209) 4.8% (41)  10.4% (90) 1.5% (13)  13.6% (119) 3.3% (28) 
Bowel section overall b 48.7% (425) 10.0% (87)  21.1% (184) 8.4% (73)  27.6% (241) 1.6% (14) 
 
 
              
 
 
 
Prolapse Dysfunction 
 
              
Prolapse sensationa 6,6% (57) 1.6% (14)  6.1% (53) 1.4% (12)  0.2% (4) 0.2% (2) 
Vaginal Pressure or heavinessa 10,9% (94) 2.0% (17)  9.6% (83) 1.6% (14)  1.1% (11) 0.4% (3) 
Prolapse reduction to voida 1,5% (12) 0.2% (2)  1.1% (9) 0.2% (2)  0.2% (3) 0.0% (0) 
Prolapse reduction to defaecatea 2% (17) 0.5% (4)  1.5% (14) 0.4% (3)  0.2% (3) 0.1% (1) 
Prolapse - How much of a bother 4,1% (35) 1.4% (12)  3.4% (29) 1.2% (10)  0.4% (6) 0.2% (2) 
Prolapse section overall b 13.9% (121) 2.8% (24)  12.0% (105) 2.5% (22)  1.8% (16) .2% (2) 
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Sexual Dysfunction 
 
Sufficient lubrication (No) 23,9% (196) - -  16.0% (133) -  -   7.6% (63) - - 
During intercourse vaginal sensation is 
(Abnormal) 
21,2% (176) 7.7% (64)  15.7% (130) 5.5% (46)  5.5% (46) 2.2% (18) 
Vaginal Laxitya 21% (180) 2.7% (23)  18.3% (155) 2.5% (21)  2.7% (25) 0.2% (2) 
Vaginal tightness/Vaginismusa 29,1% (244) 5.6% (49)  15.5% (130) 2.4% (20)  13.6% (114) 3.2% (29) 
Dyspareuniaa 43,6% (367) 5.9% (50)  22.1% (186) 2.1% (18)  21.5% (181) 3.7% (31) 
Dyspareunia Superficial 18,9% (159) 2.9% (24)  10.0% (84) 1.1% (9)  8.9% (75) 1.7% (14) 
Dyspareunia Deep 16,0% (135) 1.1% (9)  7.8% (66) 0.4% (3)  8.2% (69) 0.7% (6) 
Dyspareunia Mixed 6,9% (58) 1.9% (16)  2.9% (24) 0.7% (6)  4.0% (34) 1.2% (10) 
Dyspareunia Unknown 1.8% (15) 0.1% (1)  1.4% (12) - -  0.4% (3) 0.1% (1) 
Coital Incontinence 5% (43) 0.5% (4)  4.4% (37) 0.4% (3)  0.6% (6) 3.3% (1) 
Sexual Function - How much of a bother 23,7% (203) 5.9% (50)  18.6% (158) 4.3% (36)  5.1% (45) 1.7% (14) 
Sexual section overall b 57.8% (504) 10.4% (91)  27.1% (236) 8.5% (74)  30.7% (268) 1.9% (17) 
 
 
    
 
 
        
 
Combined data for various incontinences 
 
   
 
 
        
Urge Urinary Incontinence 8.3% (72) 2.1% (18)  4.2% (36) 1.4% (12)  4.2% (36) 0.7% (6) 
Stress Urinary Incontinence 23.6% (204) 4.3% (37)  12.8% (111) 2.0% (17)  10.8% (93) 2.4% (20) 
Mixed Urinary Incontinence 21.9% (189) 3.2% (28)  17.0% (147) 1.7% (15)  4.9% (42) 1.5% (13) 
Any Urinary Incontinence 53.9% (465) 9.6% (83)  34.1% (294) 5.1 % (44)  19.8% (171) 4.5% (39) 
Faecal     Incontinence 9.1% (79) 0.5% (4)  7.5% (65) 0.2% (2)  1.6% (14) 0.2% (2) 
               
* Percentage is given out of total participants                             
a Primary symptoms are marked 
b Section scores include primary symptoms only 
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Table 4.3    Median section scores corresponding to various primary symptoms at 12 months 
 
                        postnatally and the rate postnatal persistence of prepregnancy symptoms 
                        
 
Denovo       
 
   Persistent        Persistence    Persistent 
1 
 
PFD 
 
       PFD 
 
rate 
 
worsened 
  M [IQR]* M [IQR]   % N   % N 
            
    
  Urinary Symptoms 
     
Frequency 5 [0-11] 4 [0-10] 
 
44.6% 103 
 
8.7% 9 
Nocturia 6 [0-12] 6.5 [0.5-12.5] 32.1% 44 
 
9.1% 4 
Urgency 4 [0-8] 
 
5 [0-10] 
 
74.2% 256 
 
17.6% 45 
Urge Incontinence 5 [1-9] 
 
8 [3-13] 
 
70.1% 75 
 
32% 24 
Stress Incontinence 4 [0-9] 
 
6 [0-12] 
 
82.6% 133 
 
11.3% 15 
            
    
Faecal     Symptoms 
     
Flatus Incontinence 5 [0-10] 6 [2-10] 
 
64.8% 212 
 
17.5% 37 
Faecal     Incontinence 
with diarrhoea 
8 [3-13] 9 [6-12] 
 
36.1% 13 
 
15.4% 2 
Faecal     Incontinence 
with solid stool 
7 [2-12] - - 
 
- - 
 
- - 
Obstructed Defaecation  7 [3-11] 8 [4-12] 
 
48.9% 23 
 
13% 3 
            
    
Prolapse Symptoms 
     
Prolapse Sensation 2 [0-6] 
 
6 - 
 
22.2% 2 
 
50% 1 
Vaginal Pressure or 
heaviness 
2 [0-4] 
 
1 [0-4] 
 
34.6% 9 
 
33.3% 3 
Prolapse reduction to 
void 
3 [0-7] 
 
4 - 
 
100.0% 3 
 
- - 
Prolapse reduction to 
defecate 
3 [0-6] 
 
6.5 - 
 
20.0% 2 
 
- - 
    
 
 
Sexual Symptoms 
 
    
Vaginal Laxity 3 [1-5] 
 
3 [0-6] 
 
56.1% 23 
 
4.4% 1 
Vaginal 
Tightness/Vaginismus 
3 [0-6] 
 
3 [0-6] 
 
52.3% 114 
 
16.7% 19 
Dyspareunia 3 [1-5] 
 
3 [0-6] 
 
68.0% 181 
 
14.9% 27 
                        
            * Median Section Score and Interquartile Range  M[IQR]  
      
1 Postnatal score worse than prenatal in the PPFD group 
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Table 4.4   The Relative Risk (RR) of getting de novo primary PFD symptoms postnatally or worsening of prepregnancy symptoms postnatally in relation to mode of delivery              
            
                                                  
Primary    Total Denovo    or worsened postnatally PFD *                             Denovo      PFD   Persistent PFD worsened postnatally  
Symptom  RR CI p= RR CI p= №  RR CI p= RR CI p= №  RR CI p= RR CI p= № 
                         
                         
      Unadjusted     Adjusted         Unadjusted     Adjusted         Unadjusted     Adjusted     
                        
Urinary  dysfunction  symptoms 
                         
Urinary SVD 1.2 (1.1-1.38) 0.000 1.3 (1.15-1.45) 0.000 172  1.4 (1.13-1.83) 0.003 1.6 (1.29-2.08) 0.000 58  1.1 (0.99-1.23) 0.084 1.1 (1-1.26) 0.046 114 
Section Vacuum 1.1 (1-1.3) 0.042 1.2 (1.05-1.37) 0.008 145  1.2 (0.87-1.53) 0.328 1.3 (0.95-1.7) 0.102 46  1.1 (1-1.27) 0.044 1.2 (1.02-1.3) 0.024 99 
 Forceps 1.4 (1.2-1.54) 0.000 1.4 (1.21-1.55) 0.000 90  1.7 (1.31-2.21) 0.000 1.8 (1.36-2.31) 0.000 32  1.2 (1.04-1.33) 0.009 1.2 (1.03-1.3) 0.014 58 
                         
Urinary  SVD 1.1 (0.64-1.95) 0.686 1.1 (0.64-2.02) 0.665 31  1.1 (0.59-1.9) 0.854 1.1 (0.57-1.95) 0.873 25  3.4 (0.41-28.41) 0.255 3.2 (0.31-32.24) 0.333 6 
Frequency Vacuum 1.2 (0.67-2.24) 0.517 1.3 (0.7-2.47) 0.389 21  1.2 (0.66-2.29) 0.51 1.3 (0.68-2.46) 0.437 20  1.2 (0.07-18.99) 0.903 0.4 (0.02-13.09) 0.642 1 
 Forceps 1.9 (1.01-3.62) 0.047 1.9 (0.98-3.64) 0.057 17  1.9 (1-3.73) 0.05 1.9 (0.96-3.68) 0.067 16  2.2 (0.14-35.05) 0.579 0.3 (0.01-14.53) 0.58 1 
                         
Nocturia SVD 1.1 (0.47-2.57) 0.831 1.3 (0.51-3.08) 0.617 13  1.1 (0.45-2.77) 0.818 1.3 (0.5-3.47) 0.572 11  1.1 (0.1-11.79) 0.957 0.3 (0.01-13) 0.543 2 
 Vacuum 0.9 (0.35-2.55) 0.919 1 (0.36-2.86) 0.978 7  1 (0.33-2.76) 0.936 1.1 (0.36-3.38) 0.854 6  0.9 (0.06-15.02) 0.965 0.7 (0.02-28.75) 0.857 1 
 Forceps 2.1 (0.8-5.38) 0.133 2 (0.75-5.46) 0.164 8  2.4 (0.89-6.35) 0.083 2.4 (0.87-6.81) 0.09 8  - - - - - - 0 
                        
Urinary SVD 1.4 (0.98-2) 0.063 1.6 (1.1-2.3) 0.014 87  1.4 (0.95-2.09) 0.085 1.5 (1.02-2.34) 0.039 69  1.6 (0.68-3.61) 0.29 1.9 (0.77-4.61) 0.164 18 
Urgency Vacuum 1.2 (0.83-1.85) 0.302 1.3 (0.86-1.99) 0.209 48  1.2 (0.76-1.86) 0.458 1.2 (0.77-1.99) 0.378 37  1.6 (0.64-3.93) 0.324 1.7 (0.65-4.44) 0.278 11 
 Forceps 1.8 (1.19-2.82) 0.006 1.9 (1.21-2.92) 0.005 37  1.8 (1.09-2.86) 0.02 1.8 (1.1-2.99) 0.02 29  2.2 (0.84-5.98) 0.106 2.2 (0.79-6.02) 0.134 8 
                         
Urge SVD 1.7 (1.14-2.44) 0.08 1.8 (1.2-2.64) 0.004 84  1.7 (0.17-2.6) 0.007 1.9 (1.26-2.89) 0.002 80  1.2 (0.26-5.28) 0.828 1.4 (0.19-9.7) 0.761 4 
Urinary Vacuum 1.5 (0.96-2.24) 0.079 1.5 (0.97-2.35) 0.071 46  1.5 (0.92-2.29) 0.107 1.6 (0.96-2.51) 0.071 41  2.1 (0.49-8.65) 0.32 2.8 (0.42-18.07) 0.291 5 
Incontin. Forceps 1.8 (1.15-2.96) 0.011 1.9 (1.16-3.04) 0.011 30  1.9 (1.14-3.16) 0.012 1.9 (1.16-3.27) 0.012 27  1.9 (0.39-9.6) 0.418 2.2 (0.29-16.55) 0.445 3 
                         
Stress SVD 1.7 (1.26-2.42) 0.001 1.9 (1.36-2.68) 0.000 120  1.7 (1.22-2.4) 0.002 1.9 (1.32-2.66) 0.000 107  2.8 (0.8-9.91) 0.105 3.7 (0.9-15.23) 0.07 13 
Urinary Vacuum 1.5 (1.05-2.18) 0.026 1.6 (1.09-2.34) 0.015 65  1.4 (0.98-2.1) 0.062 1.6 (1.07-2.37) 0.023 59  2.6 (0.65-10.42) 0.176 3.2 (0.65-15.31) 0.154 6 
Incontin. Forceps 2 (1.33-2.97) 0.001 2 (1.3-2.95) 0.001 44  2 (1.34-3.07) 0.001 2 (1.3-3.04) 0.001 42  1.5 (0.25-9.03) 0.652 1.7 (0.26-11.78) 0.569 2 
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Faecal dysfunction symptoms 
                        
                        
Faecal     SVD 1.1 (0.95-1.34) 0.172 1.2 (0.99-1.41) 0.062 145  1.3 (0.93-1.7) 0.138 1.2 (0.89-1.65) 0.231 29  1.1 (0.91-1.32) 0.337 1.2 (0.95-1.41) 0.150 116 
Section Vacuum 1 (0.82-1.22) 0.993 1 (0.85-1.27) 0.718 93  1 (0.68-1.4) 0.878 1 (0.67-1.39) 0.847 38  1.1 (0.9-1.36) 0.347 1.1 (0.91-1.39) 0.290 55 
 Forceps 1 (0.83-1.33) 0.696 1 (0.83-1.33) 0.690 51  1.2 (0.81-1.74) 0.380 1.2 (0.81-1.73) 0.383 28  1.2 (0.89-1.5) 0.28 1.1 (0.87-1.44) 0.374 23 
                         
Flatus  SVD 1.4 (1-2.03) 0.048 1.4 (0.97-2.01) 0.075 89  1.3 (0.88-1.91) 0.185 1.3 (0.87-1.93) 0.205 73  1.9 (0.77-4.57) 0.164 1.6 (0.62-4.12) 0.327 16 
Incontin Vacuum 1 (0.68-1.58) 0.866 1.1 (0.69-1.63) 0.797 40  0.9 (0.57-1.43) 0.666 0.9 (0.59-1.52) 0.816 33  1.4 (0.5-4.1) 0.498 1.4 (0.45-4.12) 0.576 7 
 Forceps 1.7 (1.07-2.6) 0.023 1.7 (1.06-2.61) 0.026 34  1.3 (0.77-2.05) 0.355 1.3 (0.76-2.06) 0.381 27  3.4 (1.19-9.69) 0.022 3.3 (1.11-10.13) 0.032 7 
                         
Faecal     SVD 0.8 (0.36-1.59) 0.46 0.9 (0.4-1.86) 0.713 14  0.8 (0.37-1.68) 0.536 0.9 (0.41-1.95) 0.785 14  - - - - - - 0 
Inc. with Vacuum 1.3 (0.64-2.74) 0.451 1.5 (0.71-3.24) 0.28 15  1.4 (0.68-3.02) 0.34 1.6 (0.76-3.56) 0.206 15  - - - - - - 0 
Diarrhoea Forceps 1.3 (0.56-3.17) 0.52 1.7 (0.69-4.12) 0.25 8  1.2 (0.49-3.09) 0.655 1.6 (0.62-4.05) 0.343 7  - - - - - - 1 
                         
Obstruc-ted  SVD 1.4 (0.6-3.32) 0.433 1.3 (0.55-3.24) 0.531 15  1.5 (0.6-3.67) 0.396 1.4 (0.56-3.71) 0.443 14  - - - - - - 1 
Defaecation  Vacuum 1.5 (0.6-3.82) 0.386 1.4 (0.52-3.56) 0.535 10  1.5 (0.57-4.1) 0.402 1.4 (0.49-3.81) 0.549 9  - - - - - - 1 
 Forceps 0.6 (0.12-2.73) 0.491 0.5 (0.11-2.47) 0.409 2  0.6 (0.13-3.1) 0.583 0.6 (0.12-2.81) 0.498 2  - - - - - - 0 
                         
                         
                         
Prolapse  symptoms 
                         
                         
Prolapse  SVD 3 (1.7-5.23) 0.000 3.4 (1.97-6.01) 0.000 50  4.2 (2.09-8.33) 0.000 4.7 (2.31-9.49) 0.000 48  0.7 (0.29-1.74) 0.45 0.9 (0.08-10.8) 0.959 2 
Section Vacuum 2.3 (1.21-4.2) 0.011 2.7 (1.47-4.97) 0.001 26  3.1 (1.45-6.47) 0.003 3.5 (1.66-7.37) 0.001 23  1 (0.36-2.79) 1 0.8 (0.2-2.96) 0.698 3 
 Forceps 4.3 (2.35-7.93) 0.000 4.1 (2.17-7.79) 0.000 26  6.4 (3.1-13.34) 0.000 6.3 (2.96-13.61) 0.000 24  0.5 (0.13-1.96) 0.321 0.4 (0.07-2.2) 0.285 2 
                        
Prolapse  SVD 3.8 (1.45-9.87) 0.007 4.4 (1.62-11.8) 0.004 25  3.8 (1.46-9.95) 0.006 4.4 (1.63-11.87) 0.003 25  - - - - - - 0 
Sensation Vacuum 2.7 (0.92-7.65) 0.07 2.8 (0.95-8.46) 0.062 11  2.7 (0.92-7.66) 0.07 2.8 (0.93-8.3) 0.068 11  - - - - - - 0 
 Forceps 5.6 (1.97-15.9) 0.001 4.9 (1.68-14.05) 0.004 12  5.3 (1.83-15.16) 0.002 4.5 (1.54-13.28) 0.006 11  - - - - - - 1 
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Sexual dysfunction symptoms 
                         
                         
Sexual SVD 1.2 (1.06-1.42) 0.008 1.2 (1.03-1.4) 0.018 156  1.4 (1.1-1.81) 0.007 1.4 (1.05-1.74) 0.019 87  1.1 (0.92-1.27) 0.347 1.1 (0.93-1.31) 0.266 69 
Dysfunc. Vacuum 1.1 (0.92-1.3) 0.292 1.1 (0.91-1.29) 0.382 113  1.1 (0.82-1.49) 0.496 1.1 (0.8-1.47) 0.605 51  1.1 (0.94-1.33) 0.228 1.1 (0.93-1.35) 0.223 62 
Section Forceps 1.2 (0.98-1.45) 0.082 1.2 (0.95-1.42) 0.135 64  1.4 (1.02-1.93) 0.036 1.4 (1.02-1.93) 0.038 32  1 (0.81-1.28) 0.853 1 (0.8-1.27) 0.943 32 
                         
Vaginal  SVD 4.3 (2.41-7.82) 0.000 4.5 (2.45-8.12) 0.000 75  4.3 (2.36-7.66) 0.000 4.4 (2.4-7.95) 0.000 74  - - - - - - 1 
Laxity Vacuum 3.7 (1.99-6.94) 0.000 3.7 (1.98-7.1) 0.000 40  3.7 (1.99-6.95) 0.000 3.8 (1.99-7.16) 0.000 40  - - - - - - 0 
 Forceps 4.8 (2.46-9.23) 0.000 4.7 (2.41-9.2) 0.000 27  4.6 (2.37-8.9) 0.000 4.5 (2.3-8.81) 0.000 27  - - - - - - 0 
                         
Vaginal  SVD 1 (0.67-1.54) 0.928 0.9 (0.58-1.37) 0.605 53  1 (0.68-1.63) 0.834 1 (0.63-1.55) 0.947 48  0.8 (0.22-2.67) 0.683 0.4 (0.09-1.79) 0.232 5 
Tightness /  Vacuum 1.3 (0.87-2.07) 0.181 1.2 (0.75-1.86) 0.47 43  1.3 (0.83-2.1) 0.247 1.2 (0.75-2) 0.408 37  1.5 (0.46-4.89) 0.507 0.9 (0.23-3.22) 0.826 6 
Vaginism. Forceps 0.8 (0.45-1.53) 0.554 0.8 (0.46-1.57) 0.597 14  0.8 (0.39-1.53) 0.468 0.8 (0.4-1.59) 0.515 11  1.3 (0.3-5.28) 0.75 1.5 (0.33-7) 0.597 3 
                         
Dyspare- SVD 1 (0.72-1.44) 0.92 0.9 (0.63-1.28) 0.563 76  1.1 (0.76-1.58) 0.634 1 (0.67-1.43) 0.911 69  0.7 (0.24-1.98) 0.498 0.5 (0.16-1.71) 0.288 7 
unia Vacuum 1 (0.71-1.53) 0.845 0.9 (0.63-1.4) 0.761 48  1 (0.69-1.56) 0.87 1 (0.62-1.46) 0.832 42  1 (0.35-3.12) 0.931 0.9 (0.24-3.12) 0.814 6 
 Forceps 1.4 (0.88-2.08) 0.169 1.3 (0.84-2.03) 0.228 33  1.3 (0.8-2.08) 0.293 1.3 (0.81-2.16) 0.259 26  2 (0.71-5.78) 0.186 1.9 (0.61-5.63) 0.272 7 
                                                  
*Total PFD includes all DNPFD and PPFD only worsened postnatally                   
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Table 4.5     Prepregnancy PFD characteristics in PPFD group with worsened and unchanged  
                         symptoms  postantally. 
                    
    PPFD  Bother presence 1 Compartment > 1 Compartment  
  prevalence in affected Affected Affected 
    № % of all № % N % N % 
Stress 
 Incontinence 
Worsened PPFD 24 2.8 9 37.5 4 16.0 20 84 
 Unchanged PPFD 137 15.7 35 25.5 32 23.4 105 76.6 
          
Urge  
Incontinence 
Worsened PPFD 15 1.7 9 60 3 20.0 12 80 
 Unchanged PPFD 92 10.6 28 30.4 16 17.4 76 82.6 
          
Urinary 
Frequency 
Worsened PPFD 9 1 2 22.2 4 44.4 5 55.6 
 Unchanged PPFD 222 25.5 47 21.3 74 33.3 148 66.7 
          
Urgency Worsened PPFD 45 5.2 15 33.3 9 20.0 36 80 
 Unchanged PPFD 300 34.4 58 19.3 80 26.7 220 73.3 
          
Nocturia Worsened PPFD 4 0.5 1 25 1 25.0 3 75 
 Unchanged PPFD 133 15.3 33 24.8 39 29.3 94 70.7 
          
Flatus 
incontinence 
Worsened PPFD 37 4.2 17 45.9 3 8.1 34 91.9 
 Unchanged PPFD 290 33.3 94 32.5 50 17.2 240 82.8 
          
Fecal 
Incontinence  
Worsened PPFD 2 0.2 1 50 1 50.0 1 50 
with diarrhoea Unchanged PPFD 34 3.9 15 43.7 3 8.8 31 91.2 
          
Vaginal 
tightness/ 
Worsened PPFD 19 2.2 6 31.6 6 31.6 13 68.4 
vaginismus Unchanged PPFD 203 23.3 55 27.1 44 21.7 159 78.3 
          
Dyspareunia Worsened PPFD 27 3.1 9 33.3 5 18.5 22 81.5 
 Unchanged PPFD 244 28 71 29.1 46 18.9 198 81.1 
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5.1  Abstract 
 
 
Introduction The natural history of pelvic organ prolapse (POP) is poorly understood. 
We investigated the prevalence and risk factors of postnatal POP in premenopausal 
primiparous women and the associated effect of mode of delivery. 
 
Methods We conducted a prospective cohort study in a tertiary teaching hospital 
attending 9,000 deliveries annually. Collagen-diseases history and clinical assessment 
was performed in 202 primiparae at ≥1 year postnatally. Assessment included Pelvic 
Organ Prolapse Quantification (POP-Q), Beighton mobility score, 2/3D-transperineal 
ultrasound (US) and quantification of collagen type III levels. Association with POP was 
assessed using various statistical tests, including logistic regression, where results with 
p<0.1 in univariate analysis were included in multivariate analysis. 
 
Results POP had a high prevalence: uterine prolapse 89%, cystocele 90%, rectocele 70% 
and up to 65% having grade two on POP-Q staging. The majority had multi-compartment 
involvement, and 80% were asymptomatic. POP was significantly associated with joint 
hypermobility, vertebral hernia, varicose veins, asthma and high collagen type III levels 
(p<0.05). In multivariate analysis, only levator ani muscle (LAM) avulsion was significant 
in selected cases (p<0.05). Caesarean section (CS) was significantly protective against 
cystocele and rectocele but not for uterine prolapse. 
 
Conclusions Mild to moderate POP has a very high prevalence in premenopausal 
primiparous women. There is a significant association between POP, collagen levels, 
history of collagen disease and childbirth-related pelvic floor trauma. These findings 
support a congenital contribution to POP aetiology, especially for uterine prolapse; 
however, pelvic trauma seems to play paramount role. CS is significantly protective 
against some types of prolapse only. 
137 
 
5.2   Introduction 
 
The association between childbearing and pelvic organ prolapse (POP) giving rise to 
symptoms of pelvic floor dysfunction (PFD) is commonly recognised8, 57, 140. However, 
POP is present not only in women giving birth but also in premenopausal, nulliparous 
women, in whom the prevalence of prolapse is similar to women post-Caesarean section 
(CS), with the latter delivery mode considered to be partially protective compared with 
vaginal delivery118, 141. Initially it was shown that POP is associated with reduction in 
total collagen content, with higher levels of weaker immature collagen and no change in 
collagen type I/III ratios18. However, a later study demonstrated that levels of collagen 
type I(providing strength and being mainly present in bone structures and, to a lesser 
extent, in soft tissue) is minimally changed in women with POP; collagen type III 
(providing elasticity) is increased, leading to decreased collagen I/III ratio110. POP is also 
associated with joint hypermobility and various medical conditions linked with 
abnormal collagen17, 116. All these factors are indicative of the systemic manifestation of 
collagen abnormalities and suggest a role for congenital predisposition in POP aetiology 
86, 118-119. Additionally, prolapse is associated with levator ani muscle (LAM) trauma142. 
 
We hypothesised that postnatal POP in premenopausal primiparous women is not a 
condition caused by pregnancy alone but could be a clinical manifestation of a pre-
existing, undiagnosed condition or a congenital predisposition triggered by pregnancy 
and delivery. The 4P-study reported here (Prevalence and Predictors of Pelvic Floor 
Dysfunction in Primips) aimed to elucidate the natural history of POP by investigating 
the role of a congenital component in postnatal POP in premenopausal primiparous 
women while at the same time considering such major confounding factor as LAM 
trauma . 
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5.3   Materials and Methods 
 
The 4P is a prospective cohort study nested within the parent Screening for Pregnancy 
Endpoints (SCOPE Ireland study; www.scopestudy.net), previously described in detail139. 
The study was approved by the Clinical Research Ethics Committee of the Cork Teaching 
Hospitals (CREC) Ireland and performed in a tertiary maternity hospital attending 
approximately 9,000 deliveries a year. All participants, 872 nulliparous women, 
completed the Australian Pelvic Floor Questionnaire28 in early pregnancy and 1 year 
postnatally. The recruitment phase occurred between February 2008 and March 2011. 
All participants were invited for clinical follow-up between March and December 2012. 
We had a response rate of 60.8% (530), and the proposal for follow-up was accepted by 
46.8% (408). Participants who had more than one delivery or were repeatedly pregnant 
at the time of follow-up [23.6% (206)] were excluded from the study (Appendix II). 
Clinical follow-up of 202 (23.2% of all invited)  participants who met the inclusion 
criteria consisted of POP-Q assessment measured on rest and on maximal Valsalva, joint 
hypermobility assessment using the Beighton score, transperineal 2D/4D ultrasound 
(US) scan for prolapse quantification, blood serum collection for procollagen 
quantification and a collection of personal and/or family history of collagen-related or 
other diseases previously shown to be associated with PFD and POP (Appendix VI). The 
Beighton joint mobility score is a system proposed to quantify joint hypermobility and is 
mainly used in rheumatological and orthopaedic practice. A generalised joint laxity is 
considered to be present with a score of four or more143. 
 
According to Dietz and Lekskulchai, POP can be quantified on 2D transperineal US scan 
(Tp-USS)42. Two images are acquired—one at rest and one at maximal Valsalva 
maintained for not less than 6 s in order to achieve the greatest pelvic organ descent117. 
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The inferior margin of the pubic bone is considered as a reference line. The distance 
from the most distant bladder point or anorectal junction is measured to the reference 
line. Prolapse is then classified into significant and nonsignificant categories. For 
significant cystocele, we proposed a cut-off level of 10 mm below the symphysis pubis 
(outside the pelvis) and 15 mm for rectocele; there was no cut-off level for uterine 
prolapse. LAM trauma, especially its puborectalis aspect, has a recognised association 
with POP. US-diagnosed avulsion is considered to be present if the urethro-LAM 
insertion distance is >25 mm on tomographic US investigation (TUI) [15]. We measured 
procollagen type III N-terminal propeptide (PIIINP) level in 96 participants, using 
commercial enzyme-linked immunosorbent assay (ELISA) tests by Uscn Life Science Inc. 
Wuhan. Participants with highest and lowest values for point C (leading edge of cervix on 
POP-Q assessment) were selected from the cohort for procollagen quantification. The 
main outcome measures were cystocele, rectocele and uterine prolapse. 
 
5.3.1    Statistical analysis 
 
All statistical analyses were performed using IBM SPSS 19 and Stata Software 10.0. All 
statistical tests were two sided, and a p value <0.05 was considered statistically 
significant. Log-linear binomial regression was used to estimate the relative risk (RR) of 
developing various types of POP in relation to mode of delivery (MoD). All regression 
models were adjusted for maternal age, body mass index (BMI), education, smoking and 
marital status. When convergence was not achieved, a recognised problem with this 
model, log-linear Poisson regression with “robust” estimation variance was used125. In 
separate models, we classified MoD into spontaneous vaginal, instrumental vaginal and 
CS deliveries to increase statistical power of the analysis. The association between 
various POP types and collagen level was assessed using Student’s t test. The association 
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between POP and various medical conditions was analysed using chi-square test. 
Correlation between Beighton hypermobility score and POP was tested with Kruskal–
Wallis test and Spearman rank correlation, as appropriate. We investigated the 
correlation between hypermobility score and presence of various types of prolapse in 
isolation as well as in combination. An ordered logistic regression was used to assess the 
impact of LAM trauma and MoD, among other risk factors (RFs), on main outcome 
measures. RFs investigated were: LAM hiatus >25 cm2, LAM avulsion, subpubic arch 
angle, collagen type III level, family and personal history of collagen diseases, foetal 
birthweight and head circumference, duration of first and second stage of labour, MoD, 
type of maternity care, induction of labour, acceleration of labour with oxytocin, epidural 
analgesia, perineal tear, episiotomy and perineal suturing. As a reference group, we used 
patients with no prolapse, who had a vaginal delivery, had an intact LAM, a levator hiatal 
area <25 cm2, absence of any medical history of collagen disease, no induction of labour, 
no epidural analgesia, no episiotomy etc. and who had a subpubic angle >90° and <100°. 
 
5.4   Results 
 
Clinical follow-up was attended by 202 participants (33.3% of all eligible for follow-up). 
The study population consisted of 99.5% Caucasian women with mean age 31.2 years, 
mean BMI 25.1 kg/m2 and mean weight 68.0 kg. All demographic characteristics of 
women who participated in the 4P clinical follow-up study were similar to those in 
participants of the Screening for Obstetric and Pregnancy Endpoints (SCOPE) Ireland 
(Table 5.1).  
We found a high prevalence of various types of POP. Most prevalent was cystocele, 
present in 90% of participants, followed by uterine prolapse (89%) and rectocele (70%). 
None of the participants had prolapse grade 3 or higher (Table 5.2).  
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In the majority of cases (65%), there was a coexistence of the anterior-, central- and 
posterior-compartment prolapse. Two-compartment involvement was the second most 
common (25%), with cystocele and uterine prolapsed being the most frequently 
associated conditions. Solitary POP was the rarest finding in this study group (Table 5.3).   
 
Despite the high prevalence of POP on POP-Q examination, only 20% of participants with 
prolapse were symptomatic. The prevalence of symptoms is presented in Table 5.4 as 
binary variables. There was a better association between prolapse diagnosis and 
presence of symptoms on Tp-USS, which outlines patients with significant prolapse only. 
On Tp-USS, 33% of participants with POP were symptomatic (Table 5.4).  We found a 
statistically significant correlation between procollagen type III (PIIINP) levels and 
uterine prolapse. Mean PIIINP level (SD) was higher in participants with uterine vs. 
nonuterine prolapse: 101(39) μg/ml vs. 69 (25) μg/ml. Mean difference was 32 μg/ml 
[95% confidence interval (CI) 3–60, p=0.01)] However, there was no significant 
association between collagen type III levels and presence of cystocele or rectocele. 
 
On examining risk factors in medical history, we found a statistically significant 
association between various types of POP and family history of uterine prolapse, 
cystocele, varicose veins and personal history of vertebral hernia, varicose veins and 
asthma (p<0.05) (Appendix VI). A statistically significant association was found between 
Beighton score and rectocele (p=0.036) but not for cystocele and uterine prolapse. 
However, when we analysed the correlation with a combined score for all prolapses, a 
statistically significant association was detected (p=0.022). We analysed the correlation 
between various POPs and different risk factors (Table 5.5). A particular POP was 
associated with presence of other types of prolapse; however, the most persistent and 
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significant risk factor was LAM trauma. During analysis of the impact of MoD on 
prolapse, in order to increase statistical power, we combined all instrumental deliveries 
and all CS (Table 5.6).We found that CS reduced the risk of cystocele and rectocele but 
not of uterine prolapse. Instrumental deliveries slightly but not significantly reduced the 
risk of rectocele. 
 
5.5   Discussion 
 
In this study, we aimed to evaluate the role of childbirth in the development of postnatal 
POP by assessing primiparous women only at least 1 year postnatally to exclude 
transitional postnatal changes in the pelvic floor. Additionally, we intended to test the 
hypothesis stating that POP is a congenitally determined condition rather than a result of 
childbearing alone and especially of vaginal delivery. We hypothesised that if the 
condition were congenitally determined and caused by abnormal collagen quantity or 
quality, this change should have a systemic pattern, involving other parts of the body, as 
well having a family history of collagen-related disorders.  
 
The prevalence of different types of POP appeared very high in our study. However, in 
the majority, prolapse grade was I–II and was asymptomatic. Our data are consistent 
with previous epidemiological studies, and the question of changing the prolapse 
classification to a more clinically relevant one has been raised in the past 55. There seems 
to be a better clinical correlation between presence of prolapse symptoms and US 
findings, where prolapse is classified into clinically significant or nonsignificant42. The 
actual POP-Q system comprehensively describes different types of POP. However, the 
system has a poor association with clinically meaningful prolapse, resulting in labelling 
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the majority of patients as having prolapse and causing unnecessary anxiety and 
sometimes even surgical interventions. 
 
 Collagen plays an important role in the human body, offering biomechanical strength 
and elasticity to connective tissue. The process of collagen synthesis consists of five 
steps. The first two are intracellular, occurring in fibroblasts; the remaining three are 
extracellular120. When a procollagen molecule leaves the cell, it is transforming from 
procollagen into tropocollagen by proteolytic cleavage of carboxy and amino terminals. 
These terminals can be detected and quantified as markers of collagen synthesis in blood 
serum or frozen tissue homogenates121. Procollagen N-terminal propeptides (PNP) and 
C-terminal propeptides (PCP) are specific to collagen type and can be quantified by 
radioimmunoassay 46 or ELISA test122.  There are 28 types of collagen; however only 
types I, II and III are major supporting collagens144. Type I is the most prevalent and 
widespread in the body, constituting 90% of total body collagen, especially being 
abundantly present in bone tissue, where strength is required. Collagen type II is mostly 
found in cartilage and type III in soft tissue, e.g. skin, ligaments144-145. There is 
controversy regarding collagen content in patients with prolapse, the consensus being 
collagen type I is minimally changed or has a tendency to slightly lower levels in severely 
prolapsed patients; collagen type III seems to undergo the most important change, and 
its concentration appears to be significantly increased, which changes the type I/III 
ratio111, 120. Edwall et al. suggested this finding may be due to an increased collagen 
turnover in patients with prolapse following intensive breakdown, especially for 
collagen type III. 
In our study, the majority of participants were relatively young (78% <34 years), and 
POP was only grade I–II. We decided to investigate the synthesis of collagen type III only 
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because, according to previous studies, this is where we would expect to find the most 
significant change111, 120. Our results were consistent with previous findings, showing a 
statistically significant increase in collagen type III synthesis in participants with uterine 
prolapse. However, we found no statistically significant association with cystocele or 
rectocele. This may be due to the fact that the dry weight of uterine attachment 
ligaments comprises 70– 80% collagen, where collagen type III has the highest content 
in the body; in fascial tissue, such as vesicovaginal or rectovaginal septum, collagen III 
content is lower46, 144.  
 
Collagen abnormality appears to be a systemic issue. Although genes coding collagen 
synthesis may have different expressions in various tissues, there is a body of evidences 
indicating that collagen-related problems seem to have a systemic manifestation. It has 
been demonstrated that POP is associated with joint hypermobility; abdominal, inguinal 
and vertebral hernias; varicose veins; mitral valve prolapse etc17, 46, 115-116.  Our results 
are consistent with these findings, showing a statistically significant association between 
POP and various family and personal medical history risk factors. In clinical practice, 
introducing a relatively simple investigation for collagen levels, such as ELISA of blood 
serum, could help identify antenatally the patients at higher risk of POP. However, larger 
studies are needed to confirm the potential benefit of this investigation, which 
demonstrates that uterine prolapse, for instance, is associated with pregnancy per se, 
rather than with MoD.  
 
A multivariate analysis was performed to assess the correlation of significant risk factors 
described above and the impact of LAM trauma and MoD on POP, excluding most 
common confounders. The analysis showed that the associations between collagen level 
and family and personal history of collagen-related diseases were confounded. In 
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multivariate analysis, levator avulsion was significantly associated with different types of 
POP, and the presence of rectocele was associated with uterine prolapse. The latter 
partially confirms the role of multicompartment involvement of POP in the majority of 
participants as a reflection of generalised pelvic floor weakness. Low yield of statistically 
significant results in multivariate analysis could probably be explained by the limited 
number of observations of these variables in our study. Multivariate analysis did not 
demonstrate that vaginal delivery increases the risk POP; however, surprisingly, we 
found that CS is significantly protective against the development of rectocele and 
cystocele only and does not affect the occurrence of uterine prolapse (Table 5.6). 
Attempting to explain this selective impact of MoD on different types of POP, we 
hypothesised that the significantly protective effect of CS against cystocele and rectocele, 
in contrast to uterine prolapse, could possibly be explained by the different attachment 
mechanism of the uterus on the one hand and vagina on the other. The main uterine 
support consists of cardinal and uterosacral ligaments. Their insertion point is 
concentrically focussed the around lower uterus and is perpendicular to the birth canal 
axis. Paravaginal support was demonstrated by DeLancy to have three levels of 
attachment146. Although level one, which is similar to the uterine attachment, plays an 
important supportive role, the area of level two is much larger. It consists of 
vesicovaginal fascia and rectovaginal septum, both running parallel to the birth canal 
axis. Level two resembles a sail framed by arcus tendineus and fascia of levator ani 
muscles. Thus, vesicovaginal fascia and rectovaginal septum are peripherally attached, 
whereas the midline part, projecting on the urogenital hiatus, is the most mobile and 
exposed area. In addition, there is a different distribution of pressure vectors during 
labour on supportive structures through the birth canal. During vaginal delivery, the 
uterine pressure vector is directed along the longitudinal uterine axis. Suspension 
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ligaments, focussed around the exit of the fully dilated uterus, have opposing 
contradirectional resistance in a parallel plane. In the vagina, the pressure vector is 
perpendicular to vesicovaginal fascia and rectovaginal septum147.  The main impact on 
uterine position appears to result from pregnancy, during which gravitation facilitates 
continuous overdistension of the uterine ligaments, which contain a higher level of 
abnormal collagen type III. In the case of rectocele and cystocele, damage is probably 
produced during labour, when the foetal head is progressing through the birth canal and 
is overstretching the vagina. This can lead to avulsion injury of the paravaginal 
supportive structures. Considering this, additional strategies apart from CS must be 
investigated to prevent POP and especially uterine prolapse; such strategies include 
education around avoiding risk factors, such as smoking, which has been shown to 
impair collagen quality148, or performing life-long pelvic floor exercises to reinforce the 
pelvic floor. 
 
5.5.1    Strengths and limitations   
 
The main strength of our study is its comprehensive approach to the investigation of 
POP. It included detailed family and personal history of related medical conditions, use 
of a validated questionnaire, POP-Q assessment, transperineal scan and collagen 
quantification. Additionally, this study encompasses a large number of well-phenotyped 
nulliparous participants followed up to 1 year postnatally and is representative of the 
entire population. Although we had a clinical follow-up rate of 33% of eligible 
participants, demographic characteristics of these women was similar to the SCOPE 
cohort (Table 5.1), which has been shown prepregnancy to be representative of the 
entire nulliparous population139. High homogeneity of the study population is another 
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strength, allowing us to overcome naturally occurring confounders for POP, such as 
advanced age and interracial differences. The majority of participants was relatively 
young (78% <34 years) and Caucasian (99%), which enables a better understanding of 
the natural history of POP. Previous studies have shown that white women are 
considered more prone to develop prolapse and urinary incontinence (UI)8, 137. All 
patients were delivered in the same hospital following similar protocols and obstetric 
approaches, which excludes various obstetric management confounders. The main 
limitation of the study is that our participants did not have a POP-Q and Tp-USS 
assessment in early pregnancy, i.e. at the time of recruitment. Also, we recognize that our 
study could be underpowered for making a definite conclusion on the impact of MoD on 
POP. The low clinical follow-up rate due to high exclusion numbers as a result of the next 
ongoing pregnancy is another limitation. This could also explain why the number of 
participants >34 years was slightly higher than in SCOPE data. However, we dealt with 
this issue by doing a multivariate logistic regression, including age as a confounder. The 
slight difference with SCOPE demographics can be also explained by the fact that all 
participants were at least 1 year older than at recruitment. In addition, we investigated 
the association between POP and 35 medical conditions. We acknowledge that having so 
many tests creates a possibility of chance findings. However, we investigated only 
conditions previously shown to be associated with POP. 
 
5.6   Conclusion 
 
POP has a very high prevalence among premenopausal primiparous women, with the 
majority having multicompartmental involvement. In the majority of our patients, 
prolapse was asymptomatic; however, it may well contribute to future pelvic floor 
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morbidity in the postmenopausal period. The relationship between POP and family and 
personal history of collagen abnormalities, the association between uterine prolapse and 
collagen level and the lack of correlation between MoD and uterine prolapse grade is 
suggestive of an important congenital contribution to POP aetiology. Similarly, LAM 
trauma proved to be a paramount risk factor. CS seems to be protective against cystocele 
and rectocele, with no effect on uterine prolapse; this issue warrants further research. 
POP-Q is a very comprehensive classification system; however, we agree that perhaps it 
has a more valuable role in research than in clinical settings in which grade I–II prolapse 
is assessed. Considering the fact that POP seems to have a strong congenital 
predetermination, a thorough analysis of risk factors could help identify women at a 
higher risk of POP and implement some preventive measures. 
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Table 5.1   Demographic characteristics of the population in  
                        the 4P-study and  Scope Ireland study 
 
4P/PFD study          
(n=202) 
SCOPE Ireland                        
(n=1775) 
Caucasians 201(99.5%)* 1450(97.7%) 
Age in years 
17-24 19(9.4%) 207(11.7%) 
25-29 49(24.3%) 545(30.6%) 
30-34 89(44.16%) 787(44.4%) 
35-45 45(22.3%) 235(13.3%) 
BMI 
Underweight 4(2%) 22(1.2%) 
Normal 103(51%) 1036(58.4%) 
Overweight 70(34.7%) 495(27.9%) 
Obese 25(12.4%) 221(12.5%) 
Education 
≤12 years 28(13.9%) 230(13%) 
>12 years 174(86.1%) 1544 (87%) 
Smoking 
Non smokers 148(73.3%) 1285(72.4%) 
Smokers 54(26.8%) 489(27.6%) 
Alcohol consumption 
No 39(19.3%) 339(19.1%) 
Yes 163(80.7%) 1435(80.9%) 
Mean values A 
Age in years 31.2(4.7) 29.9(4.5) 
BMI 25.1(4.1) 24.9(4.2) 
Weight in kg. 68.0(11.3) 67.5(12.2) 
   
* All values presented as number of cases and ( %) of total 
   
A  Data presented as mean value and Standard Deviation (SD) 
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Table 5.2            Prevalence of various types of POP*  (N = 202) 
Prolapse Grade Cystocele Rectocele 
Uterine 
prolapse 
0 20 (9.9%) A 60 (29.7%) 22 (10.9%) 
1  64 (31.7%) 95 (47.0%) 178 (88.1%) 
2  118 (58.4%) 47 (23.3%) 2 (0.9%) 
Total prolapsed 182 (90.1%) 142 (70.3%) 180 (89.1%) 
* Prolapse quantified according to POP-Q 
  
 
    
A  All percentage given out of total participants     
 
 
 
Table 5.3   Number of POP compartments involved  (N = 197) 
3 Compartments prolapsed 129 (65.5%) 
Cystocele + Uterine prolapse 39 (19.8%) 
Cystocele + Rectocele 7 (3.6%) 
Uterine prolapse + Rectocele 4 (2%) 
Uterine prolapse  11 (5.6%) 
Cystocele 6 (3.1%) 
Rectocele 1 (0.5%) 
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Table 5.4            Prevalence of prolapse symptoms in association with various types of prolapse (N = 202) 
          
 
POP-Q assessment 
 
Ultrasound assessment* 
 
Cystocele 
 
Rectocele 
 
Uterine prolapse 
 
All prolapses 
 
Cystocele   Rectocele 
 
Total Grade 2 
 
Total Grade 2 
 
Total 
Grade 
2 
 
Total Grade 2 
                                    
Asymptomatic A 142(78.0%) 28(23.7%) 
 
98(69%) 34(72.3%) 
 
131(72.3%) N/AC 
 
158(80.2%) 94(75.2%) 
 
18(66.7%) 
 
35(68.6%) 
Prolapse sensation A 18(9.9%) 15(12.7%) 
 
17(12%) 8(17.0%) 
 
17(9.4%) N/A 
 
19(9.6%) 15(12%) 
 
5(18.5%) 
 
8(15.7%) 
Vaginal Pressure                    
or heaviness A 27(14.8%) 22(18.6%) 
 
20(14.1%) 8(17.0%) 
 
26(14.4%) N/A 
 
30(15.2%) 23(18.4%) 
 
8(29.6%) 
 
12(23.5%) 
Prolapse reduction             
to void A 6(3.3%) 5(4.2%) 
 
5(3.5%) 3(6.4%) 
 
4(2.2%) N/A 
 
5(2.5%) 5(4.0%) 
 
1(3.7%) 
 
2(3.9%) 
Prolapse reduction to 
defecate A 2(1.1%) 1(0.9%) 
 
2(1.4%) 1(2.1%) 
 
2(1.1%) N/A 
 
2(1.1%) 2(1.6%) 
 
0(0%) 
 
0(0%) 
Associated bother A 12(6.6%) 9(7.6%) 
 
11(7.8%) 4(8.5%) 
 
10(5.6%) N/A 
 
13(6.6%) 10(8.0%) 
 
3(11.1%) 
 
6(11.8%) 
Prolapse present B 182(90.1%) 118(58.4%) 
 
142(70.3%) 47(23%) 
 
180(89.1%) 2(1%) 
 
197(97.5%) 125(61.9%) 
 
27(13.4%) 
 
51(25.3%) 
                                
* Significant only prolapse presented according to Dietz’s criteria[16] 
    
       A Percentage given out of total prolapsed within the group (last line in each column) 
       B Percentage given out of total participants 
      
       C Two participants only had uterine prolapse grade two                           
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Table 5.5   Correlation between different types of POP and various risk factors    
    
  
Univariate analysis 
 
Multivariate analysis 
  
OR CI (95%) p= 
 
OR CI (95%) p= 
   
Cystocele 
   
 
 Uterine prolapse 
 
5.8 (2.61-12.73) 0.000 
  
 
 Rectocele 
 
12.8 (4.93-33.26) 0.000 
    LAM* avulsion 
 
4.3 (1.55-11.78) 0.005 
 
2.86 (1.20-6.85) 0.018 
High collagen Type III  levels 1 (0.99-1.01) 0.944 
    Family history of collagen diseases 0.9 (0.52-1.59) 0.736 
    Personal history of collagen diseases 1.2 (0.62-2.16) 0.647 
    
   
Rectocele 
     Uterine prolapse 
 
2 (1.01-3.84) 0.046 
    LAM* avulsion 
 
1.1 (0.52-2.44) 0.767 
    High collagen Type III  levels 1 (0.98-1) 0.082 
    Family history of collagen diseases 1 (0.6-1.74) 0.945 
    Personal history of collagen diseases 1 (0.57-1.8) 0.976 
    
   
Uterine prolapse 
    Cystocele 
 
5.7 (2.18-15.11) 0.000 
    
Rectocele 
 
1.9 (0.94-3.96) 0.071 
 
15.1 
(5.62-
40.35) 0.000 
LAM* avulsion 
 
2.4 (1.14-5.06) 0.021 
 
6.15 
(2.03-
18.56) 0.001 
High collagen Type III  levels 1 (0.98-1) 0.278 
    Family history of collagen diseases 1.3 (0.78-2.21) 0.312 
    Personal history of collagen diseases 0.9 (0.51-1.59) 0.726 
    * LAM - levator ani muscle 
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Table 5.6     Correlation between various types of POP and mode of delivery * 
      
Type of 
POP Mode of delivery 
№ 
 
Unadjusted 
 
Adjusted 
  RR 95% (CI) p =   RR 95% (CI) p = 
           Cystocele Vacuum 23 
 
0.9 (0.67-1.24) 0.560 
 
0.9 (0.62-1.19) 0.363 
 
Forceps 24 
 
1.1 (0.84-1.43) 0.487 
 
1.0 (0.74-1.32) 0.919 
 
Em. Caesarean Sections 8 
 
0.6 (0.34-1.06) 0.078 
 
0.6 (0.35-1.08) 0.089 
 
El. Caesarean Sections 12 
 
0.5 (0.33-0.86) 0.011 
 
0.4 (0.27-0.7) 0.001 
           
 
All Instrumental deliveries 47 
 
1.0 (0.79-1.26) 0.996 
 
0.9 (0.72-1.19) 0.540 
 
All Caesarean Sections 20 
 
0.6 (0.38-0.82) 0.003 
 
0.5 (0.33-0.73) 0.000 
   
 
   
 
   
Rectocele Vacuum 9 
 
0.8 (0.39-1.47) 0.416 
 
0.7 (0.36-1.49) 0.394 
 
Forceps 10 
 
1.0 (0.52-1.8) 0.929 
 
0.8 (0.42-1.64) 0.595 
 
Em. Caesarean Sections 2 
 
0.3 (0.08-1.25) 0.101 
 
0.3 (0.1-1.12) 0.076 
 
El. Caesarean Sections 2 
 
0.2 (0.05-0.76) 0.019 
 
0.2 (0.03-0.66) 0.012 
           
 
All Instrumental deliveries 19 
 
0.9 (0.52-1.43) 0.557 
 
0.8 (0.46-1.36) 0.397 
 
All Caesarean Sections 4 
 
0.2 (0.09-0.65) 0.005 
 
0.2 (0.08-0.56) 0.002 
   
 
   
 
   
Uterine  Vacuum 32 
 
0.9 (0.82-1.08) 0.402 
 
0.9 (0.79-1.08) 0.349 
prolapse Forceps 28 
 
0.9 (0.79-1.08) 0.304 
 
1.0 (0.81-1.11) 0.498 
 
Em. Caesarean Sections 19 
 
1.0 (0.91-1.16) 0.626 
 
1.1 (0.93-1.24) 0.351 
 
El. Caesarean Sections 29 
 
0.9 (0.79-1.08) 0.322 
 
1.0 (0.84-1.12) 0.632 
           
 
All Instrumental deliveries 60 
 
0.9 (0.83-1.04) 0.227 
 
0.9 (0.83-1.06) 0.302 
 
All Caesarean Sections 48 
 
1.0 (0.86-1.08) 0.531 
 
1.0 (0.9-1.13) 0.913 
           *Spontaneous vaginal delivery – used as reference group           
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6.1   Abstract 
 
 
Objectives:  To investigate the postnatal prevalence of sonographically diagnosed pelvic 
floor trauma, and the correlations with various antenatal/intrapartum predictors in 
primiparous women. 
 
Methodology: A prospective cohort study, performed in a tertiary hospital with 9000 
deliveries per annum. 202(23.2% of those recruited) primiparous participants were 
clinically assessed at least one year postnatally, with Pelvic Organ Prolapse 
Quantification (POP-Q), 2/3D-transperineal ultrasound (TpUS) and collagen type III 
levels quantification. 
 
Results: Clinically significant POP had a high prevalence on POP-Q staging: uterine 
prolapse-63%, cystocele-42%, rectocele-23%. Ballooning of the levator ani muscle 
(LAM) hiatus was detected in 33.2% and LAM avulsion in 29% of participants, with 
partial LAM avulsion in 15% and complete in 14%. Postnatal POP symptoms were 
positively associated with similar prepregnancy symptoms (OR [95% CI]) (OR 7.2 [1.19-
44.33]), LAM avulsion (OR 4.8 [1.99-11.34]), forceps delivery (OR 1.8 [0.96-3.25]) and 
negatively associated with Caesarean Section (CS) (OR-0.2 [0.09-0.63]). LAM 
abnormality was associated with forceps delivery (OR 4.9 [1.44-16.97]) and prolapse 
(OR between 6.8 and 11.7 [2.34-78.51]), whereas collagen levels did not play a role 
1.007 [0.99-1.02]. 
 
Conclusion: Clinically significant POP was common in relatively young premenopausal 
primiparae. A partial or full levator avulsion was seen in 29% of participants, being 
associated with POP and symptoms related to it. Congenital factors seem to play little 
role in the aetiology of levator muscle trauma, whereas the main risk factor seems to be 
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forceps delivery. Avoidance of difficult vaginal deliveries may prevent severe pelvic floor 
trauma. 
 
6.2   Introduction 
 
Pelvic floor dysfunction (PFD) is a common problem, with childbearing recognised as 
one of the major risk factors6. Numerous epidemiological and clinical studies have been 
undertaken on various aspects of PFD, such as urinary and faecal incontinence, prolapse 
or sexual dysfunction. There has been increasing interest over the last decade in 
innovative methodologies investigating morphological changes of pelvic floor, especially 
3D transperineal ultrasound (3D-TpUS).   This technique has good test-retest and intra-
observer repeatability and is considerably cheaper and in some aspects superior to 
magnetic resonance imaging (MRI), especially when assessing dynamic images, eg for 
the investigation of prolapse16, 104, 149. Several groups have examined the role of trauma 
to the puborectalis aspect of the levator ani muscle (LAM) in development of PFD100, 108. 
The appearances of LAM avulsion seem to be very uncommon in nulliparous women, 
however it is present in 12-36% of women after first vaginal delivery106. Additionally, 
transperineal ultrasound allows visualisation of bladder neck mobility, urethral length, 
assessment and quantification of pelvic organ prolapse (POP), measurement of subpubic 
angle and assessment of the anal sphincter complex40, 103, 150.   
 
The present ultrasound study is a part of the 4P-study (Prevalence and Predictors of 
Pelvic floor dysfunction in Primips), which is designed to comprehensively assess 
changes in the pelvic floor after first pregnancy and delivery. In this study we aimed to 
investigate the postnatal prevalence of sonographically diagnosed morphological 
157 
 
alterations of pelvic floor functional anatomy and their correlations with various 
antenatal and intrapartum predictors in primiparous women.  
 
6.3   Methodology 
 
The 4P is a prospective cohort study, nested within the parent SCOPE Ireland study 
(Screening for Pregnancy Endpoints, www.scopestudy.net), which has previously been 
described in detail151. It was approved by Clinical Research Ethics Committee of the Cork 
Teaching Hospitals (CREC) Ireland and performed in a tertiary maternity hospital with 
9000 deliveries per annum. 
 
All 4P participants, 1484 nulliparous women (84% of those recruited for SCOPE), 
completed the validated Australian Pelvic Floor Questionnaire28 in early pregnancy at 
14- 15 weeks.  Same questionnaire was answered one year postnatally by 1060 women 
(71% of those who completed the prepregnancy one), however only 872 (59%) were 
included in the study analysis and constituted the core of 4P-Study, since 188 (13%) 
were excluded due to a second ongoing pregnancy. The recruitment phase occurred 
between February 2008 and March 2011. All 872 participants included in the initial 
analysis were invited for clinical follow up between March and December 2012. We 
received answers from 530 (60.8%) participants, the proposed follow-up being accepted 
by 408 (46.8%). Participants who had more than one delivery, or were repeatedly 
pregnant at the time of follow up 23.6% (206), were excluded from the study (Figure 1). 
The clinical follow up was attended by 202 (23.2% of all invited) participants between 
May and November 2012. All attendees had a POP-Q assessment, transperineal 2D/4D 
ultrasound scan for quantification of POP and pelvic morphology evaluation, a blood 
serum collection for pro- collagen quantification and a collection of personal history 
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and/or family history of connective tissue conditions, shown previously to be associated 
with PFD and POP (Appendix VI). 
 
POP-Q measurements were obtained on maximal Valsalva with an effort duration of at 
least 6 seconds, in order to achieve maximal pelvic organ descent117. Pb and Gh lengths 
were additionally measured at rest. The POP-Q classification does not specify what grade 
of prolapse should be considered significant, however it has been suggested that POP-Q 
Stage 1 may be considered part of the normal range152. This may not be correct for the 
central compartment however, where stage 1 prolapse seems strongly associated with 
symptoms of prolapse152. Hence, we defined ‘clinically relevant prolapse’ as cystocele 
and rectocele ≥ Stage 2, uterine prolapse ≥ stage 1. For ultrasound POP investigation on 
2D transperineal ultrasound scan (2D-TpUS) and 3D-TpUS, two images were acquired – 
at rest and on maximal Valsalva. To estimate the extent of prolapse, we measured the 
distance from the most distal part of the bladder or anorectal junction to a horizontal 
line placed through the inferior margin of the pubic bone153. 
 
There are no studies to date correlating the degree of prolapse diagnosed on POP-Q vs. 
ultrasound. However, previous studies reported a better correlation between presence 
of symptoms  and grade of ultrasound prolapse154. We used an ultrasound POP 
classification categorising prolapse into clinically significant and non-significant42. A cut-
off level of 10mm below the symphysis pubis was proposed for definition of significant 
cystocele and 15 mm below the SP for significant rectocele. We used the reference line 
(that is a cut-off of 0) as the definition of significant uterine prolapse based on 
unpublished data provided by HP Dietz as there is currently no published cut- off for 
central compartment descent. 
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LAM integrity was assessed using 3D-TpUS in tomographic ultrasound imaging (TUI) 
mode, the image being acquired on maximum pelvic floor muscle contraction. The plane 
of minimal hiatal dimension was selected as reference plane.  To cover the whole width 
of LAM, five tomographic slices cephalad to the reference plane, with a slice thickness of 
2.5 mm, were included in the analysis. A LAM avulsion was diagnosed if the gap between 
the centre of the urethra and the LAM insertion (Levator- urethra gap or LUG) was ≥25 
mm101. A complete LAM avulsion was diagnosed if a gap ≥ 25 mm was observed in the 
reference slice and in the two slices cephalad to it. Any other combination of abnormal 
slices was considered a partial LAM avulsion102. We also assessed ballooning of the 
levator hiatus, which is defined as distension of hiatal area >25cm2 and has been shown 
to be associated with LAM trauma and symptoms and signs of prolapse45. The subpubic 
arch angle was measured in the axial plane close to the plane of minimal hiatal 
dimensions, where the pubic rami join. The image was manipulated to obtain maximal 
pubic rami length103. 
 
We measured the Procollagen type III N-Terminal Propeptide (PIIINP) level in 96 
participants, using commercial ELISA tests manufactured by Uscn Life Science Inc. 
Wuhan. Participants with highest and lowest value for point C (leading edge of cervix on 
POP-Q assessment) were selected from the cohort for procollagen quantification. The 
methodology was described in detail previously154.  
6.3.1   Statistical analysis 
 
Statistical analysis was performed using IBM SPSS 19 and Stata Software 10.0. All 
statistical tests were two-sided and a p-value <0.05 was considered statistically 
significant. To investigate the effect of potential risk factors (RFs) on PFD, stepwise 
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ordinal logistic regression was used to calculate the Odds Ratio (OR) and 95% 
Confidence Interval (95% CI). In ordinal logistic regression, the outcome measure was 
ordinal with more than two categories. RFs with borderline statistical significance 
(p<0.1) were used for multivariate logistic regression. Main outcome measures were, 
rectocele, uterine prolapse, LAM trauma, and LAM hiatal ballooning. The examined risk 
factors were subpubic arch angle, collagen type 3 levels, personal / family history of 
collagen related diseases,  induction of labour, mode of delivery, Oxytocin augmentation, 
duration of labour, foetal  head circumference and birthweight. 
 
6.4   Results 
 
Clinical follow up was attended by 202 primiparous women (33.3% of all eligible for 
follow up). Among our participants 99.5% were Caucasian, with mean age 31.2 years, 
mean BMI of 25.1 kg/m2 and mean weight 68.0 kg. Demographic characteristics of 
women who participated in 4P-study clinical follow up and SCOPE Ireland were similar 
(Table 6.1). The SCOPE cohort has been shown previously to be representative for the 
entire population151. 
 
In order to avoid transitory postnatal pelvic floor changes, participants were invited for 
clinical follow up at least one year postnatally. The average delivery to clinical 
assessment interval was 1 year and 9 months (ranging from 1.1 to 4.1 years). Of all 
participants 158 (80.2%) were asymptomatic, 19 (9.6%) complained of symptoms of a 
vaginal lump or bulge, 30 (15.2%) of vaginal pressure or heaviness, 4 (2.2%) of prolapse 
reduction to void, 10 (5.6%) of prolapse reduction to defecate and 10 (5.6%) reported 
associated bother due to prolapse symptoms. 
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On clinical examination the Mean (Standard Deviation) POP-Q values for various points 
on maximal Valsalva were as following: Ba -1.21 (0.84)cm, Bp -1.92 (0,75)cm, C -5.23 
(1.03)cm. On 2D-TpUS maximal descent of the bladder on Valsalva was to 0.45 (SD 1.16) 
cm below the symphyseal reference line. Maximal descent of the rectal ampulla was to 
0.46 (SD 1.17) cm above the reference line. 
 
The prevalence of various types of POP on POP-Q and 3D-TpUS is presented in Table 6.2. 
Clinically significant uterine prolapse (Stage 1 or higher) on POP-Q measurement 
(described in methods section) was present in 63% participants. Clinically significant 
cystocele (stage 2 or higher) was 3 fold higher on POP-Q examination compared to the 
finding of a significant cystocele on ultrasound (bladder 10 mm or more below the SP) at 
41.6% vs. 13.9%. Significant posterior compartment descent (ICS POP-Q stage 2 or 
higher, or descent of the ampulla to 15 mm below the SP or more) was similar for both 
diagnostic methods – around 24%.  
 
The 3D-TpUS revealed that nearly one third of participants (29.2%) had some sort of 
abnormal LAM morphology. The rate of partial LAM avulsion was one third higher 
comparing to complete avulsion (21.8% vs. 14.4%) right sided avulsion being more 
common that left sided (10.9% vs. 2.5%), and bilateral avulsion being common at 
15.8%). One third of participants (67; 33.2%) had ballooning of LAM hiatus, of which 38 
(56%) had associated LAM avulsion.  
Analysing the factors associated with presence of prolapse symptoms we found  
statistically significant correlations with prepregnancy presence of prolapse symptoms 
(OR 2.7 - 7.2), complete LAM avulsion (OR 4.8 - 9.5), LAM hiatal ballooning (OR 2.5 – 5.2) 
and  forceps delivery (OR 1.8). Caesarean Section delivery was protective (OR 0.2 – 0.4) 
(Table 6.3). 
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Additionally, we analysed the association of various antepartum and intrapartum factors 
with LAM trauma and ballooning of LAM hiatus. On univariate analysis we found 
statistically significant or borderline significance correlation between any LAM trauma 
and use of Oxytocin in labour (OR 1.8), duration of 2nd stage of labour (OR 1.008), 
forceps delivery (OR 4.5), episiotomy (OR 4.2) and presence of cystocele postnatally (OR 
4.2) (Table 6.4).  
 
Ballooning of LAM hiatus was associated with forceps delivery (OR 4.8), episiotomy (OR 
1.9), presence of postnatal cystocele, rectocele and uterine prolapse – (OR 7.5, 2.6 and 
7.6 respectively), and LAM avulsion (OR 2.8 for partial and 17.4 for complete avulsion) 
(Table 6.5).  
 
On multivariate analysis LAM avulsion was statistically significant associated with 
duration of 2nd stage of labour (OR 1.01), forceps delivery (OR 4.9), postnatal presence 
of uterine prolapse (OR 6.84) and cystocele (OR 11.7) (Table 6.4). Ballooning of LAM 
hiatus was significantly associated with uterine prolapse (OR 7.6) and LAM avulsion (OR 
3.2 for partial and 12.2 for complete avulsion). Forceps delivery had borderline 
significance here (OR 4.0 (p=0.074)) (Table 6.5).  
 
We did not find any association between LAM abnormality and foetal birthweight or 
head circumference, duration of labour, subpubic arch angle, collagen levels, or collagen 
disease history. Also the time interval from delivery to 3D-TpUS did not significantly 
influence the presence of LAM pathology. Caesarean Section (CS) appeared protective, 
however not statistically significant.  
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6.5   Discussion 
 
In the present study we investigated the postnatal prevalence of the pelvic floor trauma 
using 3D-TpUS in primiparous women Different from previous studies, we intended to 
describe the ultrasound appearance of the pelvic floor in primiparas at one year after 
childbirth and to link it to potential prepregnancy and intrapartum contributing 
factors107. We intentionally used this cut-off for time limit, in order to avoid inclusion of 
transitory pelvic floor changes in our study, which can persist up to 6 months postnatally 
or even more71.    
 
We found pelvic organ prolapse to be very common in primiparous women, with 
clinically significant cystocele being more prevalent on POP-Q assessment, and rectocele 
having similar detection rates on POP-Q and 3D-TpUS investigation. Around half of 
participants had clinically significant cystocele or uterine prolapse and one quarter had 
clinically significant posterior compartment descent, although nobody had any type of 
prolapse greater than stage 2 (Table 6.2). It is recognised that the correlation of POP 
findings between POP-Q assessment and on TpUS are fair to good153. However it has also 
been demonstrated that TpUS is more likely to avoid the potential confounding effect of 
important factors such as levator co-activation, full bladder or rectum (which can be 
directly visualised on the screen and dealt accordingly), whereas clinical examination 
additionally is able to displace one compartment to allow other compartments to 
descend155.  
Prolapse symptoms were not uncommon (even though 80% of participants with 
objective prolapse were asymptomatic), and were associated with LAM trauma and 
forceps delivery, whereas CS had a protective effect154. The prevalence of ultrasound 
diagnosed complete LAM avulsion obtained in this study is well within the range of data 
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reported previously, with 14.4% being close to figures reported recently in studies using 
an identical methodology41, 156. Our rate of partial avulsion is higher than demonstrated 
in previous studies, however similar to previous reports we found that right sided 
trauma is more common than left sided105. This is probably due to the fact that in Ireland 
active management of labour is advocated with high rate of forceps delivery. Slightly 
more than half of cases with ballooning of levator hiatus were associated with LAM 
trauma. A significant association was found between presence of prolapse symptoms and 
forceps delivery, whereas CS was protective. Our data from univariate analysis 
corresponded well with previous studies showing an association between LAM trauma 
with length of 2nd stage of labour, mode of delivery and episiotomy, where forceps was 
most predictive of trauma 41, 108, 156. In contrast to other reports we did not find a 
significant association with foetal birthweight and foetal head circumference108. This 
could probably reflect different obstetric practices, as active management of labour is 
largely used in Ireland and there is a high rate of instrumental deliveries, or else be due 
to power issues. In addition, definitions of avulsion vary in the published literature, 
which may explain some of the differences in results.  
 
The logistic regression analysis did not demonstrate an association between congenital 
non-modifiable factors such as subpubic arch angle, collagen levels or collagen related 
disease with LAM pathology, which most likely occurs due to mechanical impact of 
vaginal delivery, rather than due to the pelvic weakness. This conclusion confirms the 
results from previous studies using 3D-TpUS intrapartum and in early postnatal period, 
which demonstrated that crowning of the head is the immediate cause of avulsion of the 
levator ani muscle157. Additionally other research groups have demonstrated that hiatal 
dimensions, bladder neck descent, subpubic arch angle and other anthropometric 
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parameters were not associated with avulsion. Our results are in keeping with these data 
and suggest that antenatal prediction of LAM trauma may be impossible158.  
 
6.5.1   Strengths and limitations   
 
The main strength of our study is the fact that it was nested within the SCOPE study, 
giving access to a detailed database containing information about well phenotyped 
nulliparous women and intrapartum risk factors.  The present study is likely to be 
representative for the entire study population which is homogeneous and which has 
been shown to be representative of the Irish population overall. All participants were 
relatively young women, who delivered their babies in the same hospital, following 
similar obstetric management principles and protocols. A potential congenital predictor 
of pelvic organ support, Procollagen III, was included in the study design to investigate 
naturally occurring confounders. All participants were assessed both clinically by ICS 
POP-Q and by translabial ultrasound in order to comprehensively describe the state of 
pelvic organ support.  
 
 The lack of baseline assessments remains a major limitation, especially when 
interpreting clinical symptoms.  Another limitation is the limited number of observations 
due to attrition, which may limit the conclusions that can be drawn from our results, 
although the participants’ demographic characteristics in the present study were 
reasonably similar to the Cork SCOPE population. The study had limited statistical power 
due to small sample size and this is reflected in the wide 95% confidence intervals for 
some ORs. For example, family history of collagen diseases, induction of labour and 
oxytocin use during labour were not statistically significant in the univariate models 
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despite the elevated OR. This warrants further investigation of these risk factors in 
larger cohorts. 
 
6.6   Conclusion 
 
More than half of relatively young premenopausal primiparous women were shown to 
have some form of clinically significant POP at 1-4 years after their first delivery. This is 
likely to contribute to the development of PFD later in life. One third showed some 
degree of LAM trauma, which is associated with the presence of POP and symptoms 
related to it in later life.  Congenital factors seem to play little role in the aetiology of 
levator muscle trauma, whereas the main risk factor seems to be forceps delivery. 
Caesarean Section was demonstrated to be protective for presence of some symptoms. 
Avoidance of difficult vaginal deliveries may prevent severe pelvic floor trauma and 
associated symptoms. 
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Table 6.1     Demographic characteristics of the population in the 
                        4P-study and  Scope Ireland study 
 
4P/PFD 
study          
(n=202) 
SCOPE 
Ireland                        
(n=1774) 
Caucasians 201(99.5%)* 1450(97.7%) 
Age in years 
17-24 19(9.4%) 207(11.7%) 
25-29 49(24.3%) 545(30.6%) 
30-34 89(44.16%) 787(44.4%) 
35-45 45(22.3%) 235(13.3%) 
BMI 
Underweight 4(2%) 22(1.2%) 
Normal 103(51%) 1036(58.4%) 
Overweight 70(34.7%) 495(27.9%) 
Obese 25(12.4%) 221(12.5%) 
Education 
≤12 years 28(13.9%) 230(13%) 
>12 years 174(86.1%) 1544 (87%) 
Smoking 
Non smokers 148(73.3%) 1285(72.4%) 
Smokers 54(26.8%) 489(27.6%) 
Alcohol consumption 
No 39(19.3%) 339(19.1%) 
Yes 163(80.7%) 1435(80.9%) 
Mean values † 
Age in years 31.2(4.7) 29.9(4.5) 
BMI 25.1(4.1) 24.9(4.2) 
Weight in kg. 68.0(11.3) 67.5(12.2) 
   
*All values presented as number of cases and ( %) of total 
   
† Data presented as mean value and Standard Deviation (SD) 
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Table 6.2      Prevalence of various types of POP on POP-Q and 3D transperineal US   
                       assessment       (№ 202)  
 
Prolapse 
Presence 
            Cystocele              Rectocele        Uterine prolapse 
POP-Q* 3D-TpUS†   POP-Q* 3D-TpUS†   POP-Q‡ 3D-TpUS† 
         No  118(58.4%) 174(86.1%) 
 
155(76.7%) 153(75.7%) 
 
75(37%)    - 
Yes 84(41.6%) 28(13.9%) 
 
47(23.3%) 49(24.3%) 
 
127(63%)    - 
                
* Prolapse grade 2 only according to POP-Q shown as prolapse present     
† Significant only prolapse according to Dietz et al. shown as prolapse present (Dietz et al 42)  
‡ Prolapse grade 1- 2 according to POP-Q shown as prolapse present (according Dietz et al 152) 
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Table 6.3  Correlation of prolapse symptoms with various risk factors   (n=202) 
  OR CI (95%) p= 
                     Vaginal pressure or heaviness 
   
Pre-pregn. vaginal pressure/heaviness 4.4 (0.77-24.8) 0.096 
Pre-pregn. total prolapse score 4.4 (2.30-8.30) <0.0001 
Forceps delivery 1.7 (0.96-2.94) 0.071 
Emergency CS 0.4 (0.18-0.86) 0.019 
Elective CS 0.2 (0.09-0.52) 0.001 
Partial LAM avulsion  1.1 (0.35-3.70) 0.820 
Complete LAM avulsion 5.3 (2.14-13.3) <0.0001 
Ballooning of LAM hiatus  3.9 (1.73-8.58) 0.001 
                 Prolapse sensation 
   
Pre-pregn. vaginal pressure/heaviness 3.5 (1.13-10.66) 0.029 
Pre-pregn. prolapse score 2.7 (1.10-6.85) 0.03 
Forceps delivery 0.3 (0.12-0.99) 0.048 
Partial LAM avulsion  3.2 (0.84-11.92) 0.089 
Complete LAM avulsion 9.5 (3.08-29.26) <0.0001 
Ballooning of LAM hiatus 3.2 (1.21-8.28) 0.019 
         
 
 
   Presence of multiple prolapse symptoms 
  
Pre-pregn. vaginal pressure/heaviness 7.2 (1.19-44.33) 0.032 
Pre-pregn. total prolapse score 4.8 (2.37-9.55) <0.0001 
Forceps delivery 1.8 (0.96-3.25) 0.069 
Emergency CS 0.3 (0.12-0.83) 0.019 
Elective CS 0.2 (0.09-0.63) 0.004 
Partial LAM avulsion  1.6 (0.61-4.12) 0.340 
Complete LAM avulsion 4.8 (1.99-11.34) <0.0001 
Ballooning of LAM hiatus 2.5 (1.24-5.15) 0.011 
               Bother due to prolapse symptoms 
   
Pre-pregn. total prolapse score 4.2 (1.52-11.51) 0.006 
Partial LAM avulsion  1.7 (0.32-9.40) 0.519 
Complete LAM avulsion 7.4 (2.07-26.21) 0.002 
Ballooning of LAM hiatus 5.2 (1.53-17.54) 0.008 
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Table 6.4  Correlation between ultrasound diagnosed LAM avulsion and various antenatal /   
                   intrapartum factors     (n= 202)  
 
  
          Univariate analysis      Multivariate analysis 
Factors 
 
  OR CI (95%) p=   OR CI (95%) p= 
        Subpubic arch  angle 0.98 (0.95-1.02) 0.290 
    
High collagen T3  levels 1.01 (0.99-1.02) 0.224 
    
Family history of collagen diseases 1.5 (0.8-2.81) 0.209 
    
Personal history of collagen 
diseases 
0.9 (0.45-1.76) 0.743 
    
Private maternity care 0.99 (0.47-2.09) 0.991 
    
Induction of labour 1.4 (0.77-2.59) 0.265 
    
Use of Oxytocin in labour 1.8 (0.97-3.45) 0.063 
 
0.7 (0-1.63) 0.435 
Regional analgesia 0.9 (0.47-1.75) 0.779 
    
Duration of 1st stage of labour 0.99 (0.91-1.10) 0.988 
    
Duration of 2nd stage of labour 1.01 (1.00-1.01) 0.003 
 
1.01 (1.00-1.02) 0.019 
Vacuum delivery 1.9 (0.87-4.23) 0.108 
 
1.3 (0.48-3.52) 0.599 
Forceps delivery 4.5 (1.99-10.22) 
<0.000
1  
4.9 (1.44-16.97) 0.011 
Emergency CS 0.6 (0.47-1.63) 0.352 
    
Elective CS 0.7 (0.25-1.98) 0.507 
 
0.4 (0.04-4.08) 0.450 
Perineal tear 0.9 (0.65-1.25) 0.524 
    
Episiotomy 4.2 (2.24-7.78) 
<0.000
1  
1.8 (0.66-4.77) 0.251 
Foetal  birthweight 1.0 (0.99-1.01) 0.450 
    
Foetal  head circumference 1.1 (0.91-1.39) 0.296 
    
Delivery/assessment time interval 0.99 (0.99-1.00) 0.342 
    
Cystocele 4.2 (0.94-19.14) 0.061 
 
11.7 (1.73-78.51) 0.012 
Rectocele 1.3 (0.58-2.71) 0.569 
    
Uterine prolapse 1.6 (0.76-3.30) 0.218 
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Table 6.5  Correlation between ultrasound diagnosed ballooning of LAM hiatus  and various   
                   antenatal/intrapartum factors      (n= 202)  
 
  
Univariate analysis  Multivariate analysis 
Factors 
 
  OR CI (95%) p=   OR CI (95%) p= 
        Subpubic arch  angle 1.01 (0.98-1.05) 0.459 
    
High collagen T3  levels 0.99 (0.98-1.01) 0.514 
    
Family history of collagen diseases 1.5 (0.79-2.73) 0.230 
    
Personal history of collagen 
diseases 
1.5 (0.77-2.83) 0.245 
    
Private maternity care 1.1 (0.51-2.26) 0.860 
    
Induction of labour 1.3 (0.7-2.38) 0.413 
    
Use of Oxytocin in labour 1.7 (0.89-3.21) 0.111 
    
Regional analgesia 0.9 (0.45-1.69) 0.686 
    
Duration of 1st stage of labour 1.1 (0.98-1.19) 0.102 
    
Duration of 2nd stage of labour 1.0 (1.00-1.01) 0.303 
    
Vacuum delivery 1.5 (0.67-3.37) 0.326 
    
Forceps delivery 4.8 (1.91-11.82) 0.001 
 
4.0 (0.87-18.56) 0.074 
Emergency CS 0.5 (0.12-1.77) 0.264 
 
0.5 (0.07-2.98) 0.418 
Elective CS 0.6 (0.24-1.64) 0.340 
 
0.7 (0.13-3.33) 0.633 
Perineal tear 0.9 (0.68-1.31) 0.725 
    
Episiotomy 1.9 (1.05-3.52) 0.035 
 
0.6 (0.17-1.88) 0.353 
Foetal  birthweight 1.01 (1.00-1.00) 0.049 
 
1.0 (0.99-1.001) 0.192 
Foetal  head circumference 1.2 (0.94-1.45) 0.169 
    
Delivery/assessment time interval 0.73 (0.42-1.26) 0.263 
    
Cystocele 7.5 (1.65-33.59) 0.009 
 
2.1 (0.35-12.03) 0.422 
Rectocele 2.6 (1.15-5.79) 0.022 
 
1.8 (0.57-6.59) 0.311 
Uterine prolapse 7.6 (3.21-17.93) <0.0001 
 
6.8 (2.34-20.01) <0.0001 
Partial LAM avulsion  2.8 (1.25-6.24) 0.012 
 
3.2 (1.20-8.69) 0.020 
Complete LAM avulsion 17.4 (6.11-49.87) <0.0001 
 
12.2 (3.22-46.00) <0.0001 
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Several population based studies have investigated the association between PFD and 
childbirth. However, very few studies have targeted a nulliparous population. To our 
knowledge, this is the first large, comprehensive, prospective cohort study focused 
specifically on prepregnancy pelvic floor status in nulliparous women and the 
correlation of prepregnancy PFD with postnatal pelvic floor morbidity.  
 
7.1    Urinary Dysfunction (UD) 
 
The prevalence of various UD symptoms in nulliparous women, apart from urinary 
incontinence (UI), is unknown. There are some studies, like NHANES or EPINCONT, 
reporting the prevalence of urinary incontinence in nulliparous women as part of bigger 
cohorts, classifying participants by parity, age etc57, 68. We found a high prepregnancy 
prevalence of UD in this nulliparous cohort. Urinary urgency (UU) was present in 42%, 
nocturia in 17.6%, urgency urinary incontinence (UUI) in 12.4%, and stress urinary 
incontinence (SUI) in 19.7% of participants.  Overall prepregnancy UI was reported by 
24% of participants. One third of participants had clinically significant symptoms, where 
higher severity was associated with higher grade of bother score due to symptoms. UI 
had the following distribution by types: SUI/UUI/MUI (mixed urinary incontinence) – 
50%/30%/20%.  There could be an opinion that findings reported in the present study 
are unrealistically high, taking into account that these women have never been pregnant 
and childbearing is considered one of the most important risk factors. However, the 
results obtained in the current research on UI correlated very well with the above 
mentioned NHANES and EPINCONT studies, and the results regarding overactive bladder 
(OAB) symptoms were in line with the FINNO study prevalence of OAB for the general 
population131. Additionally, several studies have demonstrated that UI and prolapse are 
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not exclusively observed in parous women.  A good example, as mentioned in previous 
chapters, is Bucshbaum’s study investigating PFD in parous / nulliparous sets of 
identical twins86. Another study assessed the prevalence of SUI in young, nulliparous, 
and physically fit students. They reported a 38% rate of SUI and 15% of urethral 
sphincter incompetence159.   
 
On analysing postnatal UD, it was noticed that the prevalence rose compared to 
prepregnancy UD. Postnatally 73% of participants had at least one primary symptom of 
UD, of which 25% were severe.  Postnatal UI was present in 54% of participants with 
SUI/UUI/MUI ratios being slightly changed in favour of MUI with a drop in UUI rate: 
44%/15%/41%. It is interesting to mention, that 63% of all incontinent women had 
postnatal Denovo onset Pelvic Floor Dysfunction symptoms (DNPFD), whereas in those 
with severe UI the rate of DNPFD and Persistent prepregnancy onset PFD (PPFD)  
symptoms was similar, which means that a higher rate of severe UI was noticed in the 
PPFD group. In the PPFD group prepregnancy UUI persisted in 70%, UU in 74% and SUI 
in 83% postnatally, whereas they worsened in 16% only. Symptoms related to OAB: 
frequency nocturia and urgency, in contrast to UI, were more prevalent in PPFD group. 
However, the same group of symptoms was most prone to worsen as a result of difficult 
vaginal delivery and had maximum protection from an elective CS. 
 
7.2    Faecal dysfunction (FD) 
 
Although this study is not the first to describe bowel related problems in nulliparous 
women57, it is one of most comprehensive studies to date, covering a large spectrum of 
bowel disorders, with previous studies primarily focusing on FI. FD before first 
pregnancy and delivery was present in 41% of participants, where nearly half of them 
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had clinically significant symptoms. The prepregnancy FD section had the highest 
median score for symptoms and highest occurrence of bother among all sections. 
Bothersome symptoms were reported by 26% of study participants. FI was reported by 
5.3%, flatus incontinence (Fl.I.) by 36.8%, and obstructed defaecation (OD) by 5.5%.  
 
Postnatal anal sphincter disruption with FI has an obvious association with traumatic 
instrumental vaginal delivery. However this was not the case for prepregnancy 
pathology and other types of bowel dysfunction. As described in previous chapters, there 
is no statistical difference in prevalence of OD due to rectocele, enterocele, 
intussusception and anismus among nulliparous women, those who have had vaginal 
delivery or CS82. Dietz and Clarke have examined 178 nulliparous young women using 
3D ultrasound for rectovaginal septal integrity. Twelve percent showed signs of 
rectocele with disruption of septal integrity. As a result the authors hypothesised that 
the problem could be congenitally determined54.  
 
At one year postnatally the prevalence of FD has not changed dramatically, 49% 
reporting FD symptoms of which 21% had severe symptoms. FI and OD were most 
prevalent in the DNPFD group, whereas Fl.I in the PPFD. Overall prepregnancy FD 
persisted postnatally in 50%, where they worsened in 15% only. Vacuum delivery and 
CS were associated with a decreased risk of FD.  
 
7.3    Pelvic Organ Prolapse (POP) 
 
In the present study POP symptoms were not widespread in nulliparous women, with 
4.8% (70) of participants only reporting them. However in 26% (18) of participants they 
were clinically significant. The most commonly reported symptom was “vaginal pressure 
or heaviness” – 3.3%. Postnatally POP symptoms were reported by 14% of participants, 
176 
 
which in 20% of cases were severe. The most prevalent were “Vaginal pressure or 
heaviness” reported by 11% and prolapse sensation by 7% of participants.  
Interestingly, various types of prolapse appeared to be very prevalent in young 
primiparous women on POP-Q assessment. Cystocele was present in 90% (grade 2 in 
58%), rectocele in 70% (grade 2 in 23%), and uterine prolapse in 88% (grade 2 in 1%).  
In the majority of cases it was asymptomatic. The POP tended to present as a 
combination of various types of prolapse, with the most prevalent combination being 
uterine prolapse and cystocele (20%).  
 
The prevalence of POP in nulliparous and primiparous women has been reported 
previously. As it has been shown earlier, in absence of any obvious risk factors UI is 
present in every fifth woman and asymptomatic prolapse stage two or less in every 
second young and physically fit women84. As well, POP is associated with operations for 
abdominal hernias and varicose veins and chronic pulmonary disease, where weak 
collagen may be a congenital risk factor for POP in up to one third of women98. Thus, 
familial predisposition might play an important role in the development of UI and POP85, 
160. This aetiological aspect of collagen abnormality and congenital RFs was tested in the 
present study. I found that collagen type III had a higher concentration in women with 
uterine prolapse and no association was found with cystocele and rectocele. 
Additionally, an association was found between joint hypermobility score with rectocele 
and composite prolapse score – summing up all prolapse types present in the 
participant. An association was also found between various types of prolapse and family 
history of uterine prolapse, vertebral hernia, cystocele, and personal history of varicose 
veins, vertebral hernia and asthma.  
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The association between POP and levator ani muscle (LAM) avulsion is well 
recognised161. This aspect was also investigated in the present project. The results from 
3D transperineal scans showed that some sort of LAM avulsion was present in 30% of 
participants and in 14% a complete avulsion was diagnosed. In the multivariate logistic 
regression models forceps delivery was associated with a statistically significant 
increased odds of all types of prolapse, whereas CS was protective only for cystocele and 
rectocele, but not for uterine prolapse. Additionally POP was associated with 3rd degree 
perineal tear. No association was found with previously reported foetal birthweight, 
head circumference or long second stage of labour.  
 
7.3    Sexual dysfunction (SD) 
 
At least one primary symptom of SD was reported prenatally by 41% of participants, of 
which 27% were clinically significant. Dyspareunia had a prevalence of 31%, vaginal 
tightness/vaginismus – 25%, vaginal laxity - 5%. In the majority of cases dyspareunia 
was mild, with similar rates of superficial and deep types. SD has a reported prevalence 
of 19-50%58 in the general population. We could not identify studies specifically 
describing baseline SD in the nulliparous population. The majority of studies focused on 
prenatal versus postnatal sexual satisfaction or comparison of SD following different 
modes of delivery.  
 
As mentioned previously, endometriosis is more common in nulliparous women with 
dyspareunia being one of the leading symptoms89. This may partially explain the findings 
of the present study, as dyspareunia was the most commonly reported SD symptom 
affecting 1 in 3 nulliparous women.  An unexpected finding in our study was coital UI, 
present in 1.8% of respondents. These data are in keeping with a Danish population-
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based study, performed on a sample of 2860 randomly selected women, which showed a 
prevalence of coital incontinence in 2% of the general population and 12% in patients 
with UI133. Postnatal SD had a prevalence of 58%, with 18% of participants mentioning 
severe symptoms. Dyspareunia was reported by 44%, vaginismus by 29% and vaginal 
laxity underwent a dramatic increase to 21%. Similar rates and severity of superficial 
and deep dyspareunia were noticed in both DNPFD and PPFD groups. Prepregnancy 
symptoms overall persisted postnatally in 59% and worsened in 12% only. CS delivery 
was protective against SD. 
  
7.4    PFD as integrity 
 
This research project has shown that 70% of young non-pregnant women had baseline 
PFD before their first pregnancy and 90% after first childbirth. This is a surprisingly 
large number of women and it has never been described previously. The majority of 
women with prepregnancy PFD had a variation of symptoms but these symptoms were 
described as mild with low bothersome scores. However, the prepregnancy affected 
women constituted the majority of those who developed postnatal PFD. Moreover, 
prenatal PFD persisted in approximately 80% of cases postnatally. Postnatal PFD was 
more severe and more disturbing in those affected prepregnancy versus those with a 
Denovo postnatal condition.  
 
The majority of participants with PFD had multicompartment involvement. CS proved to 
be protective against urinary and prolapse dysfunction but with minimal effect on faecal 
and sexual postnatal pathology. Forceps delivery was a significant risk factor in the 
univariate analyses, however in the multivariate logistic regression analyses it remained 
statistically significant for POP only.  
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Data from the objective POP-Q assessment have shown further interesting findings. The 
majority of postnatal women had some sort of POP at 1 year postnatally, however only 
43% of them were symptomatic, with the majority of symptoms being mild.  
 
7.5   Strengths & limitations   
 
Strengths: 
 
The main strength of this study is the prospective design, large number of nulliparous 
patients within the cohort and the extensive and detailed characteristics and medical 
history of the participating women undertaken. In addition, a validated, comprehensive 
questionnaire covering all areas of PFD was used, which in addition included questions 
regarding the severity or bothersome nature of symptoms and the impact of PFD on 
patients’ daily living. The nulliparous cohort recruited for the present research project, 
was shown to be likely to represent the population in general. The research population 
was very homogenous, consisting of nulliparous women, with the majority being 
relatively young (83% <34 years old) and Caucasian (99%). There are numerous studies 
mentioning interracial differences in pelvic floor anatomy and prevalence of PFD 8, 137, 
162-163. White women are considered more prone to develop prolapse and UI. This point 
confers extra strength to our study, by giving robust information on the magnitude of 
PFD prevalence in a nulliparous Caucasian population, without confounding interracial 
factors. Additionally, all participants were delivered in the same hospital using similar 
obstetric approaches and protocols, what excludes a possible obstetric management 
confounder. More than a quarter of participants attended for clinical follow up to 
confirm the questionnaire based findings. In the present study data regarding pelvic 
floor status were collected in early first pregnancy and at one year postnatally. By 
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comparing these findings the real impact of childbearing on pelvic floor morbidity could 
be estimated and help to elucidate the natural history PFD. 
 
Limitations: 
 
This was an opportunistic study using the SCOPE Ireland cohort study. A power 
calculation could not be performed as a result. Although the majority of previous PFD 
studies have a similar number of participants (≈ 00-1500 in average) to the present 
study, the present project demonstrated that in some cases our numbers were not large 
enough to achieve adequate statistical power. Particularly this was seen in the second 
paper, when assessing the effect of the mode of delivery on worsening of some particular 
persistent symptoms postnatally. However, this could guide future studies on sample 
size planning and power calculation.  
 
Another limitation is the high attrition rate. It may appear at a glance that the clinical 
follow up of 4P-Study was attended only by 8.5% (202) of participants from the total 
number of recruited for the SCOPE Ireland study (2579). However it is necessary to 
mention that the two studies were not connected and simply shared the same cohort of 
participants.  From those recruited for the 4P-Study (1484) the final clinical follow up 
was attended by 13.6% (202), or 23% from those eligible - who completed the 
prepregnancy and postnatal questionnaire and constituted the core of the study. Such a 
low figure can be explained by the fact that 26% (394) of participants were already 
pregnant in their next pregnancy and another 28% (424) did not answer the second 
questionnaire, making them ineligible for clinical follow up. This is always a risk in 
attempting to survey women within the first year of childbirth. 
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The SCOPE cohort, which is likely to be representative for the entire population 
(discussed in the limitations section of paper 1), was used as a benchmark to compare 
with the demographic characteristics of the 4P-Study participants at different research 
stages. The difference in demographic characteristics between SCOPE Ireland and 4P-
study participants never exceeded 3% (Table 6.1), which demonstrates that even the 
smallest group of 202 participants who attended the clinical follow up study had similar 
characteristics to the participants from the SCOPE study and accordingly with the entire 
population. Albeit, it is important to mention that in the final stages the attrition rate 
within the 4P-Study was quite high and the final obtained data may not be 
representative to the entire population.  The Australian Pelvic Floor Questionnaire is a 
comprehensive tool for the assessment of PFD, however some of its questions are not 
very well focussed. Additionally, its symptom’s severity grading system is suboptimal for 
differentiating mild pathology from symptoms occurring occasionally. Grade one 
severity (mild), is asking if the symptom is present less than once a week and this could 
result in a large spectrum of interpretations. Although the International Continence 
Society does not specify the frequency of symptoms while defining incontinence, many 
researchers would report only symptoms occurring once a month or less as presence of 
disease.  However despite this limitation, our findings are in line with previous studies. 
Also participants completed prenatal questionnaires in early pregnancy, where there is a 
potential for confusion reporting prepregnancy symptoms incorrectly. However, this 
issue was dealt with and it was demonstrated in the first and second studies that the 
chance of recall bias is minimal. It has been shown previously that remembering an 
important health event is not prone to be affected by recall bias138. Additionally, it is 
worth mentioning that this is a common limitation in observational research. Another 
limitation is the fact that patients were not clinically examined at recruitment to verify 
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questionnaire findings, since symptoms from different compartments may coexist and 
overlap. Also, it should be acknowledged that it is not possible to exclude that some risk 
factors did not reach statistical significance in the multivariate logistic regression models 
due to the limited number of observations for some outcomes, as well as the fact that 
some risk factors could become significant due to chance, considering that so many risk 
factors were included in the analysis simultaneously.   
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Conclusion 
 
CHAPTER 8:   Conclusion 
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This research project confirmed the previously reported high prevalence of PFD in 
nulliparous women. Additionally, it has shown that there is a larger spectrum of 
symptoms than those reported previously in women who have not yet embarked on 
their first pregnancy. Up to a quarter of these women had bothersome symptoms. The 
most common symptoms were urinary and faecal urgency and frequency, incomplete 
bladder and bowel evacuation, weak stream, UI, defaecation straining, constipation, 
vaginal heaviness and dyspareunia. The majority of nulliparous women with PFD had 
multicompartment involvement. Sometimes symptoms from different compartments 
may overlap with a potential of misdiagnosis. For this reason a comprehensive 
investigation of PFD is required, in order to identify and treat the real causative factor. 
The majority of prepregnancy symptoms persisted postnatally, however only 10 to 15 
percent of them worsened as a result of first childbirth. The main damage to the pelvic 
floor was probably done before the first pregnancy and can be attributed to intrinsic 
pelvic floor weakness. The group of patients with Prepregnancy Persistent PFD (PPFD) 
had a higher prevalence of severe and bothersome symptoms compared to Denovo      
postnatal onset PFD (DNPFD). In the logistic regression models CS delivery seemed to 
have a higher protective effect on preventing postnatal worsening of prepregnancy 
symptoms compared to DNPFD. Interestingly, this finding had a higher magnitude in the 
case of OAB compared to SUI. Vaginal delivery, including instrumental, did not increase 
the risk of PFD, apart from prolapse section, which was mostly affected by forceps 
delivery. In contrast to vaginal delivery, CS delivery was protective for all types of PFD.   
POP was an extremely common finding in the present study. On POP-Q assessment some 
degree of POP was present in 90% of participants who attended for clinical follow up, 
with no cases of prolapse bigger than grade 2 and very few only being symptomatic. The 
majority of participants with POP had multicompartment involvement in different 
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combinations. Although POP-Q is a very comprehensive classification system, it does not 
define clinically meaningful prolapse and a revision from this point of view would be 
very welcome by practicing clinicians. There was a significant association between 
uterine prolapse and high collagen type III levels. The same association was obtained for 
presence of family history for a set of collagen related medical conditions, as well as with 
joint hypermobility. All these findings are very suggestive of congenital contribution to 
the aetiology of POP and could lead to development of prevention strategies. CS delivery 
seems to be protective for development of cystocele and rectocele, but not for uterine 
prolapse.  
 
3D-Transperineal scan is a very efficient and novel methodology in detecting pelvic floor 
trauma. Some degree of LAM trauma was detected in 1:3 women after the first 
childbearing. A complete LAM avulsion was diagnosed in 1:6 participants, most 
commonly on the right side. LAM trauma was associated with POP presence and POP 
related symptoms. Also it was positively associated with forceps delivery and its risk 
being reduced by CS. No statistically significant link was found between LAM trauma and 
family history of collagen disease, and collagen levels.  
 
Recommendations for future research: 
 
This study could potentially have a big impact on future PFD research in nulliparous 
women. To our knowledge, this is the first study comprehensively describing PFD in all 
four compartments, specifically in nulliparous women. The prevalence findings could 
well contribute to the planning of future studies investigating various symptoms of PFD 
before and after first childbearing. A research group have already contacted us after the 
first publications to inquire about additional details, in order to design their study.  
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In the present work for the first time it was outlined that more than half of postnatal PFD 
in primiparous women has a prepregnancy origin, while the first childbearing has a 
negative impact on 15% of cases only of persistent PFD. These patients should be the 
main target population for future research, since this is the group where the most 
significant protection from CS could be expected. The present study was suggestive of 
this, however the sample size was too small to achieve statistical significance and to 
investigate characteristics specifically of these women. LAM trauma is a potential 
confounder for appearance of prolapse symptoms and this should be taken in 
consideration in the future. Additionally, the potential protective effect of CS delivery on 
persistent OAB, and development of cystocele and rectocele, needs confirmation in fu-
ture research and could potentially outline the group of patients who can benefit from it. 
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APPENDIX I: INTRODUCTION (CHAPTER 1) TABLES 
Abbreviations used in Appendix I  
UD – urinary dysfunction                         UI – urinary incontinence                                       VD – vaginal delivery 
FD – faecal dysfunction                            SUI  - stress urinary incontinence                         CS – Caesarean section 
POP – pelvic organ prolapse                   UUI – urge urinary incontinence 
SD – sexual dysfunction                            FI – faecal incontinence 
 
 
Table A-1.1:    Summary of the studies which investigated the prevalence and risk factors for various types of PFD before and after first           
                              pregnancy (continues over 6 pages) 
 
 
 
Author and date 
 
Sample 
 Size 
(N) 
 
Reported 
data 
classified 
by parity 
 
Types of 
PFD 
reported 
 
 
 
Summary of findings 
MacLennan, A.H., et al. 
(20006) 
3010 Yes UD 
FD 
POP 
SD 
Pelvic floor disorders are strongly associated with female gender, ageing, pregnancy, 
parity and instrumental delivery. Caesarean section (CS) vs. vaginal delivery (VD) does 
not offer significant reduction in long term pelvic floor morbidity. 
Hendrix, S. L., A. Clark, et 
al. (20028). 
27,432 No POP The prevalence of POP in WHI study is as following: uterine prolapse - 14.2%; cystocele 
- 34.3%; rectocele - 18.6%. Black women have the lowest risk for POP. Hispanic women 
have the highest risk for uterine prolapse. Parity and obesity are strongly associated 
with increased risk for uterine prolapse, cystocele, and rectocele 
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Casey, B. M., J. I. Schaffer, 
et al. (200510) 
3887 Yes UD The PFD at 7 months after delivery is greater in women who: received oxytocin, had a 
forceps delivery, had an infant weighing >4000 g. or who had an episiotomy performed. 
CS is partially protective for urge and stress UI. 
 
Skoner, M.M., W.D. 
Thompson,  and V.A. 
Caron (199411) 
140 No UD Main risk factors for stress urinary incontinence (SUI) are VD, episiotomy or tear during 
delivery (3.78-fold increase), family history of similar condition and multiple urinary 
tract infections. High parity (four or greater) is not a strong predictor 
 
Buchsbaum, G. M., M. 
Chin, et al. (200248) 
149 Yes UD Among assessed nulliparous nuns 30% had SUI, 24% UUI, 35% mixed UI, and 11% had 
urine loss unrelated to stress and urge. Significant risk factors (RFs) for UI were BMI, 
multiple urinary tract infections, and depression. Childbirth does not seem to be the 
only most significant RF for presence of urinary symptoms. 
 
Whitehead WE, Borrud L, 
Goode PS, et al. (200953) 
2229 No FD FD prevalence is 8.3% of which 6.2% is liquid stool,1.6% -, solid stool and 3.1% mucus. 
Prevalence increases from 2.6% in 20 to 29 year olds up to 15.3% in 70 years and older. 
FI is significantly associated with advancing age, loose or watery stools and urinary 
incontinence. Chronic diarrhea is a strong modifiable risk factor. 
Swift, S. (200555). Review No POP In some epidemiological studies up 80-90% of women have prolapse grade I to II on 
POP-Q assessment.  
 
Uustal Fornell, E., G. 
Wingren, et al. (200467). 
1340 No UD 
FD 
POP 
Women with UD are similarly likely to suffer from FD and POP and vice versa. Other 
associated factors for PFD were obesity, chronic bronchitis, VD and multiparity, age, 
heredity and diseases suggestive of collagen disorders.  
 
Rortveit, G., Y. S. 
Hannestad, et al. 
(200168). 
27,900 Yes UD Urinary incontinence (UI) was reported by 25% of participants. Prevalences among 
nulliparous women ranged from 8% to 32%, increasing with age. Only stress and mixed 
types of incontinence are associated with parity. All effects of parity seem to disappear 
in older age. 
 
Nygaard, I., et al. 
(200869) 
396 Yes UD 
FD 
POP 
 
Prevalence of PFD in nullips is 12.8%, UI 6.5%, faecal incontinence (FI) 6.3%, prolapse 
0.6% 
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O'Halloran, T., et al., 
(201270) 
1,002 Yes UD The rate of any UI in nulligravid women is 12.6%, incontinence being slightly more 
common in students 13.2%, with highest rates in students who are sexually active and 
using combined oral contraception 21.5% . 
 
Fonti Y, et al. (200971) Review No PFD Transitory postnatal pelvic floor changes may persist up to 6 months postnatally or 
even more. 
 
Chan, S.S., et al. (201272) 388 Yes UD 
FD 
The prevalence of SUI, urge urinary incontinence (UUI), and FI were 25.9 %, 8.2 %, and 
4.0 %, respectively, 12 months after delivery. VD, antenatal SUI, and UUI were 
associated with SUI; antenatal UUI and increasing maternal BMI at the first trimester 
were associated with UUI. Antenatal FI was associated with FI. Pregnancy, regardless of 
route of delivery and obstetric practice, had an effect on UI and FI. 
 
Torrisi, G., G. Minini, et al. 
(201273) 
744 Yes UD 
FD 
SD 
 
At 3 months postpartum the prevalence of UI is 21.6%, of FI-4.3% (3.2% - liquid; 1.1% 
solid incontinence), of flatal incontinence 12%,   New onset of UI or FI during 
pregnancy, positive family history and VD are independent risk factors for the 
persistence of symptoms of UI and FI in the early postpartum period. The sexual score 
improves in majority 3 months after delivery.  
 
Borello-France, D., et al. 
(200674) 
834 Yes UD 
FD 
In women delivered by CS, UI was reported in 22.9%, whereas FI in 7.6% at six months 
postpartum. 
 
Fritel, X., V. Ringa, et al. 
(201275). 
Review Yes UD  CS is associated with a lower rate of postpartum SUI and less need for surgical 
correction of SUI later in life.  Nevertheless, it is difficult to postulate this association as 
causal. 
 
Brown, S. J., S. Donath, et 
al. (201076) 
1,507 Yes UD Prevalence of UI before the index pregnancy was 10.8% increasing to 55.9% in the 
third trimester. SUI (36.9%) and mixed incontinence (MUI) (13.1%) were more 
common during pregnancy than urge incontinence (UI) alone (5.9%). UI before 
pregnancy was associated with childhood enuresis higher maternal and previous 
miscarriages or terminations. Occasional leakage (<1/ month) before pregnancy is the 
strongest predictor of UI in pregnancy (OR = 3.6, 95% CI 2.8-4.7).  
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Gartland, D., S. Donath, et 
al. (201277). 
1507 Yes UD Persistent UI at 9 months postanatlly has a prevalence of 25% . It is associated with 
presence of symptoms in pregnancy, prolonged labour in combination with operative 
vaginal birth.  
 
Svare, J. A., B. B. Hansen, 
et al. (201478) 
575 Yes UD UI at one year after the first VD is strongly associated with UI during the pregnancy and 
inversely associated with oxytocin augmentation. 
 
Ekstrom, A., D. Altman, et 
al. (200879) 
435 Yes UD A history of SUI before pregnancy (OR 5.2, 95% CI 1.5-19) and at 3 months follow-up 
(OR 3.9, 95% CI 1.7-8.5) is independent predictors for SUI at 9 months follow-up. VD is 
associated with an increased risk for lower urinary tract symptoms 9 months after 
childbirth when compared to elective CS. 
 
Laine K, Skjeldestad FE 
(201380) 
2846 Yes FD The lowest prevalence of FI was after a previous CS only (6.4%).  The highest - after 
previous delivery complicated by obstetric anal sphincter injury (24.4%). The 
prevalence of FI in nulliparous women was 7.7%, being associated to low educational 
level and comorbidity. Other RFS were increased with increasing parity and UI which 
was associated with anal incontinence in all parity groups.  
 
Brincat, C., C. Lewicky-
Gaupp, et al. (200981) 
 
240 Yes FD The prevalence of faecal incontinence at 12months postpartum is 5.4% 
Murad-Regadas, S. M. et 
al. (200982) 
105 Yes FD 
POP 
Presence of obstructed defaecation  due to: intussusception, anismus, sigmoidocele and 
enterocele is not influenced by parity (including nulliparity) or mode of delivery. 
 
Dietz, H.P. and K.P. Mann 
(201483) 
 
764 No POP ICS POP-Q staging system requires revision. Stage 1 prolapse of the anterior and 
posterior vaginal wall should probably be regarded as normal. Stage 1 uterine prolapse 
as currently defined seems highly relevant. 
 
Larsen, W.I. and Yavorek, 
T.A. (200684) 
144 Yes  
UD 
POP 
Fifty percent of participants had stage I or II POP, 19% reporting incontinence. 
Incontinence was associated running, and no risk factors were identified for prolapse. 
Prolapse stage I and II represents normal support. 
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Buchsbaum GM, Duecy 
EE. (200685) 
101 parous 
 
101 nullips 
 
Yes 
 
POP 
There is a 74.3% to 91.1% concordance by compartment in prolapse stage within 
nulliaprous and parous sister pairs. This high concordance of POP stages suggests a 
familial predisposition toward developing this condition. However, a more advanced 
risk POP is associated with VD. 
 
Buchsbaum GM, Duecy 
EE. (200886) 
101 parous 
 
101 nullips 
 
Yes 
UD 
POP 
All identical twins had identical continence status and pelvic support in all three 
compartments, regardless of mode of delivery or difference in parity. 
Shaw, C. (200287) systematic 
review 
No SD The reported prevalence of SD in general population varies between 0.6%-64%. Coital 
incontinence has a prevalence of 2% in community samples and 10% to 56% in clinical 
settings. 
 
Stones, R.W. et al. 
(200688) 
3,150 No SD Prevalence of dyspareunia in Chinese population is 4.7%. Dyspareunia is strongly 
associated with urinary symptoms, particularly in those with combined urinary urge 
and incontinence (26.8%). Dyspareunia is associated with early sexual debut, primary 
level of education, and membership of minority ethnic communities 
 
Bellelis, P., J. A. Dias, Jr., 
et al. (201089) 
892 Yes SD Chronic pelvic pain is the most prevalent symptom (56.8%) of endometriosis, followed 
by deep dyspareunia (57.4%). The majority (56.5%) of patients with endometriosis are 
nulliparous.  
 
Pastor, Z. (201390) systematic 
review 
No SD The reported prevalence of coital incontinence is 0.2-66%. It is usually caused by SUI. 
Urodynamic diagnoses of detrusor overactivity and SUI are observed in orgasmic 
incontinence. 
 
Hosseini, L., E. Iran-Pour, 
et al. (201291) 
114 VD 
99 CS 
Yes SD Two years postpartum there are no significant SD differences between women having 
CS and VD. This includes: desire, arousal, lubrication, orgasm, pain, and satisfaction. 
However to note, 80% of women having VD reported vaginal laxity. 
 
Klein, K., C. Worda, et al. 
(200992) 
55 
44 controls 
Yes SD Sexual function does not significantly differ at 12-18 months postnatally between 
women who had VD without episiotomy, heavy perineal laceration, or secondary 
operative interventions and women having elective CS 
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Connolly, A., J. Thorp, et 
al. (200593). 
150 Yes SD At 6 months postpartum 90% of the women had resumed intercourse, 17% of women 
reported dyspareunia; less than 5% described the pain as major, 61% of women 
reported orgasm. Delivery mode and episiotomy were not associated with intercourse 
resumption or anorgasmia; dyspareunia was only associated with breast-feeding at 12 
weeks (RR = 3.36, 95% CI = 1.77-6.37). Sexual function was described as similar to or 
improved over that prior to pregnancy. 
 
van Brummen, H.J., et al 
(200694) 
524 No SD Sexual satisfaction does not seem to be associated with antenatal and intrapartum 
factors. Sexual dissatisfaction at 1 year postpartum was related to sexuall activity in 
early pregnancy. 
 
Zorn, B. H., H. 
Montgomery, et al. 
(199995) 
115 UI 
80 controls 
N/A UD There is a strong association between depression and UI, where linking factor may be 
altered serotonin function. This may help explaining the efficacy of serotonergic 
antidepressants in the treatment of urge incontinence. 
 
Abramov, Y., P. K. Sand, 
et al. (200596) 
271 No FD Age, menopause, obesity, parity, and stress urinary incontinence are the major risk 
factors for female anal incontinence. Emergency CS after initiation of labor is associated 
with a lower prevalence of anal incontinence, whereas no anal incontinence is noted in 
women who had only elective CSs. 
 
Hojberg KE, Salvig JD, 
(200097) 
1726 No FD The general prevalence of FI is 8.6%, including: liquid FI 2.3% solid FI 0.6%, flatus 
incontinence at least once a week - 4.2%. The latter is associated with age > 35 years, 
previous lower abdominal or urological surgery, anal sphincter tear, birth weight > 4kg 
and episiotomy. Increasing parity, spontaneous perineal tear were not associated.  
 
Rinne, K. M. and P. P. 
Kirkinen (199998) 
85 No POP POP is associated with parity, foetal birth weight, operations of abdominal hernias and 
also had more chronic pulmonary disease, e.g. asthma However, POP is not associated 
with instrumental and preterm deliveries. About 30%. of patients with POP have 
familial history of similar condition.  
 
Sze, E.H. and G. Hobbs 
(201299) 
101 
 
164 controls 
Yes POP Vaginal birth has little effect on the pelvic support changes beyond the puerperium 
while menopause predisposes women to POP outside the hymen. 
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Table A-1.2:   Summary of the studies investigating anatomical changes of pelvic structures using transperineal ultrasound scan     
                             (continues over 2 pages) 
 
 
Author and date. 
 
Sample 
Size (N) 
 
 
Type of 
research 
 
 
Investigated 
structure  
 
Summary of findings 
Toozs-Hobson P, 
Balmforth J, et al. 
(200813) 
156 Risk factors LAM hiatal area 
measurement 
Bladder neck mobility 
 
Although VD is associated with more distensible levator hiatus and a 
greater degree of bladder neck mobility, these changes partially improve 
at 6 month compared to 6 weeks postnatally. 
Shek, K. L. and H. P. 
Dietz (201041) 
367 Risk factors LAM avulsion Vaginal delivery, forceps and a longer second stage increase the riskof 
levator trauma. Epidural pain relief may exert a protective effect. 
 
Dietz, H. P. and O. 
Lekskulchai 
(200742) 
735 Methodology 
& 
Reliability  
confirmation 
 
POP 
quantification 
Descent of the bladder on transperineal scan to > or = 10 mm and of the 
rectum to > or = 15 mm below the symphysis pubis are strongly 
associated with symptoms, and can be used as cut-offs for the diagnosis of 
significant prolapse. 
 
Dietz, H. P., C. Shek, 
et al. (200845). 
544 Methodology 
 
LAM distensibility 
detection 
A hiatal area of > 25 cm2 on Valsalva is defined as abnormal distensibility 
or 'ballooning' of the levator hiatus. 
Zhuang, R.R., et al 
(2011100) 
69 Reliability  
confirmation 
 
LAM avulsion 
Both MRI and 3D Tomographic perineal scan are reliable methods to 
assess LAM avulsion with good correlation between methods. 
 
Dietz, H.P., A. Abbu, 
and K.L. Shek 
(2008101) 
118 Methodology 
& 
Reliability  
Confirmation 
 
 
LAM avulsion detection 
Levator-urethral gap is a reproducible measurement and strongly 
associated with LAM avulsion trauma diagnosed on vaginal palpation. A 
cut-off of 25 mm may be used for the diagnosis of levator avulsion injury. 
Dietz, H.P., et al. 
(2011102) 
736 Methodology 
 
LAM avulsion detection Abnormality in three central slices on tomographic ultrasound  is 
diagnostic for complete avulsion of the puborectalis muscle.  
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Choi, S., S. S. Chan, et 
al. (2013103) 
27 Methodology 
& 
Reliability  
Confirmation 
 
 
Subpubic arch angle 
3DTUS is a reliable method to measure subpubic arch angle with 
satisfactory intra/inter operator repeatability and reproducibility.  
 
 
 
Braekken, I. H., M. 
Majida, et al. 
(2008104).  
17 Reliability  
confirmation 
LAM hiatal area 
measurement 
LAM thickness 
Bladder neck mobility 
 
Perineal ultrasound is a reliable method for quantification of morphology 
and function of the pelvic floor structures. 
Adisuroso, T., K. L. 
Shek, et al. (2012105) 
497 Reliability  
confirmation 
LAM avulsion The published methodology of minimal criteria for diagnosis of LAM 
avulsion is sufficiently robust for clinical practice and highly unlikely to 
cause false-positive diagnosis. 
 
Dietz HP (2013106) Review  LAM avulsion The reported prevalence of LAM avulsion in primiparous women is 12-
36% 
 
Albrich, S. B., R. M. 
Laterza, et al. 
(2012107) 
157 Risk factors LAM avulsion The risk of levator defect after vaginal delivery is >7 times higher than 
after caesarean section. However, emergency caesarean section do not 
completely prevent LAM trauma. 
 
Valsky, D. V., M. 
Lipschuetz, et al. 
(2009108). 
210 Prevalence  
& 
Risk factors 
LAM avulsion The prevalence of LAM trauma inprimiparas was 18.8%. The main risk 
factors were large foetal  head circumference and long second stage of 
labour. 
 
Shek, K. L., V. 
Chantarasorn, et al. 
(2012109) 
488 Clinical 
 follow up 
LAM avulsion 
 
LAM distensibility 
detection 
On comparing imaging data obtained at 3-6 months and 2-3 years 
postpartum there is no evidence of regression or healing of childbearing 
related changes to levator distensibility. However, it was documented 
anatomical improvement in two women diagnosed with levator avulsion 
at 3-6 months postpartum. 
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Table A-1.3:    Summary of the studies which investigated the association between pelvic organ prolapse and collagen abnormalities       
                              (continues over 2 pages) 
 
 
 
Author and date. 
 
Sample Size 
(N) 
 
 
Results 
significance 
 
Sampling 
side 
 
 
 
Summary of findings 
Jackson, S. R., N. C. Avery, 
et al. (199618) 
Not available Significant vaginal 
epithelium 
POP is associated with a reduction in total collagen content. Collagen turnover is up 
to four times higher in prolapse tissue. Collagen-type ratios, is similar in both groups. 
Increased collagenolytic activity causes loss of collagen from prolapse tissue. 
 
Keane, D. P., T. J. Sims, et 
al.(199720) 
36 SUI 
25 Controls 
Significant periurethral 
Tissue 
There is significantly less collagen in the tissues of nulliparous women with SUI. In 
addition, there was a decreased ratio of type I to type III collagen. 
 
Edwall, L., K. Carlstrom, 
et al (200821) 
48 POP 
28 controls 
Significant urogenital 
tissue 
In women with POP there is higher tissue concentrations of PICP (procollagen type I 
carboxyterminal) and especially PIIINP (procollagen type III aminoterminal), 
suggesting an increased collagen breakdown in POP. There is a different pattern in 
case of SUI without POP, where tissue levels of collagen turnover markers are low, 
indicating reduced collagen breakdown. 
 
Knuuti, E., S. Kauppila, et 
al. (201146) 
43 Significant blood serum Recurrent genital prolapse is more common in women with joint hypermobility as 
compared to normal mobility. Plain hypermobility is associated with higher 
concentrations for PICP, whereas combination of recurrent prolapse and joint 
hypermobility with PIIINP. 
 
 
Ewies, A. A., F. Al-Azzawi, 
et al. (2003110) 
25 POP 
25 controls 
Significant cardinal 
ligaments 
In women with prolpase there is higher expression of collagen III and tenascin, and 
lower quantities of elastin. Collagen I expression is directly related to the age and 
menopausal status rather than to prolapse. In contrast collagen III expression is 
directly related to the presence of POP rather than age or menopausal status and is 
suppressed with the use of HRT. 
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Gabriel, B., D. Denschlag, 
et al. (2005111) 
25 POP 
16 controls 
Significant uterosacral 
ligaments 
In women with POP there is no difference in collagen I expression as compared to 
those without POP, whereas the collagen III expression was significantly related to 
the presence of POP rather than age or parity. The higher collagen III expression 
might be a typical characteristic of POP patients' connective tissue. 
 
Lauer-Fields JL, Juska D, 
(2002112) 
Review N/A Conjunctive 
tissue 
The matrix metalloproteinase (MMP) is implicated in tissue remodeling in different 
diseases associated with abnormal turnover of extracellular matrix components. 
Substrate flexibility, MMP active sites, and MMP exosites all contribute to collagen 
degradation.  
 
Skorupski P, Jankiewicz 
K, (2013113) 
132 Significant Blood PCR 
gene 
polymorphism 
assessment 
A combination of effects of MMP-1 and -MMP-3 may play a role in the development 
of POP. 
Friedman, D. W., C. D. 
Boyd, et al. (1993114). 
9 inguinal 
hernia 
15 controls 
Significant skin 
fibroblasts 
A constitutive and systemic increase in type III collagen synthesis may result in 
reduced collagen fibril assembly in the abdominal wall, eventually leading to the 
development of herniation 
 
Strohbehn, K., J. A. Jakary, 
et al. (1997115) 
647 Significant N/A Younger women with POP compared to older once have higher than expected 
prevalence of congenital anomalies, as well as rheumatologic and neurologic 
diseases. 
 
Lammers, K., S. L. Lince, 
et al. (2012116) 
110 POP 
110 controls 
Significant N/A Patients with POP have a higher prevalence of varicose veins, joint hypermobility, 
rectal prolapse and family members with POP as compared to the controls.  POP and 
other collagen-associated disorders may have a common aetiology, being related to 
the levels of the collagens. 
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Appendix II: STARD flowchart indicating recruited numbers recruited Numbers 
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Appendix III: Prepregnancy Australian Pelvic Floor Questionnaire (Page1) 
Appendix i: Prepregnancy Australian Pelvic Floor Questionnaire (Page1) 
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 Appendix III: Prepregnancy Australian Pelvic Floor Questionnaire (Page2) 
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Appendix IV: Postnatal Australian Pelvic Floor Questionnaire (Page1) 
Appendix ii: Postnatal Australian Pelvic Floor Questionnaire (Page1) 
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Appendix IV: Postnatal Australian Pelvic Floor Questionnaire (Page2) 
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Appendix V: Study 2 results not included in the article 
 
An increase in postnatal prevalence of PFD was detected in all 4 sections of the 
questionnaire.  
Table A - 5.1    Prepregnancy prevalence and postnatal change of urinary symptoms 
 
  Prepregnancy Increase Postnatally 
  N % 
  
N % 
 
Urinary Frequency 192 26,5 % 
 
147 20,2 % 
Nocturia  112 15,5 % 
 
65 8,9 % 
Nocturnal enuresis 2 0.3 % 
 
4 0.5 % 
Urgency 294 40,6 % 
 
357 49,0 % 
Urge Incontinence 88 12,2 % x 2.5 215 29,5 % 
Stress Incontinence 135 18,7 % x 2.3 321 44,0 % 
Weak Stream 164 22,7 % 
 
171 23,5 % 
Incomplete Bladder Emptying 167 23,1 % 
 
206 28,3 % 
Strain to Empty 87 12,0 % 
 
108 14,8 % 
Pad Usage 46 6,4 % x 2.2 102 14,0 % 
Reduced Fluid Intake 33 4,6 % 
 
44 6,0 % 
Recurrent UTI 89 12,3 % 
 
70 9,6 % 
Dysuria  71 9,8 % 
 
58 8,0 % 
Impact on Social Life 32 4,4 
 
x 2 61 8,4 % 
Bladder - How much of a bother 73 10,1 % x 2 149 20,4 % 
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Table A - 5.2    Prepregnancy prevalence and postnatal change of faecal symptoms 
 
  Pre-Pregnancy 
 
Postnatally 
  N % 
  
N % 
 
Defaecation   Frequency  126 17,5 % 
 
95 13,0 % 
Consistency of Bowel 
Motion 
374 51,9 % 
 
369 50,6 % 
Defaecation   Straining 428 59,2 % 
 
447 61,4 % 
Laxative Use 56 7,7 % 
 
53 7,3 % 
Do You Feel Constipated 378 52,4 % 
 
343 47,1 % 
Flatus incontinence 276 38,3 % 
 
330 45,3 % 
Faecal      Urgency 345 47,9 % 
 
395 54,2 % 
Faecal      Incontinence with 
diarrhoea 
31 4,3 % 
 
57 7,8 % 
Faecal      Incontinence with 
normal stool 
5 0.7 % 
 
12 1,6 % 
Incomplete Bowel 
Evacuation 
308 42,6 % 
 
307 42,4 % 
Obstructed Defaecation   42 5,8 % 
 
44 6,1 % 
Bowel - How much of a 
bother 
194 26,9 % 
 
173 23,9 % 
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Table A - 5.3    Prepregnancy prevalence and postnatal change of sexual symptoms 
 
  Prepregnancy Increase Postnatally 
  N % 
  
N % 
 
Sexually active < 1/week 218 29,9 % 
 
6 0.8 % 
Sexually active >= 1/week 412 56,4 % 
 
321 44,0 % 
Sexually active most 
days/daily 
66 9,0 % 
 
321 44,0 % 
Sexually active /  No 21 2,9 % 
 
38 5,2 % 
Sufficient lubrication 127 17,7 % 
 
173 24,4 % 
Abnormal vaginal sensation 
during intercourse  
89 12,4 % x 1.7 150 21,1 % 
Vaginal Laxity 35 4,9 % x 4.2 148 20,6 % 
Vaginal tightness/vaginismus 187 26,2 % 
 
209 29,1 % 
Dyspareunia 230 32,1 % x 1.3 305 42,7 % 
Coital Incontinence 11 1,5 % x 3.2 35 4,9 % 
Sexual Function - How much of 
a bother 
67 9,3 % x 2.5 168 23,5 % 
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Table A - 5.4    Prepregnancy prevalence and postnatal change of prolapse symptoms 
 
  Prepregnancy Increase Postnatally 
  N % 
  
N % 
 
Prolapse sensation 8 1,1 % x 6 47 6,5 % 
Vaginal Pressure or heaviness 24 3,3 % x 3.5 81 11,2 % 
Prolapse reduction to void 3 0.4 % x 4.5 13 1,8 % 
Prolapse reduction to defaecate 11 1,5 %  15 2,1 % 
Prolapse - How much of a bother 7 1,0 % x 4.0 29 4,0 % 
 
 
In the urinary dysfunction section the prevalence of prepregnancy symptoms remained 
unchanged postnatally with the exception of urinary and urge incontinence, which 
increased 2 - 2.5 fold. In the faecal dysfunction section nearly similar prevalence of 
prepregnancy and postnatal symptoms was noted. Amazingly high prevalence of some 
sexual symptoms like vaginal laxity or dyspareunia was noted prepregnancy. Their 
prevalence increased 2 to 4 fold postnatally.  Prolapse symptoms were not very common 
in nulliparous women and, as expected, significantly increased in prevalence postnatally 
reaching a 3 to 6 fold increase. A noticeable increase of prevalence bother due to 
symptoms was noted postnatally in all sections apart from faecal dysfunction, where it 
remained unchanged.  
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Additionally it was found a very high persistence of prenatal symptoms postnatally. 
 
Figure A - 5.1    The persistence rate of prepregnancy symptoms postnatally  
(Persistent symptoms in dark) 
 
 
 
 
The figure above indicates the persistence of prepregnancy pathology postnatally within 
each section. The analysis was based here on section score. As shown in the figure, the 
majority of pre pregnancy PFD persisted postnatally. The only exception was prolapse 
dysfunction, where pathology persisted in less than half of cases. 
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In order to better elucidate the structure of postnatal symptoms, the total postnatal 
pathology was divided into two groups:   
 
1) The Persistent Prenatal PFD (PPFD) – where symptoms were present 
prepregnancy and persisted postnatally. 
2) DeNovo onset postnatal PFD (DN PFD) – where participants were asymptomatic 
prepregnancy and first noticed symptoms after delivery. 
 
Figure A - 5.2    Relationship between PPFD and DNPFD in the structure of postnatal      
                               pathology 
A predominance of PPFD postnatal symptoms over DNPFD was discovered in all sections 
apart from prolapse section.  
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The severity of postnatal symptoms was compared between the two groups.   
Figure A - 5.3    Comparison of severity of PPFD and DNPFD symptoms  
 
 
 
 
 
 
 
It was established that he median section severity score was higher in the PPFD Group 
comparing to DN PFD. Prolapse section was not included in analysis due to very low 
prevalence of symptoms in the prepregnancy group 
 
Similarly the bothersome incidence was 2-3 folds higher in the PPFD group (apart from 
the bowel section), as well as the grade of bothersome was overall higher in the PPFD 
pathology, where more participants complained of grade 2 and 3 bothersome due to the 
presence of symptoms. 
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Table A - 5.5    Comparison of bother prevalence and grade 
 
Bother 
grade 
Bothered * 
prenatally 
Bothered * 
postnatally 
Postnatal Denovo      
bothersome * 
Postnatal 
Persistent 
bothersome * 
  Urinary dysfunction 
1 63(86%) 123(83%) 94(90%) 27(64%) 
2 8(11%) 23(15%) 9(9%) 13(31%) 
3 2(3%) 3(2%) 1(1%) 2(5%) 
Tot. 
Bothered** 
73(10%) 149(20%) 104 (70%) 42(58%) 
  Faecal      dysfunction 
1 148(76%) 135(78%) 62(83%) 71(74%) 
2 36(19%) 31(18%) 11(15%) 20(21%) 
3 10(5%) 7(4%) 2(3%) 5(5%) 
Tot. 
Bothered** 
194(27%) 173(24%) 75(43%) 96(51%) 
  Prolapse dysfunction 
1 4(57%) 18(62%) 15(63%) 1(33%) 
2 3(43%) 6(21%) 4(17%) 2(67%) 
3 0 5(17%) 5(21%) 0 
Tot. 
Bothered** 
7(1%) 29(4%) 24(83%%) 3(50%) 
  Sexual dysfunction 
1 51(76%) 126(75%) 102(78%) 21(62%) 
2 13(19%) 31(18%) 21(16%) 10(29%) 
3 3(4%) 11(7%) 8(6%) 3(9%) 
Tot. 
Bothered** 
67(9%)  168(24%)  131(78%)  34(51%)  
 
*     Out of total bothered in the group  
**    Out of total symptomatic PFD  
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Appendix VI: Medical conditions associated with POP and PFD 
 
  Medical conditions associated with POP and PFD 
  1 Joint hypermobility (Double jointed) 
2 Varicose vein disease 
3 Stretch marks  / stria  of the skin 
4 Uterine prolapse / womb collapse  
5 Bladder prolapse / collapse 
6 Bowel prolapse / collapse 
7 Stress Urinary Incontinence 
8 Urge Urinary Incontinence 
9 Obstructed Defaecation  (Incomplete bowel emptying) 
10 Chronic Obstructive Pulmonary Disease (COPD) 
11 Asthma 
12 Bronchectatic disease 
13 Chronic cough 
14 Mitral valve prolapse 
15 Presence of various hernias 
16 Operation for  hernias 
17 Spine disks dislodgment (Vertebral hernia) 
18 Polycystic Ovary Syndrome (PCO) 
19 Hyperinsulinemia 
20 Diabetes Mellitus Type 1 
21 Diabetes Mellitus Type 2 
22 Diabetes Mellitus unknown type 
23 Ehlers-Danlos syndrome 
24 Marfan’s syndrome 
25 Achard syndrome 
26 Osteogenesis Imperfecta 
27 Homocystinuria 
28 Systemic lupus erythematosus (SLE or lupus) 
29 Rheumatoid arthritis (RA) 
30 Polymyositis 
31 Dermatomyositis 
32 Systemic sclerosis (scleroderma) 
33 Sjogren’s syndrome 
34 Mixed connective tissue disease 
35 Dupuytren's contracture 
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